
<html lang="en"     class="pb-page"  data-request-id="df500d6b-4a69-4fde-8041-440c92cd84de"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00151;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition" /></meta><meta name="dc.Creator" content="Seung-Hwa  Kwak" /></meta><meta name="dc.Creator" content="Tesia N.  Stephenson" /></meta><meta name="dc.Creator" content="Hye-Eun  Lee" /></meta><meta name="dc.Creator" content="Yun  Ge" /></meta><meta name="dc.Creator" content="Hyunji  Lee" /></meta><meta name="dc.Creator" content="Sophia M.  Min" /></meta><meta name="dc.Creator" content="Jea Hyun  Kim" /></meta><meta name="dc.Creator" content="Do-Yeon  Kwon" /></meta><meta name="dc.Creator" content="You Mie  Lee" /></meta><meta name="dc.Creator" content="Jiyong  Hong" /></meta><meta name="dc.Description" content="Tumors adapt to hypoxia by regulating angiogenesis, metastatic potential, and metabolism. These adaptations mediated by hypoxia-inducible factor 1 (HIF-1) make tumors more aggressive and resistant ..." /></meta><meta name="Description" content="Tumors adapt to hypoxia by regulating angiogenesis, metastatic potential, and metabolism. These adaptations mediated by hypoxia-inducible factor 1 (HIF-1) make tumors more aggressive and resistant ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 24, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00151" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00151" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00151" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00151" /></link>
        
    
    

<title>Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00151" /></meta><meta property="og:title" content="Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0007.jpeg" /></meta><meta property="og:description" content="Tumors adapt to hypoxia by regulating angiogenesis, metastatic potential, and metabolism. These adaptations mediated by hypoxia-inducible factor 1 (HIF-1) make tumors more aggressive and resistant to chemotherapy and radiation. Therefore, HIF-1 is a validated therapeutic target for cancer. In order to develop new HIF-1 inhibitors for cancer chemotherapy by harnessing the potential of the natural product manassantin A, we synthesized and evaluated manassantin A analogues with modifications in the tetrahydrofuran core region of manassantin A. Our structure–activity relationship study indicated that the α,α′-trans-configuration of the central ring of manassantin A is critical to HIF-1 inhibition. We also demonstrated that a combination of manassantin A with an epidermal growth factor receptor inhibitor shows cooperative antitumor activity (∼80% inhibition for combination vs ∼30% inhibition for monotherapy). Our findings will provide important frameworks for the future therapeutic development of manassantin A-derived chemotherapeutic agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00151"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00151">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00151&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00151&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00151&amp;href=/doi/10.1021/acs.jmedchem.0c00151" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6821-6833</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00115" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00208" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Seung-Hwa Kwak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Seung-Hwa Kwak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Seung-Hwa++Kwak">Seung-Hwa Kwak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tesia N. Stephenson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tesia N. Stephenson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tesia+N.++Stephenson">Tesia N. Stephenson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hye-Eun Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hye-Eun Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hye-Eun++Lee">Hye-Eun Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yun Ge</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yun Ge</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Ge">Yun Ge</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hyunji Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hyunji Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hyunji++Lee">Hyunji Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sophia M. Min</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sophia M. Min</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sophia+M.++Min">Sophia M. Min</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jea Hyun Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jea Hyun Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jea+Hyun++Kim">Jea Hyun Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Do-Yeon Kwon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Do-Yeon Kwon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Do-Yeon++Kwon">Do-Yeon Kwon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">You Mie Lee</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">You Mie Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#0d6174604d666378236c6e23667f"><span class="__cf_email__" data-cfemail="caa6b3a78aa1a4bfe4aba9e4a1b8">[email protected]</span></a>. Tel: 82-53-950-8566. Fax: 82-53-950-8557.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=You+Mie++Lee">You Mie Lee</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5756-7169" title="Orcid link">http://orcid.org/0000-0002-5756-7169</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jiyong Hong</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiyong Hong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Duke University, Durham, North Carolina 27708, United States</div><div class="loa-info-affiliations-info">Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#513b38283e3f367f393e3f361135243a347f343524"><span class="__cf_email__" data-cfemail="90faf9e9fffef7bef8fffef7d0f4e5fbf5bef5f4e5">[email protected]</span></a>. Tel: 1-919-660-1545. Fax: 1-919-660-1605.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiyong++Hong">Jiyong Hong</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5253-0949" title="Orcid link">http://orcid.org/0000-0002-5253-0949</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00151&amp;href=/doi/10.1021%2Facs.jmedchem.0c00151" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6821–6833</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 24, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 February 2020</li><li><span class="item_label"><b>Published</b> online</span>24 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00151" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00151</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6821%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSeung-Hwa%2BKwak%252C%2BTesia%2BN.%2BStephenson%252C%2BHye-Eun%2BLee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D13%26contentID%3Dacs.jmedchem.0c00151%26title%3DEvaluation%2Bof%2BManassantin%2BA%2BTetrahydrofuran%2BCore%2BRegion%2BAnalogues%2Band%2BCooperative%2BTherapeutic%2BEffects%2Bwith%2BEGFR%2BInhibition%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6833%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00151"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">856</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00151" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Seung-Hwa&quot;,&quot;last_name&quot;:&quot;Kwak&quot;},{&quot;first_name&quot;:&quot;Tesia&quot;,&quot;last_name&quot;:&quot;N. Stephenson&quot;},{&quot;first_name&quot;:&quot;Hye-Eun&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Ge&quot;},{&quot;first_name&quot;:&quot;Hyunji&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Sophia&quot;,&quot;last_name&quot;:&quot;M. Min&quot;},{&quot;first_name&quot;:&quot;Jea&quot;,&quot;last_name&quot;:&quot;Hyun Kim&quot;},{&quot;first_name&quot;:&quot;Do-Yeon&quot;,&quot;last_name&quot;:&quot;Kwon&quot;},{&quot;first_name&quot;:&quot;You&quot;,&quot;last_name&quot;:&quot;Mie Lee&quot;},{&quot;first_name&quot;:&quot;Jiyong&quot;,&quot;last_name&quot;:&quot;Hong&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6821-6833&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00151&quot;},&quot;abstract&quot;:&quot;Tumors adapt to hypoxia by regulating angiogenesis, metastatic potential, and metabolism. These adaptations mediated by hypoxia-inducible factor 1 (HIF-1) make tumors more aggressive and resistant to chemotherapy and radiation. Therefore, HIF-1 is a validated therapeutic target for cancer. In order to develop new HIF-1 inhibitors for cancer chemotherapy by harnessing the potential of the natural product manassantin A, we synthesized and evaluated manassantin A analogues with modifications in the tetrahydrofuran core region of manassantin A. Our structure–activity relationship study indicated that the α,α′-trans-configuration of the central ring of manassantin A is critical to HIF-1 inhibition. We also demonstrated that a combination of manassantin A with an epidermal growth factor receptor inhibitor shows cooperative antitumor activity (∼80% inhibition for combination vs ∼30% inhibition for monotherapy). Our findings will provide important frameworks for the future therapeutic development of manassantin A-der&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00151&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00151" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00151&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00151" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00151&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00151" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00151&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00151&amp;href=/doi/10.1021/acs.jmedchem.0c00151" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00151" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00151" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00151%26sid%3Dliteratum%253Aachs%26pmid%3D32579356%26genre%3Darticle%26aulast%3DKwak%26date%3D2020%26atitle%3DEvaluation%2Bof%2BManassantin%2BA%2BTetrahydrofuran%2BCore%2BRegion%2BAnalogues%2Band%2BCooperative%2BTherapeutic%2BEffects%2Bwith%2BEGFR%2BInhibition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D13%26spage%3D6821%26epage%3D6833%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291235" title="Column chromatography">Column chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/jmcmar.2020.63.issue-13/20200709/jmcmar.2020.63.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tumors adapt to hypoxia by regulating angiogenesis, metastatic potential, and metabolism. These adaptations mediated by hypoxia-inducible factor 1 (HIF-1) make tumors more aggressive and resistant to chemotherapy and radiation. Therefore, HIF-1 is a validated therapeutic target for cancer. In order to develop new HIF-1 inhibitors for cancer chemotherapy by harnessing the potential of the natural product manassantin A, we synthesized and evaluated manassantin A analogues with modifications in the tetrahydrofuran core region of manassantin A. Our structure–activity relationship study indicated that the α,α′-<i>trans</i>-configuration of the central ring of manassantin A is critical to HIF-1 inhibition. We also demonstrated that a combination of manassantin A with an epidermal growth factor receptor inhibitor shows cooperative antitumor activity (∼80% inhibition for combination vs ∼30% inhibition for monotherapy). Our findings will provide important frameworks for the future therapeutic development of manassantin A-derived chemotherapeutic agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">According to estimates from the International Agency for Research on Cancer (IARC), there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide in 2018.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Globally, about 1 in 6 deaths is due to cancer. By 2040, the global burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths simply due to the growth and aging of the population. The exact global economic impact of cancer is unknown but is thought to be in the hundreds of billions of dollars per year. In the United States alone, the estimated direct medical cost for cancer in 2015 was $80 billion.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The estimated annual health care expenditure for cancer in Europe in 2014 was €83 billion (about $110 billion).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Therefore, there is an urgent need to develop effective treatment strategies for a wide range of cancers.</div><div class="NLM_p">The normal oxygen level in most mammalian tissues is 2–9%. However, hypoxia is defined by <2% of tissue oxygen levels, and it occurs in various pathological conditions, including cancer progression. Mammalian tissues utilize hypoxia-inducible factor 1 (HIF-1) to cope with the stress of hypoxia.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> HIF-1 is an α/β heterodimeric transcription factor<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and activates several hundred genes involved in angiogenesis (<i>VEGF</i>), glucose transport (<i>GLUT1</i>), glycolytic pathways (<i>LDH-A</i>), and other processes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">HIF-1 helps tumors adapt to hypoxia, subsequently making tumors more aggressive and resistant to chemotherapy and radiation,<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11">(7−11)</a> thereby resulting in poor clinical outcomes.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> Histological and clinical evidence suggests that HIF-1 is a promising drug target for cancer.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Thus, it is crucial to advance our understanding of the HIF-1 regulation in tumor development and progression, which will lead to significant therapeutic benefits. However, our understanding of HIF-1 regulation is still limited due to the complexity of HIF-1 regulatory mechanisms. Therefore, a need exists for chemical probes with novel mechanisms of action to delineate the regulatory mechanisms of HIF-1 and hypoxia signaling.</div><div class="NLM_p">The dineolignan manassantin A (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is a natural product isolated from an aquatic plant, <i>Saururuscernuus</i> L. (Saururaceae).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Manassantin A (<b>1</b>) is a potent inhibitor of HIF-1 activity (IC<sub>50</sub> ∼ 10 nM) <i>in vitro</i>.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Intrigued by the great potential of manassantin A as a HIF-1 chemical probe for studying the hypoxia signaling pathway, we devised a convergent synthetic route to manassantin A that is amenable to the development of manassantin A-derived chemical probes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Upon the completion of manassantin A synthesis, we evaluated the potential of manassantin A as a HIF-1 inhibitor. Manassantin A potently reduces the HIF-1α protein expression under hypoxia and significantly decreases the expression of hypoxia-induced HIF-1 downstream target genes, such as vascular endothelial growth factor (<i>VEGF</i>) and cyclin-dependent kinase 6 (<i>Cdk6</i>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Our preliminary structure–activity relationship (SAR) study of manassantin A analogues with modifications in the side chains identified potent manassantin A analogues with reduced structural complexity and increased ligand efficiency.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and SAR plan of manassantin A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In order to define the pharmacophore of manassantin A and develop analogues with increased potency and selectivity for future preclinical and clinical studies, it is required to define the role of the tetrahydrofuran (THF) core of manassantin A in HIF-1 inhibition. Herein, we describe our efforts toward the synthesis and SAR study of manassantin A analogues with modifications in the THF core region to guide the design of chemically more tractable manassantin A analogues for anticancer therapeutic development. We also report the cooperative antitumor activity of manassantin A with a clinically used epidermal growth factor receptor (EGFR) inhibitor.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Manassantin A (<b>1</b>) consists of two regions (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>): tetrahydrofuran (THF) core and side chain regions. Following our previous study on the role of the manassantin A side chain regions in the HIF-1 inhibition by <b>1</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> we envisioned the preparation of analogues with modifications in the THF core region in an effort to complete a comprehensive SAR of <b>1</b>. As the asymmetric synthesis of the THF core of <b>1</b> requires a lengthy synthetic sequence,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> we also aimed to identify manassantin A analogues with reduced structural complexity and improved chemical tractability. We anticipated that our effort would help understand the effect of ring type and size, conformation, heteroatom, and hydrogen bonding on the HIF-1 inhibition by <b>1</b>. Such information will allow structural modifications to increase specificity, decrease off-target effects, and improve drug performance.</div><div class="NLM_p">First, to evaluate the effect of the two methyl groups on HIF-1 inhibition, two tetrahydrofuran analogues (<b>4</b> and <b>11</b>) were designed. Since the C7 and C7′′′ ketone analogue of <b>1</b> was as potent as <b>1</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> we prepared the corresponding ketone analogues for SAR studies. Our previous synthesis of <b>1</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> provided the basis for the synthesis of the C8′′ monomethyl THF analogue <b>4</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A). Starting from the known monomethyl THF <b>2</b>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Bn deprotection followed by BEMP-mediated S<sub>N</sub>2-coupling of the resulting bis-phenol with the tosylate <b>3</b> provided the desired C8′′ monomethyl THF analogue <b>4</b> in 58% for two steps.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Analogues <b>4</b>, <b>11</b>, <b>15</b>, <b>20a</b>, and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd/C, H<sub>2</sub>, EtOAc/EtOH, 25 °C, 24 h, 71%; (b) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 83%; (c) methyl acrylate, Grubbs’ II, PMHS, toluene, 110 °C, 30 min, 130 °C, 12 h, 45%; (d) (<i>R</i>)-2-Me-CBS-oxazaborolidine, BH<sub>3</sub>·SMe<sub>2</sub>, THF, 0 °C, 30 min, 58%, 80% ee; (e) PPTS, toluene, 70 °C, 12 h, 86%; (f) <b>9</b>, <i>t</i>-BuLi, THF, −78 °C, 1 h, 20%; (g) BF<sub>3</sub>·OEt<sub>2</sub>, NaBH<sub>3</sub>CN, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>CN, −78 °C, 1 h, 49%; (h) TBAF, THF, 0–25 °C, 1 h, 88%; (i) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 25 °C, 1 h, 73%; (j) <b>9</b>, <i>n</i>-BuLi, THF, −78 °C, 4 h, 64%; (k) LiAlH<sub>4</sub>, THF, 0 to 25 °C, 10 min, 56%; (l) AuCl<sub>3</sub>, CH<sub>3</sub>CN, 25 °C, 10 min, 57%; (m) TBAF, THF, 0–25 °C, 10 min, 47%; (n) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1.5 h, 76%; (o) <b>9</b>, <i>t</i>-BuLi, THF, −78 °C, 6 h, 40%; (p) (<i>S</i>)-α,α-diphenyl-2-pyrrolidinemethanol, B(OMe)<sub>3</sub>, BH<sub>3</sub>·SMe<sub>2</sub>, THF, 25 °C, 1 h, 80%, 97% ee; (q) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −20 °C, 3 h; (r) RNH<sub>2</sub>, 25 °C, 12 h, (<b>19a</b>) 73%, (<b>19b</b>) 64%; (s) TBAF, THF, 0 to 25 °C, 10 min (R = allyl, 55%; R = Bn, 82%); (t) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 25 °C, 1 h, (<b>20a</b>) 72%, (<b>20b</b>) 26%; (u) Pd/C, H<sub>2</sub>, HOAc, 25 °C, 24 h, 50%.</p></p></figure><div class="NLM_p">To further simplify the structure of manassantin A (<b>1</b>), we prepared the C8′ and C8′′ desmethyl THF analogue <b>11</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B). The synthesis began with the cross-metathesis–isomerization<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> of the known allyl alcohol <b>5</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with methyl acrylate in the presence of Grubbs II and PMHS to afford the γ-keto ester <b>6</b>. The Corey–Bakshi–Shibata (CBS) reduction<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> of <b>6</b> afforded the (<i>S</i>)-γ-hydroxy alcohol <b>7</b> (80% ee).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The PPTS-catalyzed lactonization of <b>7</b> gave the lactone <b>8</b> in 86%, which was converted to the corresponding hemiketal by the addition of an aryl lithium reagent generated <i>in situ</i> from the aryl bromide <b>9</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The reductive deoxygenation<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> of the resulting hemiketal successfully provided the 2,5-<i>trans</i>-THF <b>10</b> as a single diastereomer (49%). The stereochemistry of <b>10</b> was determined to be <i>trans</i> by NMR analysis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> TBS deprotection and coupling of the resulting bis-phenol with <b>3</b> completed the synthesis of the C8′ and C8′′ desmethyl THF analogue <b>11</b>.</div><div class="NLM_p">To gain an insight into the role of the ring size in HIF-1 inhibition, we prepared the tetrahydropyran (THP) analogue <b>15</b> of <b>1</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C). Treatment of the Weinreb amide <b>12</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with <b>9</b> and <i>n</i>-BuLi followed by LiAlH<sub>4</sub> reduction of the resulting 1,5-diketone afforded the 1,5-diol <b>13</b> in 56% yield. Next, for the synthesis of the THP core, the Au(III)-catalyzed cyclization reaction<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> of <b>13</b> provided the 2,6-<i>cis</i>-tetrahydropyran <b>14</b> as a single diastereomer.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Final TBS deprotection of <b>14</b> and coupling with <b>3</b> provided the desired THP analogue <b>15</b>.</div><div class="NLM_p">The oxygen atom in the THF core of <b>1</b> is expected to play an important role in manassantin’s binding to its molecular target(s) by functioning as a hydrogen bond acceptor, mediating polar interactions, or adopting a specific ring conformation. To explore the role of the oxygen atom in HIF-1 inhibition, we designed the two pyrrolidine analogues (<b>20a</b> and <b>21</b>). As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>D, the addition of an aryl lithium reagent, generated <i>in situ</i> from <b>9</b> and <i>t</i>-BuLi, to the known Weinreb amide <b>16</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> gave the 1,4-diketone <b>17</b> in 40%. For the enantioselective reduction of <b>17</b>, (<i>S</i>)-α,α-diphenyl-2-pyrrolidinemethanol was used in combination with BH<sub>3</sub>·SMe<sub>2</sub> as a reducing agent to afford the 1,4-<i>syn</i>-diol <b>18</b> in 97% ee (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf" class="ext-link">Supporting Information</a> for details).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Mesylate formation of <b>18</b> followed by cyclization in the presence of allylamine or benzylamine afforded the <i>N</i>-allyl (<b>19a</b>)- and <i>N</i>-benzyl (<b>19b</b>)-protected pyrrolidines. TBS deprotection of <b>19a</b> and <b>19b</b> followed by BEMP-mediated coupling of the resulting bis-phenols and <b>3</b> successfully provided <b>20a</b> and <b>20b</b>, respectively. Treatment of <b>20b</b> with Pd/C for debenzylation gave the pyrrolidine analogue <b>21</b>.</div><div class="NLM_p">We envisioned that a chemically more tractable ring system that can recapitulate the overall linear-shaped conformation of the 2,3-<i>cis</i>-3,4-<i>trans</i>-4,5-<i>cis</i>-configuration of the THF core of manassantin A (<b>1</b>) may retain the potency of <b>1</b> toward the hypoxia signaling pathway. To test this hypothesis, we prepared several 5- and 6-membered ring analogues, <b>25a</b>, <b>25b</b>, <b>28</b>, and <b>33</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Analogues <b>25a</b>, <b>25b</b>, <b>28</b>, <b>33</b>, and <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>23</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 2–4 h, (<b>24a</b>) 99%, (<b>24b</b>) 8%; (b) Pd/C, H<sub>2</sub>, EtOH, 25 °C, 24 h, X = C: 34%, X = N: 89%; (c) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, (<b>25a</b>) 27%, (<b>25b</b>) 43%; (d) TsNHNH<sub>2</sub>, MeOH, 60 °C, 15 h, quant.; (e) <i>t</i>-BuXphosAuCl, LiO<i>t</i>-Bu, NaBArF, 1,2-dichloroethane, reflux, 16 h, 13%; (f) TBAF, THF, 0–25 °C, 1 h, 88%; (g) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 73%; (h) <b>30</b>, <i>n</i>-BuLi, THF, −78 °C, 1 h, 39%; (i) <b>30</b>, <i>t</i>-BuLi, THF/HMPA, −78 °C, 1 h, 63%; (j) TBAF, THF, 0–25 °C, 40 min, 79%; (k) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 86%; (l) PPh<sub>3</sub>, toluene, reflux, 2 h, 60%; (m) <b>36</b>, LHMDS, THF, −78 to 0 °C, 5.5 h, 8.4%; (n) TBAF, THF, 0–25 °C, 1 h, 55%; (o) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 45%.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>A, preparation of the benzene (<b>25a</b>) and pyridine (<b>25b</b>) analogues started with the Suzuki coupling reaction of boronic acid <b>23</b> with 1,3-dibromobenzene (<b>22a</b>) and 1,3-dibromopyridine (<b>22b</b>), respectively. Debenzylation of <b>24a</b>,<b>b</b> and BEMP-mediated coupling of the resulting bis-phenols with <b>3</b> provided the desired benzene (<b>25a</b>) and pyridine (<b>25b</b>) core analogues.</div><div class="NLM_p">For the synthesis of the cyclopentene core analogue <b>28</b>, the 1,5-diketone <b>26</b> was treated with <i>p</i>-toluenesulfonyl hydrazide to provide the bis-tosylhydrazone intermediate (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>B). The subsequent base-promoted/gold-catalyzed intramolecular detosylative cyclization<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> provided the cyclopentene <b>27</b>. TBS deprotection, followed by BEMP-mediated coupling, completed the synthesis of <b>28</b> in 64% in two steps.</div><div class="NLM_p">To access the dithiane core analogue <b>33</b>, we used the 1,3-dithiane umpolung chemistry. Monoalkylation of 1,3-dithiane (<b>29</b>) with the benzyl bromide <b>30</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> afforded <b>31</b>, which was coupled to <b>30</b> to give the bis-alkylated dithiane <b>32</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>C). Final TBS deprotection and the BEMP-mediated coupling reaction accomplished the synthesis of the dithiane core analogue <b>33</b> in a 68% yield.</div><div class="NLM_p last">Next, we replaced the THF core of <b>1</b> with a double bond to determine if the THF core is a side chain tether or serves a larger role in mediating molecular target interactions. The known benzyl bromide <b>34</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> was converted to the corresponding phosphonium salt <b>35</b> by treating with PPh<sub>3</sub> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>D). The Wittig reaction of <b>35</b> with aldehyde <b>36</b>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> followed by TBS-deprotection, produced the <i>trans</i>-alkene <b>37</b> as determined by NMR analysis.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The BEMP-mediated coupling of <b>37</b> and <b>3</b> afforded the <i>trans</i>-alkene analogue <b>38</b>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Characterization</h3><div class="NLM_p">After the completion of analogue synthesis, we performed a dual luciferase-reporter assay to assess the effect of manassantin A analogues on HIF-1 transactivation activity. We used HEK-293T cells transiently transfected with both pGL3-5 × HRE-Luc and pRL-SV40 encoding Renilla-luciferase (pRen-Luc) vectors to investigate the effect of manassantin analogues on HIF-1 transactivation activity. HEK-293T cells were treated with hypoxia (1% O<sub>2</sub>) and serially diluted compounds for 24 h. The luciferase signals were normalized to the activity of Renilla luciferase and quantified as relative light units (RLU).</div><div class="NLM_p">Several manassantin analogues such as <b>4</b>, <b>11</b>, and <b>21</b> reduced the luciferase signal in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The luciferase assay provided several valuable insights into the SAR of <b>1</b>. First, the C8″ monomethyl (<b>4</b>) and C8′,8″ desmethyl analogues (<b>11</b>) potently inhibited HIF-1 transactivation activity.  In particular, the potency of <b>11</b> was comparable to that of <b>1</b>, suggesting the methyl groups of the THF core of manassantin A are not crucial to HIF-1 inhibition. These analogues lacking the methyl groups, in particular <b>11</b>, significantly shortens the overall synthesis. The 2,6-<i>cis</i>-THP core analogue <b>15</b> was less potent than manassantin A. The lack of activity of <b>15</b> may be attributed to the change in ring size or conformation by the replacement of 2,5-<i>trans</i>-THF with 2,6-<i>cis</i>-THP (<b>11</b> vs <b>15</b>). The pyrrolidine analogue <b>21</b> was slightly less potent than <b>11</b>. However, the <i>N</i>-allyl substituted pyrrolidine analogue <b>20a</b> was completely inactive. This is likely due to the loss of hydrogen bonding capability or the bulkiness of the <i>N</i>-allyl group. This data indicated that the THF core of manassantin A can be replaced by an α,α′-<i>trans</i>-disubstituted ring without significant loss of activity, but the ring is required to have hydrogen bonding capability.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activity of manassantin A (ManA) and analogues for HIF-1 inhibition. HEK-293T cells were transfected with pGL3-5HRE-VEGF-luciferase and pRL-SV40 plasmids, and treated with 0, 0.01, 0.1, and 1 μM of ManA (manassantin A) and analogues or 10 μM of 17-AAG (17-(allylamino)-17-demethoxygeldanamycin), as a positive control under hypoxia for 24 h. Relative luciferase activity was determined after normalized to the Renilla luciferase activity. Three independent experiments were performed. # <i>P</i> < 0.0001 versus vehicle control group, % <i>P</i> < 0.001 versus vehicle control group, $ <i>P</i> < 0.01 versus vehicle control group, and * <i>P</i> < 0.1 versus vehicle control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The chemically more tractable analogues such as the benzene and pyridine analogues (<b>25a</b> and <b>25b</b>) were completely inactive due to their flat geometry, confirming our previous finding that the relative orientation of the side chains is crucial to the activity of <b>1</b>. The cyclopentene analogue <b>28</b>, 1,3-dithiane analogue <b>33</b>, and <i>trans</i>-alkene analogue <b>38</b> were all inactive.</div><div class="NLM_p">To characterize the effect of ring conformation of manassantin A (<b>1</b>) on HIF-1 inhibition, we optimized the conformations of truncated structures<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> of manassantin A (<b>1</b>) and analogues (<b>11</b> and <b>25b</b>) using Maestro 11.2 (Schrödinger, NY). As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, manassantin A (<b>1</b>) adopted a nearly linear conformation due to the 2,5-<i>trans</i>-configuration of the THF ring. An active analogue <b>11</b> also adopted a linear conformation like <b>1</b>. However, an inactive analogue, <b>25b</b>, adopted a shape remarkably different from that of <b>1</b>. The conformational analysis of <b>1</b>, <b>11</b>, and <b>25b</b> clearly showed that the side chains are required to position in the correct orientation for high potency, which suggests that the α,α′-<i>trans</i>-configuration of <b>1</b> is critical to HIF-1 inhibition. Thus, designing a ligand that mimics the overall conformation of <b>1</b> may improve the potency toward the hypoxia signaling pathway.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlays of optimized conformations of manassantin A (<b>1</b>) and analogues (<b>11</b> and <b>25b</b>). To avoid any unnecessary complications and/or exaggeration by the flexible side chains, truncated structures of <b>1</b>, <b>11</b>, and <b>25b</b> were used instead of the full structures. Initial geometries were determined by conformational search based on MMFF and OPLS3. (A and B) Superimposition of an active manassantin A analog (gray: <b>1</b>; green: <b>11</b>). (C and D) Superimposition of an inactive manassantin A analog (gray: <b>1</b>; sky blue: <b>25b</b>). (E) Truncated structures <b>1</b>, <b>11</b>, and <b>25b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cooperative Therapeutic Effect of Manassantin A with EGFR Inhibition</h3><div class="NLM_p">Although precision-based targeting of specific growth factors/receptors and/or pathways has been effective in certain tumor types, most of the cancers, if not all, treated with targeted drugs eventually develop resistance. In addition, intratumoral heterogeneity and clonal evolution, which are common in solid tumors, are also likely to contribute to resistance to some targeted therapies. Therefore, the emergence of resistant cancer cells in several targeted therapies indicates that simultaneous administration of multiple agents may be essential for the successful treatment of human cancers.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> In this regard, HIF-1 inhibitors can be extremely useful in maximizing the therapeutic benefits of standard treatments. For example, targeting blood vessels in tumors results in starvation of the tumor from oxygen and nutrients.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> As tumor vasculatures have leaky and chaotic structures, hypoxic regions are generated again as tumors grow.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In turn, HIF-1α is overexpressed by recurrent hypoxia and increases the expression of HIF target genes involved in angiogenesis and chemoresistance. Therefore, we hypothesized that the use of HIF-1α inhibitors in combination with anticancer agents is likely to improve the treatment outcome.</div><div class="NLM_p">To test the hypothesis, we evaluated a combination of gefitinib (an EGFR inhibitor) and manassantin A in a Lewis lung carcinoma (LLC) allograft experiment. The tumor microenvironment including abnormal surrounding blood vessels is an important factor determining the effect of anticancer drugs. It is highly challenging to precisely replicate the tumor microenvironment in an <i>in vitro</i> model. Therefore, we directly tested the combination of manassantin A and gefitinib in an <i>in vivo</i> lung cancer model and evaluated the efficacy of combination therapy. LLC cells were inoculated in the mouse flank subcutaneously (s.c.) and treated with manassantin A and/or gefitinib  intraperitoneally (i.p.) every 3 days for 15 days. Manassantin A or gefitinib alone inhibited tumor growth by ∼30% (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). However, manassantin A, together with gefitinib, suppressed tumor growth in a cooperative manner (∼80% inhibition). Decreased tumor weight in manassantin A-treated and/or gefitinib-treated mice showed similar phenomena (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), whereas the body weight did not significantly change (<a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a>). Although several manassantin A-related compounds are known to be effective in tumor xenograft models,<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> there has been no report of the <i>in vivo</i> antitumor activity of manassantin A. To the best of our knowledge, this is also the first report of the cooperative therapeutic effect of a small molecule HIF-1 inhibitor with EGFR inhibition. Our encouraging <i>in vivo</i> testing result warrants further exploration of the therapeutic potential of manassantin A in combination with other treatment methods such as radiation and cancer immunotherapy.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Manassantin A (ManA) cooperatively inhibits tumor growth in combination with an EGFR inhibitor, gefitinib (Gef). Lewis lung carcinoma cells (2 × 10<sup>5</sup>) were inoculated into both flanks of C57Bl/6 mice (Day 0). From two days after inoculation, mice (<i>n</i> = 5 per group) were treated intraperitoneally with manassantin A (5 mg/kg body weight) and/or gefitinib (5 mg/kg body weight) three times a week for 17 days and then sacrificed. Tumor size (A) and tumor weight (B) were measured three times a week and on the final day, respectively. Tumor masses were photographed and shown in a box right the graph. * <i>P</i> < 0.05 versus vehicle control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">To explore the therapeutic potential of manassantin A (<b>1</b>) for cancer treatment, we prepared and evaluated THF core analogues of manassantin A. Our SAR study of manassantin A analogues provided valuable insights into the role of the THF core of manassantin A in HIF-1 inhibition. Among the analogues tested, <b>4</b>, <b>11</b>, and <b>21</b> with reduced structural complexity and enhanced chemical tractability inhibited HIF-1 transactivation activity under hypoxia. Moreover, manassantin A cooperatively inhibited  tumor growth in combination with an EGFR inhibitor, demonstrating its therapeutic potential in combination therapies. We expect that our findings will allow further structural modifications of manassantin A in order to enhance the potency and specificity of manassantin A analogues for novel anticancer drug development.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Chemistry Procedures</h3><div class="NLM_p last">All reactions were conducted in oven-dried glassware under nitrogen. Unless otherwise stated, all reagents were purchased from commercial suppliers and used without further purification. All solvents were American Chemical Society (ACS) grade or better and used without further purification, except tetrahydrofuran (THF), which was freshly distilled from sodium/benzophenone each time before use. Analytical thin-layer chromatography (TLC) was performed with glass-backed silica gel (60 Å) plates with a fluorescent indication (Whatman). Visualization was accomplished by UV irradiation at 254 nm and/or by staining with <i>p</i>-anisaldehyde solution. Flash column chromatography was performed by using silica gel (particle size 230–400 mesh, 60 Å). All <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with a Varian 400 (400 MHz) and a Bruker 500 (500 MHz) spectrometer. All NMR δ values are given in parts per million (ppm) and are referenced to the residual solvent signals (δ = 7.26 ppm of CDCl<sub>3</sub>; δ = 2.05 ppm of CD<sub>3</sub>COCD<sub>3</sub>) for <sup>1</sup>H NMR spectra, or the solvent signals for <sup>13</sup>C spectra. Coupling constants (<i>J</i>) are given in hertz (Hz), and multiplicities are indicated using the conventional abbreviation (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet or overlap of nonequivalent resonances, br = broad). Electrospray ionization (ESI) mass spectrometry (MS) was recorded with an Agilent 1100 series (LC/MSD trap) spectrometer in order to obtain the molecular masses of compounds. Optical rotation values were measured with a Rudolph Research Analytical (A21102 API/1W) polarimeter. The purity of final compounds used in bioassays was determined by analytical HPLC and was found to be 90.7–99.6%. The analysis was performed on an HPLC (Phenomenex Kinetix C18 column, 3 × 30 mm, mobile phase A = H<sub>2</sub>O/CH<sub>3</sub>OH/HCO<sub>2</sub>H (100:2:0.3), and mobile phase B = H<sub>2</sub>O/CH<sub>3</sub>CN/HCO<sub>2</sub>H (2:100:0.3). Flow injections are in 50:50 mobile phase A/mobile phase B at 0.5 mL/min).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis of Manassantin A Analogues</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> General Procedure for Bn Deprotection (GP1)</h4><div class="NLM_p last">To a stirred solution of the aryl benzyl ether (1 equiv) in an appropriate solvent was added 10% palladium on activated carbon. After stirring for 24 h under a H<sub>2</sub> atmosphere at 25 °C, the reaction mixture was filtered through a pad of Celite, and the filtrate was concentrated <i>in vacuo</i>. The residue was purified as indicated.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Procedure for Coupling Reaction (<a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>)</h4><div class="NLM_p last">To a cooled (−78 °C) solution of a substrate (1 equiv) in an appropriate solvent was added dropwise <i>n</i>-BuLi (2.5 M in hexanes, 1–4 equiv) or <i>t</i>-BuLi (1.7 M in pentane, 1–4 equiv). After stirring for 1 h at −78 °C, the reaction mixture was treated with an electrophile (1–6 equiv) in anhydrous THF. After stirring for 1–6 h at −78 °C, the reaction was quenched by the addition of saturated aqueous NH<sub>4</sub>Cl, and the resulting mixture was diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified as indicated.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Procedure for TBS Deprotection (GP3)</h4><div class="NLM_p last">To a cooled (0 °C) solution of the TBS silyl ether (1 equiv) in anhydrous THF (0.03 M) was added TBAF (1 M in THF, 3 equiv). After stirring for 5 min at 0 °C, the reaction mixture was warmed to 25 °C. After stirring for 10 min to 1 h, the reaction was quenched by an addition of saturated aqueous NH<sub>4</sub>Cl, and the resulting mixture was extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified as indicated.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure for the Suzuki Coupling Reaction GP4</h4><div class="NLM_p last">To a solution of the 1,3-dibromo benzene or pyridine (1 equiv) in anhydrous DMF (0.39 M) was added the aryl boronic acid (2 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), and Pd(dppf)Cl<sub>2</sub> (0.5 mol %) at 25 °C. The resulting mixture was heated to 60 °C and stirred for 2–4 h. After cooling to 0 °C, the reaction was quenched by the addition of H<sub>2</sub>O, and the resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified as indicated.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure for the BEMP-Mediated Coupling Reaction (GP5)</h4><div class="NLM_p">To a cooled (0 °C) solution of the bis-phenol (1 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.05 M) was added dropwise BEMP (2.3 equiv). The reaction mixture was stirred at the same temperature for 10 min before the tosylate <b>3</b> (2.5–4 equiv) was added. After stirring for 1 h at 25 °C, the reaction was quenched by the addition of saturated aqueous NH<sub>4</sub>Cl and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified as indicated.</div><div id="sec4_2_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> (2<i>R</i>,2′<i>R</i>)-2,2′-((((2<i>S</i>,3<i>R</i>,5<i>S</i>)-3-Methyltetrahydrofuran-2,5-diyl)bis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>4</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from the aryl benzyl ether <b>2</b> (13 mg, 0.02 mmol) and 10% palladium on activated carbon in EtOAc/EtOH (3:1, 3 mL) according to <a class="ref internalNav" href="#sec4_2_1" aria-label="GP1">GP1</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 4:1) afforded the bis-phenol (6 mg, 71%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.95 (s, 1H), 6.92–6.84 (m, 4H), 6.78 (d, <i>J</i> = 8.1 Hz, 1H), 5.54 (s, 2H), 5.35–5.26 (m, 2H), 3.90 (s, 6H), 2.64–2.52 (m, 1H), 2.21–2.13 (m, 2H), 0.70 (d, <i>J</i> = 7.0 Hz, 3H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>O<sub>5</sub> 331.1540, found 331.1543. The analogue <b>4</b> was synthesized from the bis-phenol (10 mg, 0.03 mmol) and the tosylate <b>3</b> (44.1 mg, 0.12 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 1:1) afforded the analogue <b>4</b> (18 mg, 83%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86–7.76 (m, 2H), 7.66 (s, 2H), 6.92 (s, 1H), 6.89–6.83 (m, 3H), 6.81–6.73 (m, 3H), 6.70 (d, <i>J</i> = 8.8 Hz, 1H), 5.46 (q, <i>J</i> = 4.0 Hz, 2H), 5.23 (dd, <i>J</i> = 7.2, 5.7 Hz, 2H), 3.95 (s, 6H), 3.93 (s, 6H), 3.83 (s, 6H), 2.55–2.48 (m, 1H), 2.15–2.07 (m, 2H), 1.70 (d, <i>J</i> = 7.0 Hz, 6H), 0.64 (d, <i>J</i> = 7.1 Hz, 3H); HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>41</sub>H<sub>46</sub>O<sub>11</sub> 737.2932, found 737.2941; purity 95.07%, <i>t</i><sub>R</sub> 7.693 min.</div></div><div id="sec4_2_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Methyl 4-(4-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methoxyphenyl)-4-oxobutanoate (<b>6</b>)</h5><div class="NLM_p last">To a solution of the allyl alcohol <b>5</b> (1.3 g, 4.4 mmol) in anhydrous toluene (100 mL) were added methyl acrylate (3.9 mL, 44 mmol) and Grubbs’ second-generation catalyst (186 mg, 0.22 mmol). After stirring for 30 min at 110 °C, the remaining methyl acrylate was removed <i>in vacuo</i>. PMHS (1.3 mL, 0.88 mmol) was added and stirred for 12 h at 130 °C on reflux conditions. After that, all volatiles were removed <i>in vacuo</i>, and the residue was purified by column chromatography (silica gel, hexanes/EtOAc, 8:1) to afford <b>6</b> (700 mg, 45%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56–7.46 (m, 2H), 6.87 (d, <i>J</i> = 8.0 Hz, 1H), 3.84 (s, 3H), 3.69 (s, 3H), 3.27 (t, <i>J</i> = 6.6 Hz, 2H), 2.73 (t, <i>J</i> = 6.6 Hz, 2H), 0.98 (s, 9H), 0.16 (s, 6H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 196.14, 172.81, 150.98, 149.65, 131.13, 122.15, 120.27, 111.11, 54.97, 50.83, 32.71, 27.66, 25.15, 18.22, −5.28; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>28</sub>O<sub>5</sub>Si 353.1785, found 353.1785.</div></div><div id="sec4_2_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Methyl (<i>S</i>)-4-(4-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methoxyphenyl)-4-hydroxybutanoate (<b>7</b>)</h5><div class="NLM_p last">A solution of (<i>R</i>)-Me-CBS-oxazaborolidine (1 M in toluene, 0.09 mL, 0.09 mmol) was added to BH<sub>3</sub>·SMe<sub>2</sub> (132 μL, 1.39 mmol), and the reaction mixture was stirred under a nitrogen atmosphere at 25 °C before cooling to −20 °C. After stirring 10 min, the solution of γ-keto ester <b>6</b> (330 mg, 0.93 mmol) in anhydrous THF (15 mL) was added dropwise at −20 °C. After stirring for 30 min, the reaction was quenched by the addition of saturated aqueous NH<sub>4</sub>Cl, and the resulting mixture was diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with H<sub>2</sub>O, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:1) to afford <b>7</b> (190 mg, 58%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.00 (d, <i>J</i> = 5.1 Hz, 1H), 6.81 (s, 1H), 6.80 (d, <i>J</i> = 5.2 Hz, 1H), 4.69–4.59 (m, 1H), 4.27–4.20 (m, 1H), 3.83 (s, 3H), 3.61 (s, 3H), 2.46–2.32 (m, 2H), 2.01–1.88 (m, 2H), 1.00 (s, 9H), 0.15 (s, 6H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 173.38, 150.77, 143.77, 139.40, 120.16, 117.99, 109.85, 72.20, 54.89, 50.71, 34.64, 30.12, 25.30, 18.19, −5.23; HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>18</sub>H<sub>30</sub>O<sub>5</sub>Si 377.1755, found 377.1763 .</div></div><div id="sec4_2_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (<i>S</i>)-5-(4-((<i>tert-</i>Butyldimethylsilyl)oxy)-3-methoxyphenyl)dihydrofuran-2(3<i>H</i>)-one (<b>8</b>)</h5><div class="NLM_p last">The alcohol <b>7</b> (150 mg, 0.42 mmol) in anhydrous toluene (10 mL) was treated with pyridinium <i>p</i>-toluene sulfonate (211 mg, 0.84 mmol). After stirring for 12 h at 70 °C, the reaction was quenched by the addition of H<sub>2</sub>O, and the resulting mixture was diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were and washed with water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, hexanes/EtOAc, 6:1) to afford the lactone <b>8</b> (115 mg, 86%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.06 (br s, 1H), 6.87 (br s, 2H), 5.52–5.42 (m, 1H), 3.83 (s, 3H), 2.72–2.50 (m, 3H), 2.29–2.21 (m, 1H), 1.01 (s, 9H), 0.16 (s, 6H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 176.23, 151.17, 144.99, 133.76, 120.54, 118.44, 110.06, 81.25, 55.01, 30.77, 25.25, 18.18, −5.26; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>26</sub>O<sub>4</sub>Si 323.1673, found 323.1678.</div></div><div id="sec4_2_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (2<i>S</i>,5<i>S</i>)-2,5-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)tetrahydrofuran (<b>10</b>)</h5><div class="NLM_p last">Compound <b>8</b> (60 mg, 0.18 mmol) in anhydrous THF (1 mL) was reacted with the aryl bromide <b>9</b> (79 mg, 0.25 mmol) in anhydrous THF (1 mL) and <i>t</i>-BuLi (1.7 M in pentane, 0.21 mL, 0.37 mmol) according to <a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 5:1) afforded the cyclic hemiketal (20 mg, 20%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.50 (d, <i>J</i> = 1.8 Hz, 1H), 7.44 (dd, <i>J</i> = 1.9, 8.2 Hz, 1H), 6.93–6.75 (m, 4H), 4.74 (t, <i>J</i> = 6.5 Hz, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 3.03 (td, <i>J</i> = 6.9, 1.6 Hz, 2H), 2.50 (s, 1H), 2.17 (q, <i>J</i> = 6.8 Hz, 2H), 0.99 (s, 18H), 0.16 (s, 12H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.74, 150.50, 150.37, 144.10, 143.64, 140.47, 140.33, 137.05, 120.53, 120.07, 119.95, 118.42, 118.34, 111.17, 110.49, 110.35, 88.75, 81.00, 55.56, 55.42, 55.29, 39.02, 34.96, 25.74, 18.45, −4.61; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>30</sub>H<sub>48</sub>O<sub>6</sub>Si<sub>2</sub> 561.3062, found 561.3047. To a cooled (−78 °C) solution of hemiketal (27 mg, 0.04 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added NaBH<sub>3</sub>CN (6 mg, 0.09 mmol) in anhydrous CH<sub>3</sub>CN (2 mL). After stirring for 10 min at −78 °C, BF<sub>3</sub>·OEt<sub>2</sub> (18 μL, 0.14 mmol) was added, and the resulting mixture was stirred for 1 h at −78 °C. The reaction was quenched by the addition of saturated aqueous NaHCO<sub>3</sub>, and the resulting mixture was diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The organic layers were washed with water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, hexanes/EtOAc, 8:1) to afford <b>10</b> (13 mg, 49%) as a colorless oil: [α]<sub class="stack">D</sub><sup class="stack">22.9</sup> −27.27 (<i>c</i> 0.18, CHCl<sub>3</sub>); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.92 (br s, 2H), 6.82 (br s, 4H), 5.16 (t, <i>J</i> = 6.7 Hz, 2H), 3.82 (s, 6H), 2.44–2.40 (m, 2H), 2.02–1.95 (m, 2H), 0.98 (s, 18H), 0.14 (s, 12H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.88, 144.17, 137.02, 120.64, 118.04, 109.76, 81.33, 55.53, 35.73, 25.75, 18.46, −4.62; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>30</sub>H<sub>48</sub>O<sub>5</sub>Si<sub>2</sub> 545.3113, found 545.3114.</div></div><div id="sec4_2_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (2<i>R</i>,2′<i>R</i>)-2,2′-((((2<i>S</i>,5<i>S</i>)-Tetrahydrofuran-2,5-diyl)bis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>11</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from <b>10</b> (10 mg, 0.01 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) afforded the bis-phenol (5 mg, 88%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.96 (s, 2H), 6.92–6.85 (m, 4H), 5.57 (br s, 2H), 5.17 (t, <i>J</i> = 6.7 Hz, 2H), 3.91 (s, 6H), 2.50–2.38 (m, 2H), 2.06–1.91 (m, 2H). The analogue <b>11</b> was synthesized from the bis-phenol (5 mg, 0.01 mmol) and the tosylate <b>3</b> (23 mg, 0.06 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) afforded <b>11</b> (8.1 mg, 73%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.82 (d, <i>J</i> = 8.7 Hz, 2H), 7.67 (s, 2H), 6.92 (s, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 2H), 6.76 (s, 4H), 5.44–5.36 (m, 2H), 5.14–5.06 (m, 2H), 3.93 (s, 6H), 3.91 (s, 6H), 3.85 (s, 6H), 2.41–2.32 (m, 2H), 1.92 (s, 2H), 1.71 (d, <i>J</i> = 7.0 Hz, 6H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 153.59, 149.87, 148.99, 146.06, 137.56, 127.37, 123.64, 117.90, 115.67, 111.26, 109.81, 81.03, 55.95, 35.49, 19.27; HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>40</sub>H<sub>44</sub>O<sub>11</sub> 723.2913, found 723.2712; purity 93.54%, <i>t</i><sub>R</sub> 7.503 min.</div></div><div id="sec4_2_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 1,5-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pentane-1,5-diol (<b>13</b>)</h5><div class="NLM_p last">The 1,5-diketone was synthesized from the aryl bromide <b>9</b> (7.5 g, 24 mmol) in anhydrous THF (36 mL), <i>n</i>-BuLi (2.5 M in hexanes, 6.4 mL, 16 mmol), and the Weinreb amide <b>12</b> (873 mg, 4 mmol) in anhydrous THF (36 mL) according to <a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>. Purified by column chromatography (silica gel, hexanes/EtOAc, 8:1) afforded the 1,5-diketone (1.47 g, 64%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58–7.48 (m, 4H), 6.87 (d, <i>J</i> = 8.0 Hz, 2H), 3.87 (s, 6H), 3.06 (t, <i>J</i> = 7.0 Hz, 4H), 2.22–2.12 (m, 2H), 0.99 (s, 18H), 0.18 (s, 12H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 197.74, 150.93, 149.48, 131.48, 122.14, 120.21, 111.18, 54.95, 37.06, 25.12, 19.23, 18.19, −5.31; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>31</sub>H<sub>48</sub>O<sub>6</sub>Si<sub>2</sub> 573.3062, found 573.3069. The 1,5-diketone (200 mg, 0.34 mmol) in anhydrous THF (20 mL) was added dropwise to a stirred solution of LiAlH<sub>4</sub> (2 M in THF, 0.6 mL, 1.22 mmol) at 25 °C. The cloudy solution was stirred for 10 min and then cooled to 0 °C. The reaction was quenched by the addition of 15% NaOH solution, and the resulting mixture was diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) to afford the 1,5-diol <b>13</b> (110 mg, 56%) as a needle-shaped white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.83 (s, 2H), 6.80–6.69 (m, 4H), 4.56 (t, <i>J</i> = 8.0 Hz, 2H), 3.79 (s, 6H), 1.85–1.58 (m, 4H), 1.44–1.33 (m, 2H), 0.98 (s, 18H), 0.13 (s, 12H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 151.36, 144.80, 138.69, 121.00, 118.60, 110.08, 74.86, 55.88, 39.16, 26.13, 18.84, −4.22; HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>31</sub>H<sub>52</sub>O<sub>6</sub>Si<sub>2</sub> 599.3195, found 599.3193.</div></div><div id="sec4_2_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (2<i>R</i>,6<i>S</i>)-2,6-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)tetrahydro-2<i>H</i>-pyran (<b>14</b>)</h5><div class="NLM_p last">To a solution of <b>13</b> (100 mg, 0.17 mmol) in anhydrous CH<sub>3</sub>CN (30 mL) was added AuCl<sub>3</sub> (26 mg, 0.008 mmol). After stirring for 10 min at 25 °C, the reaction mixture was filtered through a pad of Celite and concentrated. The residue was purified by column chromatography (silica gel, hexanes/EtOAc, 100:1) to afford the 2,6-<i>cis</i>-tetrahydropyran <b>14</b> (55 mg, 57%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.95 (d, <i>J</i> = 1.9 Hz, 2H), 6.85 (dd, <i>J</i> = 2.0, 8.2 Hz, 2H), 6.79 (d, <i>J</i> = 8.1 Hz, 2H), 4.49 (d, <i>J</i> = 11.0 Hz, 2H), 3.80 (s, 6H), 1.88 (d, <i>J</i> = 13.5 Hz, 2H), 1.67–1.54 (m, 4H), 0.98 (s, 18H), 0.13 (s, 12H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 150.69, 144.12, 137.13, 120.55, 118.25, 110.20, 80.26, 55.49, 33.83, 25.77, 18.46, −4.60; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>31</sub>H<sub>50</sub>O<sub>5</sub>Si<sub>2</sub> 559.3270, found 559.3282.</div></div><div id="sec4_2_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (2<i>R</i>,2′<i>R</i>)-2,2′-((((2<i>R</i>,6<i>S</i>)-Tetrahydro-2<i>H</i>-pyran-2,6-diyl)bis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>15</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from <b>14</b> (55 mg, 0.09 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 2:1) afforded the bis-phenol (19 mg, 47%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.97 (s, 2H), 6.93–6.84 (m, 4H), 5.58 (s, 2H), 4.49 (d, <i>J</i> = 11.0 Hz, 2H), 3.89 (s, 6H), 2.05–1.99 (m, 1H), 1.93–1.84 (m, 3H), 1.70–1.60 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 146.33, 144.78, 135.60, 118.88, 114.01, 108.78, 80.29, 55.90, 33.69, 24.46, 14.21; HRMS (ESI) <i>m</i>/<i>z</i>  [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>O<sub>5</sub> 331.1540, found 331.1549. The analogue <b>15</b> was synthesized from the bis-phenol (19 mg, 0.05 mmol) and the tosylate <b>3</b> (83.8 mg, 0.23 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) afforded <b>15</b> (30 mg, 76%) as a beige solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.84 (d, <i>J</i> = 8.5 Hz, 2H), 7.65 (d, <i>J</i> = 2.2 Hz, 2H), 7.11–7.00 (m, 4H), 6.87–6.81 (m, 2H), 6.80–6.74 (m, 2H), 5.65–5.56 (m, 2H), 4.47 (d, <i>J</i> = 11.4 Hz, 2H), 3.89 (s, 6H), 3.85 (s, 6H), 3.82 (s, 6H), 2.01–1.90 (m, 2H), 1.87–1.80 (m, 2H), 1.59 (d, <i>J</i> = 6.7 Hz, 6H), 1.55–1.41 (m, 2H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 196.49, 154.00, 149.80, 149.26, 146.10, 137.90, 127.51, 123.34, 117.74, 115.14, 111.23, 110.55, 79.49, 76.75, 55.13, 33.67, 18.21; HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>41</sub>H<sub>46</sub>O<sub>11</sub> 737.2932, found 737.2937; purity 99.59%, <i>t</i><sub>R</sub> 7.813 min.</div></div><div id="sec4_2_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 1,4-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)butane-1,4-dione (<b>17</b>)</h5><div class="NLM_p last">The 1,4-diketone was synthesized from the aryl bromide <b>9</b> (927 mg, 2.93 mmol) in anhydrous THF (3 mL), <i>t</i>-BuLi (1.7 M in pentane, 1.15 mL, 1.95 mmol), and the known Weinreb amide <b>16</b> (100 mg, 0.48 mmol) in anhydrous THF (4 mL) according to <a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 8:1) afforded the 1,4-diketone <b>17</b> (108 mg, 40%) as a yellow solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.67 (dd, <i>J</i> = 8.2, 2.0 Hz, 2H), 7.61 (d, <i>J</i> = 2.0 Hz, 2H), 7.00 (d, <i>J</i> = 8.2 Hz, 2H), 3.91 (s, 6H), 3.45–3.35 (m, 4H), 1.01 (s, 18H), 0.20 (s, 12H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 150.64, 143.52, 140.20, 120.02, 118.05, 109.91, 73.26, 54.84, 36.10, 25.26, 18.16, −5.28; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>30</sub>H<sub>46</sub>O<sub>6</sub>Si<sub>2</sub> 559.2906, found 559.2914.</div></div><div id="sec4_2_5_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (1<i>R</i>,4<i>R</i>)-1,4-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)butane-1,4-diol (<b>18</b>)</h5><div class="NLM_p last">To a solution of (<i>S</i>)-α,α-diphenyl-2-pyrrolidinemethanol (3.8 mg, 0.01 mmol) in anhydrous THF (1 mL) was added B(OMe)<sub>3</sub> (1.98 μL, 0.01 mmol). The resulting mixture was stirred under a nitrogen atmosphere at 25 °C for 1 h and transferred to a solution of <b>17</b> (50 mg, 0.08 mmol) and BH<sub>3</sub>·SMe<sub>2</sub> (2 M in THF, 0.53 mL, 1.06 mmol) in anhydrous THF (1 mL). After stirring for 1 h, the reaction was quenched by the addition of 2 M HCl solution, and the resulting mixture was diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) to afford the 1,4-diol <b>18</b> (40 mg, 80%) as a white solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 6.98 (br s, 2H), 6.81–6.75 (m, 4H), 4.59 (br s, 2H), 4.22 (d, <i>J</i> = 4.0 Hz, 2H), 3.80 (s, 6H), 1.90–1.78 (m, 2H), 1.73–1.63 (m, 2H), 1.00 (s, 18H), 0.14 (s, 12H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 150.64, 143.53, 140.22, 120.02, 118.07, 109.91, 73.28, 54.83, 36.22, 25.25, 18.15, −5.29; HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>30</sub>H<sub>50</sub>O<sub>6</sub>Si<sub>2</sub> 585.3219, found 585.3041. The enantiomeric excess of <b>18</b> was determined by chiral HPLC separation (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf" class="ext-link">Figure S2</a> for details).</div></div><div id="sec4_2_5_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (2<i>S</i>,5<i>S</i>)-1-Allyl-2,5-bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pyrrolidine (<b>19a</b>)</h5><div class="NLM_p last">To a cooled (−20 °C) solution of <b>18</b> (240 mg, 0.42 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added Et<sub>3</sub>N (0.29 mL, 2.13 mmol) and MsCl (0.16 mL, 2.13 mmol). After stirring for 3 h at −20 °C, an excessive amount of allylamine (3.1 mL, 4.2 mmol) was added. The resulting mixture was allowed to warm to 25 °C and stirred for 12 h. The reaction was quenched by an addition of H<sub>2</sub>O, and the resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification by column chromatography (silica gel, hexanes/EtOAc, 100:1) afforded <b>19a</b> (492 mg, 73%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.01 (s, 2H), 6.88 (d, <i>J</i> = 8.0 Hz, 2H), 6.79 (d, <i>J</i> = 8.0 Hz, 2H), 5.74–5.61 (m, 1H), 4.91–4.74 (m, 2H), 3.82 (s, 6H), 3.75–3.67 (m, 2H), 3.01 (d, <i>J</i> = 6.8 Hz, 2H), 2.20–2.06 (m, 2H), 1.81–1.70 (m, 2H), 0.98 (s, 18H), 0.15 (s, 12H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>33</sub> H<sub>53</sub>NO<sub>4</sub>Si<sub>2</sub> 584.3586, found 584.3594.</div></div><div id="sec4_2_5_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (2<i>R</i>,2′<i>R</i>)-2,2′-((((2<i>S</i>,5<i>S</i>)-1-Allylpyrrolidine-2,5-diyl)bis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>20a</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from <b>19a</b> (20 mg, 0.03 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 1:1) afforded the bis-phenol (11 mg, 55%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.38 (s, 2H), 7.15 (s, 2H), 6.92 (d, <i>J</i> = 7.9 Hz, 2H), 6.79 (dd, <i>J</i> = 8.0, 8.0 Hz, 2H), 5.84–5.67 (m, 1H), 4.94–4.79 (m, 2H), 3.88 (s, 6H), 3.81–3.73 (m, 4H), 3.04 (d, <i>J</i> = 6.8 Hz, 2H), 2.19–2.08 (m, 2H), 1.80–1.68 (m, 2H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 147.42, 145.45, 136.25, 134.24, 119.87, 116.34, 114.57, 110.49, 66.41, 55.26, 52.37, 34.03; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>25</sub>NO<sub>4</sub> 356.1856, found 356.1864. The analogue <b>20a</b> was synthesized from the bis-phenol (44 mg, 0.12 mmol) and the tosylate <b>3</b> (270.63 mg, 0.74 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 1:1) afforded the analogue <b>20a</b> (40 mg, 72%) as a white solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.86 (dd, <i>J</i> = 8.5, 2.1 Hz, 2H), 7.66 (s, 2H), 7.17 (d, <i>J</i> = 8.2 Hz, 2H), 7.05 (d, <i>J</i> = 8.4 Hz, 2H), 6.89 (ddd, <i>J</i> = 10.4, 8.3, 1.9 Hz, 2H), 6.78 (dd, <i>J</i> = 8.1, 4.4 Hz, 2H), 5.82–5.54 (m, 3H), 4.82 (dd, <i>J</i> = 10.6, 18.2 Hz, 2H), 3.92–3.81 (m, 18H), 3.76 (t, <i>J</i> = 6.4 Hz, 2H), 2.98 (d, <i>J</i> = 6.9 Hz, 2H), 2.13–2.06 (m, 2H), 1.72–1.65 (m, 2H), 1.60 (d, <i>J</i> = 6.7 Hz, 6H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 196.53, 154.00, 150.13, 149.27, 146.04, 138.81, 134.15, 127.57, 123.36, 119.31, 116.47, 115.39, 115.24, 111.62, 111.49, 111.26, 110.70, 76.74, 66.33, 55.33, 33.99, 18.24; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>43</sub>H<sub>49</sub>NO<sub>10</sub> 740.3429, found 740.3446; purity 94.21%, <i>t</i><sub>R</sub> 6.147 min.</div></div><div id="sec4_2_5_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (2<i>S</i>,5<i>S</i>)-1-Benzyl-2,5-bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pyrrolidine (<b>19b</b>)</h5><div class="NLM_p last">To a cooled (−20 °C) solution of <b>18</b> (240 mg, 0.42 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added Et<sub>3</sub>N (0.29 mL, 2.13 mmol) and MsCl (0.16 mL, 2.13 mmol). After stirring for 3 h at −20 °C, an excessive amount of benzylamine (4.58 mL, 42 mmol) was added. The resulting mixture was allowed to warm to 25 °C and stirred for 12 h. The reaction was quenched by the addition of H<sub>2</sub>O, and the resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification by column chromatography (silica gel, hexanes/EtOAc, 100:1) afforded <b>19b</b> (170 mg, 64%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.26–7.05 (m, 4H), 6.99–6.90 (m, 4H), 6.83–6.76 (m, 3H), 3.83 (s, 3H), 3.73 (s, 3H), 3.71–3.65 (m, 2H), 3.58 (s, 2H), 2.14–2.01 (m, 2H), 2.00–1.87 (m, 2H), 1.00 (s, 18H), 0.16 (s, 12H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>37</sub>H<sub>55</sub>NO<sub>4</sub>Si<sub>2</sub> 634.3742, found 634.3756.</div></div><div id="sec4_2_5_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 4,4′-((2<i>S</i>,5<i>S</i>)-1-Benzylpyrrolidine-2,5-diyl)bis(2-methoxyphenol) (<b>20b</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from <b>19b</b> (100 mg, 0.15 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) afforded the bis-phenol (50 mg, 82%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.38 (s, 1H), 7.23–7.06 (m, 4H), 7.03–6.89 (m, 3H), 6.85–6.74 (m, 3H), 3.88 (s, 6H), 3.80 (s, 2H), 3.71–3.66 (m, 4H), 2.11–1.99 (m, 2H), 1.80–1.68 (m, 2H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>27</sub>NO<sub>4</sub> 406.2013, found 406.2018. Compound <b>20b</b> was synthesized from the bis-phenol (33 mg, 0.08 mmol) and the tosylate <b>3</b> (116 mg, 0.32 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 1:1) afforded <b>20b</b> (35 mg, 26%) as a white solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.88 (d, <i>J</i> = 8.5 Hz, 2H), 7.74–7.64 (m, 2H), 7.18 (dd, <i>J</i> = 9.3, 2.1 Hz, 2H), 7.10–7.03 (m, 5H), 6.97–6.88 (m, 3H), 6.86–6.72 (m, 3H), 5.67–5.56 (m, 2H), 4.07 (q, <i>J</i> = 7.2 Hz, 2H), 3.94–3.82 (m, 18H), 3.53 (s, 2H), 2.13–2.02 (m, 2H), 1.77–1.68 (m, 2H), 1.63–1.58 (m, 6H).</div></div><div id="sec4_2_5_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (2<i>R</i>,2′<i>R</i>)-2,2′-((((2<i>S</i>,5<i>S</i>)-Pyrrolidine-2,5-diyl)bis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>21</b>)</h5><div class="NLM_p last">The analogue <b>21</b> was synthesized from the aryl benzyl ether <b>20b</b> (21 mg, 0.02 mmol) and 10% palladium on activated carbon in HOAc (1 mL) according to <a class="ref internalNav" href="#sec4_2_1" aria-label="GP1">GP1</a>. Purification by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1) afforded the analogue <b>21</b> as a beige solid (6.9 mg, 50%): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.85 (ddd, <i>J</i> = 8.4, 2.0, 1.2 Hz, 2H), 7.65 (d, <i>J</i> = 2.1 Hz, 2H), 7.27 (s, 2H), 7.10–7.01 (m, 2H), 6.92 (dd, <i>J</i> = 8.2, 2.0 Hz, 2H), 6.76 (d, <i>J</i> = 8.2 Hz, 2H), 5.64–5.57 (m, 2H), 4.32 (br s, 2H), 3.94–3.75 (m, 18H), 2.26–2.19 (m, 2H), 1.84–1.77 (m, 2H), 1.60 (d, <i>J</i> = 6.8 Hz, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>40</sub>H<sub>45</sub>NO<sub>10</sub> 700.3116, found 700.3128; purity 98.39%, <i>t</i><sub>R</sub> 5.877 min.</div></div><div id="sec4_2_5_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 4,4′′-Bis(benzyloxy)-3,3′′-dimethoxy-1,1′:3′,1′′-terphenyl (<b>24a</b>)</h5><div class="NLM_p last">The coupling of <b>22a</b> (0.04 mL, 0.39 mmol) and <b>23</b> (203 mg, 0.78 mmol) was carried out according to <a class="ref internalNav" href="#sec4_2_4" aria-label="GP4">GP4</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 10:1) afforded <b>24a</b> (199 mg, 99%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.70 (s, 1H), 7.54–7.28 (m, 12H), 7.22–7.05 (m, 4H), 7.04–6.89 (m, 3H), 5.21 (d, <i>J</i> = 8.6 Hz, 4H), 3.97 (s, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>34</sub>H<sub>30</sub>O<sub>4</sub> 503.2217, found 503.2219.</div></div><div id="sec4_2_5_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (2<i>R</i>,2′<i>R</i>)-2,2′-((3,3′′-Dimethoxy-[1,1′:3′,1′′-terphenyl]-4,4′′-diyl)bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>25a</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from the aryl benzyl ether <b>24a</b> (28 mg, 0.04 mmol) in EtOH (0.5 mL) and 10% palladium on activated carbon according to <a class="ref internalNav" href="#sec4_2_1" aria-label="GP1">GP1</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 3:1) afforded the bis-phenol (5 mg, 34%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.68 (s, 1H), 7.52–7.41 (m, 3H), 7.18–7.08 (m, 4H), 7.01 (dd, <i>J</i> = 8.2, 2.2 Hz, 2H), 5.65 (s, 2H), 3.96 (s, 6H); HRMS (ESI) <i>m</i>/<i>z</i>  [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>18</sub>O<sub>4</sub> 323.1278, found 323.1269. The analogue <b>25a</b> was synthesized from the bis-phenol (5 mg, 0.01 mmol) and the tosyl ketone <b>3</b> (14.13 mg, 0.03 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 20:1) afforded the analogue <b>25a</b> (3 mg, 27%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.76–7.66 (m, 5H), 7.60 (s, 1H), 7.56–7.50 (m, 3H), 7.43 (d, <i>J</i> = 1.6 Hz, 2H), 7.10 (d, <i>J</i> = 2.1 Hz, 1H), 7.03 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 6.93–6.82 (m, 2H), 5.51–5.43 (m, 2H), 4.09 (s, 3H), 4.07 (s, 3H), 3.94 (s, 6H), 3.92 (s, 3H), 3.89 (s, 3H), 1.76 (d, <i>J</i> = 6.8 Hz, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>42</sub>H<sub>42</sub>O<sub>10</sub> 707.2851, found 707.2865; purity 92.45%, <i>t</i><sub>R</sub> 7.921 min.</div></div><div id="sec4_2_5_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 2,6-Bis(4-(benzyloxy)-3-methoxyphenyl)pyridine (<b>24b</b>)</h5><div class="NLM_p last">The coupling of <b>22b</b> (50.2 mg, 0.21 mmol) and <b>23</b> (219 mg, 0.85 mmol) was carried out according to <a class="ref internalNav" href="#sec4_2_4" aria-label="GP4">GP4</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 10:1) afforded <b>24b</b> (9 mg, 8%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79–7.73 (m, 2H), 7.48 (dd, <i>J</i> = 7.8, 1.0 Hz, 2H), 7.43–7.36 (m, 7H), 7.35–7.28 (m, 5H), 7.23 (d, <i>J</i> = 6.9 Hz, 1H), 6.79–6.73 (m, 2H), 5.76 (s, 4H), 4.01 (s, 6H).</div></div><div id="sec4_2_5_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (2<i>R</i>,2′<i>R</i>)-2,2′-((Pyridine-2,6-diylbis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>25b</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from the aryl benzyl ether <b>24b</b> (41 mg, 0.08 mmol) in EtOH (0.67 mL) and 10% palladium on activated carbon according to <a class="ref internalNav" href="#sec4_2_1" aria-label="GP1">GP1</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 2:1) afforded the bis-phenol (23 mg, 89%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79 (s, 2H), 7.74 (t, <i>J</i> = 7.8 Hz, 1H), 7.62–7.54 (m, 4H), 7.02 (d, <i>J</i> = 8.2 Hz, 2H), 5.76 (br s, 2H), 4.02 (s, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>4</sub> 324.1230, found 324.1248. The analogue <b>25b</b> was synthesized from the bis-phenol (22 mg, 0.06 mmol) and the tosyl ketone <b>3</b> (99 mg, 0.27 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography(silica gel, hexanes/EtOAc, 1:1) afforded the analogue <b>25b</b> (21 mg, 43%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86 (ddd, <i>J</i> = 8.6, 2.0, 1.1 Hz, 2H), 7.78 (dd, <i>J</i> = 2.2, 1.1 Hz, 2H), 7.73–7.67 (m, 3H), 7.57–7.44 (m, 4H), 6.88 (ddd, <i>J</i> = 8.5, 3.6, 1.1 Hz, 4H), 5.49 (q, <i>J</i> = 6.8 Hz, 2H), 3.97 (s, 6H), 3.95 (s, 6H), 3.93 (s, 6H), 1.78 (dd, <i>J</i> = 6.9, 1.2 Hz, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>41</sub>H<sub>41</sub>NO<sub>10</sub> 708.2803, found 708.2819; purity 91.50%, <i>t</i><sub>R</sub> 7.711 min.</div></div><div id="sec4_2_5_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 1,5-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)pentane-1,5-dione (<b>26</b>)</h5><div class="NLM_p last">The 1,5-diketone <b>26</b> was synthesized from the aryl bromide <b>9</b> (7.5 g, 24 mmol) in anhydrous THF (36 mL), <i>n</i>-BuLi (2.5 M in hexanes, 6.4 mL, 16 mmol), and the Weinreb amide <b>12</b> (873 mg, 4 mmol) in anhydrous THF (36 mL) according to <a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>. Purified by column chromatography (silica gel, hexanes/EtOAc, 8:1) afforded <b>26</b> (1.47 g, 64%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58–7.48 (m, 4H), 6.87 (d, <i>J</i> = 8.0 Hz, 2H), 3.87 (s, 6H), 3.06 (t, <i>J</i> = 7.0 Hz, 4H), 2.22–2.12 (m, 2H), 0.99 (s, 18H), 0.18 (s, 12H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 197.74, 150.93, 149.48, 131.48, 122.14, 120.21, 111.18, 54.95, 37.06, 25.12, 19.23, 18.19, −5.31; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>31</sub>H<sub>48</sub>O<sub>6</sub>Si<sub>2</sub> 573.3062, found 573.3069.</div></div><div id="sec4_2_5_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 1,2-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)cyclopent-1-ene (<b>27</b>)</h5><div class="NLM_p last">To the 1,5-diketone <b>26</b> (802 mg, 1.5 mmol) in MeOH was added TsNHNH<sub>2</sub> (701 mg, 3.7 mmol). After stirring for 15 h at 60 °C, the reaction mixture was concentrated under reduced pressure. The resulting solid was used in the next step without further purification. To a solution of the above hydrazide in 1,2-dichloroethane (20 mL) were added LiO<i>t</i>-Bu (185 mg, 2.3 mmol), <i>t-</i>BuXphosAuCl (12.5 mg, 0.01 mmol), and NaBArF (16.8 mg, 0.01 mmol). The reaction mixture was heated to 80 °C and stirred for 16 h under reflux conditions. The reaction mixture was cooled to 25 °C; the solvent was removed, and the residue was purified by column chromatography (silica gel, hexanes/EtOAc, 50:1) to afford <b>27</b> (52 mg, 13%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.76–6.65 (m, 6H), 3.54 (s, 6H), 2.85 (t, <i>J</i> = 7.2 Hz, 4H), 2.05–1.96 (m, 2H), 0.98 (s, 18H), 0.12 (s, 12H).</div></div><div id="sec4_2_5_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (2<i>R</i>,2′<i>R</i>)-2,2′-((Cyclopent-1-ene-1,2-diylbis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>28</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from <b>27</b> (51 mg, 0.09 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 2:1) afforded the bis-phenol (25.5 mg, 88%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.82–6.75 (m, 4H), 6.69–6.60 (m, 2H), 3.65 (s, 6H), 2.85 (t, <i>J</i> = 7.2 Hz, 4H), 2.02–1.96 (m, 2H). Analogue <b>28</b> was synthesized from the bis-phenol (11 mg, 0.03 mmol) and the tosylate <b>3</b> (51 mg, 0.14 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 1:1) afforded analogue <b>28</b> (18 mg, 73%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (d, <i>J</i> = 8.0 Hz, 2H), 7.65 (s, 2H), 6.88 (d, <i>J</i> = 8.8 Hz, 2H), 6.68–6.66 (m, 6H), 5.39 (q, <i>J</i> = 4.0 Hz, 2H), 3.94 (s, 6H), 3.91 (s, 6H), 3.51 (s, 6H), 2.79 (t, <i>J</i> = 7.2 Hz, 4H), 1.98–1.94 (m, 2H), 1.69 (d, <i>J</i> = 6.7 Hz, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>41</sub>H<sub>44</sub>O<sub>10</sub> 719.2827, found 719.2842; purity 94.57%, <i>t</i><sub>R</sub> 8.094 min.</div></div><div id="sec4_2_5_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> (4-((1,3-Dithian-2-yl)methyl)-2-methoxyphenoxy)(<i>tert</i>-butyl)dimethylsilane (<b>31</b>)</h5><div class="NLM_p last">Compound <b>31</b> was synthesized from 1,3-dithiane (<b>29</b>) (58 mg, 0.48 mmol) in anhydrous THF (4 mL), <i>n</i>-BuLi (2.5 M in hexanes, 0.19 mL, 0.48 mmol), and the benzyl bromide <b>30</b> (161 mg, 0.48 mmol) in anhydrous THF (0.9 mL) according to <a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 20:1) afforded <b>31</b> (71 mg, 39%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.77 (d, <i>J</i> = 7.9 Hz, 1H), 6.72 (d, <i>J</i> = 2.0 Hz, 1H), 6.69 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 4.21 (t, <i>J</i> = 7.3 Hz, 1H), 3.79 (s, 3H), 2.93 (d, <i>J</i> = 7.3 Hz, 2H), 2.90–2.77 (m, 4H), 2.17–2.06 (m, 1H), 1.92–1.79 (m, 1H), 0.98 (s, 9H), 0.14 (s, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>30</sub>O<sub>2</sub>S<sub>2</sub>Si 371.1529, found 371.1532.</div></div><div id="sec4_2_5_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> ((((1,3-Dithiane-2,2-diyl)bis(methylene))bis(2-methoxy-4,1-phenylene))bis(oxy))bis(<i>tert</i>-butyldimethylsilane) (<b>32</b>)</h5><div class="NLM_p last">Compound <b>32</b> was synthesized from the dithiane <b>31</b> (21 mg, 0.05 mmol) in THF/HMPA (10:1, 0.7 mL), <i>t</i>-BuLi (1.7 M in pentane, 33 μL, 0.05 mmol), and the benzyl bromide <b>30</b> (28 mg, 0.08 mmol) in anhydrous THF (0.4 mL) according to <a class="ref internalNav" href="#sec4_2_2" aria-label="GP2">GP2</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 20:1) afforded <b>32</b> (22 mg, 63%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.86 (d, <i>J</i> = 1.7 Hz, 2H), 6.81–6.71 (m, 4H), 3.78 (s, 6H), 3.11 (s, 4H), 2.79–2.68 (m, 4H), 1.89–1.77 (m, 2H), 0.99 (s, 18H), 0.15 (s, 12H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>32</sub>H<sub>52</sub>O<sub>4</sub>S<sub>2</sub>Si<sub>2</sub> 621.2918, found 621.2904.</div></div><div id="sec4_2_5_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (2<i>R</i>,2′<i>R</i>)-2,2′-((((1,3-Dithiane-2,2-diyl)bis(methylene))bis(2-methoxy-4,1-phenylene))bis(oxy))bis(1-(3,4-dimethoxyphenyl)propan-1-one) (Analogue <b>33</b>)</h5><div class="NLM_p last">The bis-phenol was synthesized from <b>32</b> (20 mg, 0.03 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 3:1) afforded bis-phenol (10 mg, 79%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.93–6.74 (m, 6H), 5.55 (br s, 2H), 3.87 (s, 6H), 3.13 (s, 4H), 2.89–2.77 (m, 4H), 1.98–1.79 (m, 2H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>24</sub>O<sub>4</sub>S<sub>2</sub> 393.1189, found 393.1184. Analogue <b>33</b> was synthesized from the bis-phenol (10 mg, 0.02 mmol) and the tosyl ketone <b>3</b> (35 mg, 0.1 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 1:1 to 1:2) afforded analogue <b>33</b> (17 mg, 86%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81 (d, <i>J</i> = 8.4 Hz, 2H), 7.66 (s, 2H), 6.87 (d, <i>J</i> = 8.5 Hz, 2H), 6.85 (s, 1H), 6.77–6.61 (m, 4H), 5.40 (q, <i>J</i> = 4.0 Hz, 2H), 3.93 (s, 6H), 3.91 (s, 6H), 3.79 (s, 6H), 3.04 (s, 4H), 2.82–2.63 (m, 4H), 1.86–1.76 (m, 2H), 1.71 (d, <i>J</i> = 6.7 Hz, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>42</sub>H<sub>48</sub>O<sub>10</sub>S<sub>2</sub> 777.2762, found 777.2764; purity 92.42%, <i>t</i><sub>R</sub> 7.780 min.</div></div><div id="sec4_2_5_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Bromo(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxybenzyl)triphenyl-l5-phosphane (<b>35</b>)</h5><div class="NLM_p last">To a solution of the benzyl bromide <b>34</b> (675 mg, 2.04 mmol) in anhydrous toluene (8 mL) was added PPh<sub>3</sub> (1.6 g, 6.11 mmol). The reaction mixture was heated to 80 °C and stirred for 2 h under reflux conditions. The reaction mixture was cooled to 25 °C, and the precipitate was filtered and purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 20:1) to afford the phosphonium salt <b>35</b> (720 mg, 60%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.84–7.50 (m, 15H), 6.84 (t, <i>J</i> = 2.2 Hz, 1H), 6.59 (d, <i>J</i> = 8.1 Hz, 1H), 6.43 (dt, <i>J</i> = 8.2, 2.5 Hz, 1H), 5.27 (d, <i>J</i> = 13.7 Hz, 2H), 3.46 (s, 3H), 1.93 (m, 9H), 0.07 (m, 6H).</div></div><div id="sec4_2_5_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>E</i>)-1,2-Bis(4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methoxyphenyl)ethene (<b>37</b>)</h5><div class="NLM_p last">To a cooled (−78 °C) solution of <b>35</b> (211 mg, 0.36 mmol) in anhydrous THF (2 mL, 0.5 M) was added LHMDS (1 M in THF, 0.36 mL, 0.36 mmol) dropwise. The resulting mixture was stirred at the same temperature for 20 min and treated with a solution of aldehyde <b>36</b> (142 mg, 0.53 mmol) in anhydrous THF (1 mL). After stirring for 5.5 h at 0 °C, the reaction was quenched by the addition of saturated aqueous NH<sub>4</sub>Cl solution and diluted with EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified by column chromatography (silica gel, hexanes/EtOAc 30:1) to afford the corresponding TBS-protected <i>trans</i>-alkene (15 mg, 8.4%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.01 (d, <i>J</i> = 1.9 Hz, 2H), 6.95 (dd, <i>J</i> = 2.0, 8.2 Hz, 2H), 6.90 (s, 2H), 6.82 (d, <i>J</i> = 8.1 Hz, 2H), 3.86 (s, 6H), 1.00 (s, 18H), 0.17 (s, 12H); HRMS (ESI) <i>m</i>/<i>z</i> [M + NH<sub>4</sub>]<sup>+</sup> calcd for C<sub>28</sub>H<sub>44</sub>O<sub>4</sub>Si<sub>2</sub> 518.3116, found 518.3124. The bis-phenol <b>37</b> was synthesized from the TBS-protected <i>trans</i>-alkene (83 mg, 0.16 mmol) according to <a class="ref internalNav" href="#sec4_2_3" aria-label="GP3">GP3</a>. Purification by column chromatography (silica gel, hexanes/EtOAc 2:1) afforded <b>37</b> as a white solid (24 mg, 55%): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.64 (s, 2H), 7.17 (d, <i>J</i> = 1.7 Hz, 2H), 6.98 (s, 2H), 6.97–6.96 (m, 2H), 6.79 (d, <i>J</i> = 8.1 Hz, 2H), 3.88 (s, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>16</sub>O<sub>4</sub> 273.1121, found 273.1120.</div></div><div id="sec4_2_5_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (<i>S</i>)-1-(3,4-Dimethoxyphenyl)-2-(4-((<i>E</i>)-4-(((<i>R</i>)-1-(3,4-dimethoxyphenyl)-1-oxopropan-2-yl)oxy)-3-methoxystyryl)-2-methoxyphenoxy)propan-1-one (Analogue <b>38</b>)</h5><div class="NLM_p last">Analogue <b>38</b> was synthesized from the bis-phenol <b>37</b> (25 mg, 0.09 mmol) and the tosylate <b>3</b> (134 mg, 0.36 mmol) according to <a class="ref internalNav" href="#sec4_2_5" aria-label="GP5">GP5</a>. Purification by column chromatography (silica gel, hexanes/EtOAc, 10:1) afforded the analogue <b>38</b> (27 mg, 45%) as a white solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>COCD<sub>3</sub>) δ 7.91 (dd, <i>J</i> = 8.4, 1.7 Hz, 2H), 7.72 (d, <i>J</i> = 2.0 Hz, 2H), 7.27 (d, <i>J</i> = 1.9 Hz, 1H), 7.12 (dd, <i>J</i> = 8.5, 1.4 Hz, 2H), 7.09 (d, <i>J</i> = 1.5 Hz, 1H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 6.86 (dd, <i>J</i> = 8.4, 1.4 Hz, 5H), 5.78–5.68 (m, 2H), 3.97 (s, 6H), 3.94 (s, 6H), 3.93 (s, 6H), 1.69 (d, <i>J</i> = 6.7 Hz, 6H); HRMS (ESI) <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>38</sub>H<sub>40</sub>O<sub>10</sub> 679.2519, found 679.2522; purity 90.65%, <i>t</i><sub>R</sub> 7.557 min.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Dual Luciferase-Reporter Assay</h3><div class="NLM_p last">HEK-293T cells were seeded on 96-well plates at a density of 5 × 10<sup>3</sup> cells/well and allowed to attach for 24 h. Cells were transfected with a pGL3-5 × HRE-Luc plasmid containing five copies of HREs in human <i>VEGF</i> promoter and pRL-SV40 plasmid encoding Renilla luciferase using the Vivamagic Transfection Reagent (Vivagene, Seongnam, Korea), according to the manufacturer’s instructions. Cells were treated with hypoxia (1% O<sub>2</sub>) and serially diluted compounds for 24 h after transfection. The luciferase-reporter assay was performed using the Dual-Glo Luciferase Assay System (Promega, Madison, WI, USA) according to the manufacturer’s instructions. Briefly, an equal volume of the Dual-Glo Reagent to the culture medium was added to each well, and the mixture was incubated for 10 min. The firefly luminescence was measured using a microplate reader (Infinite M200 Pro, TECAN, Männedorf, Switzerland). The Dual-Glo Stop & Glo Reagent was added, and the mixture was incubated for 10 min before the measurement of Renilla luminescence. The firefly luminescence signals were normalized to the activity of Renilla luciferase. Three independent experiments were performed.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Molecular Overlay</h3><div class="NLM_p last">The molecular overlay of manassantin A analogues was generated based on a total number of 2 analogues that were tested for their activity against HIF-1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The molecular structures were sketched and built with Maestro 11.2 (Schrödinger, NY). Low-energy conformations of manassantin A analogues were generated by LigPrep. LigPrep used the force field OPLS3e and charges in all ligand preparation steps. All possible protonation and ionization states were enumerated for each ligand at pH 7.4. Only the lowest energy conformer was kept for each ligand. Ligand conformation sampling was done by using the MacroModel module of Maestro. The extended cutoff of the MacroModel (van der Waals, 8.0; electrostatic, 20.0; and H-bond, 4.0) was used. The superimpose model was generated by using the Structure Alignment module of Schrödinger Glide. The superimposition of conformers was developed with the “atom pair” method in the Structure Alignment module.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Mice</h3><div class="NLM_p last">Animal experiments were performed using C57BL/6J mice (Japan SLC, Shizuoka, Japan), which were handled in strict compliance with the guidelines for care and use of laboratory animals issued (KNU 2017-145) by the Institutional Ethical Animal Care Committee of Kyungpook National University (Daegu, Korea).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>In Vivo</i> Animal Study</h3><div class="NLM_p last">To generate a Lewis lung carcinoma (LLC) allograft tumor model, suspensions of LLC cells (2 × 10<sup>5</sup> cells in 200 μL of serum-free culture media) were implanted subcutaneously into the dorsal flank regions of 5–6 week old male C57BL/6 mice (Day 0). From 2 days after inoculation, mice (<i>n</i> = 5 per group) were treated with manassantin A (5 mg/kg body weight) and/or gefitinib (5 mg/kg body weight) intraperitoneally three times a week for 17 days. Body weights were measured three times a week for 17 days. Tumor volumes (cm<sup>3</sup>) were calculated by multiplying the height by length by depth. Eventually, the mice were anesthetized, and their tumor tissues were harvested at the completion of the study period.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00151" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00151?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00151</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Determination of enantiomeric excess of <b>7</b> and <b>18</b>, body weight, and HPLC traces of final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES representations and relative luciferase activity (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf">jm0c00151_si_001.pdf (928.84 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_002.csv">jm0c00151_si_002.csv (1.49 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00151" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">You Mie Lee</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, Kyungpook
National University, 80 Daehak-ro, Buk-gu,  Daegu 41566, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5756-7169" title="Orcid link">http://orcid.org/0000-0002-5756-7169</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#036f7a6e43686d762d62602d6871"><span class="__cf_email__" data-cfemail="026e7b6f42696c772c63612c6970">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyong Hong</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke
University Medical Center, Durham, North Carolina 27710, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5253-0949" title="Orcid link">http://orcid.org/0000-0002-5253-0949</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b71726274757c357374757c5b7f6e707e357e7f6e"><span class="__cf_email__" data-cfemail="c4aeadbdabaaa3eaacabaaa384a0b1afa1eaa1a0b1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seung-Hwa Kwak</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tesia N. Stephenson</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hye-Eun Lee</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, Kyungpook
National University, 80 Daehak-ro, Buk-gu,  Daegu 41566, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Ge</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, Kyungpook
National University, 80 Daehak-ro, Buk-gu,  Daegu 41566, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyunji Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophia M. Min</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jea Hyun Kim</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Do-Yeon Kwon</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Duke University, Durham, North Carolina 27708, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.-H.K., T.N.S., H.L., S.M.M., J.H.K., and D.-Y.K. synthesized manassantin A and analogues used in in vitro and in vivo testing. S.-H.K. performed conformational analysis. H.-E.L. performed in vivo testing of manassantin A. Y.G. performed the in vitro luciferase assay of manassantin A and analogues. Y.M.L. designed in vitro and in vivo testing and analyzed the data. J.H. conceived the project, designed the overall experimental strategy, and analyzed and discussed the results. J.H., Y.M.L., and S.-H.K. wrote the manuscript with input from all of the authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the American Cancer Society (122057-RSG-12-045-01-CDD to J.H.) and the Korean National Research Foundation (NRF-2017R1A2B3002227 to Y.M.L.). T.N.S. was supported by the NSF Graduate Research Fellowship Program.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BEMP</td><td class="NLM_def"><p class="first last">2-<i>tert</i>-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine</p></td></tr><tr><td class="NLM_term">CDK6</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 6</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">GLUT1</td><td class="NLM_def"><p class="first last">glucose transporter 1</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HIF-1</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor</p></td></tr><tr><td class="NLM_term">HRE</td><td class="NLM_def"><p class="first last">hypoxia response element</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneally</p></td></tr><tr><td class="NLM_term">LLC</td><td class="NLM_def"><p class="first last">Lewis lung carcinoma</p></td></tr><tr><td class="NLM_term">PMHS</td><td class="NLM_def"><p class="first last">polymethylhydrosiloxane</p></td></tr><tr><td class="NLM_term">RLU</td><td class="NLM_def"><p class="first last">relative light unit</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">s.c.</td><td class="NLM_def"><p class="first last">subcutaneously</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydropyran</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torre, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.3322/caac.21492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.3322%2Fcaac.21492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=30207593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=394-424&author=F.+Brayauthor=J.+Ferlayauthor=I.+Soerjomataramauthor=R.+L.+Siegelauthor=L.+A.+Torreauthor=A.+Jemal&title=Global+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countries&doi=10.3322%2Fcaac.21492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span></div><div class="casAuthors">Bray Freddie; Ferlay Jacques; Soerjomataram Isabelle; Siegel Rebecca L; Torre Lindsey A; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">394-424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.  There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018.  In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality.  Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality).  Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality.  The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors.  It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries.  The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts.  CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaW5wv8ocuhLxanA7vODO6fW6udTcc2eaqq3hjK_DP3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D&md5=48529f8f794092779d70a27eec5c9017</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21492%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DF.%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DTorre%26aufirst%3DL.%2BA.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DGlobal%2520cancer%2520statistics%25202018%253A%2520GLOBOCAN%2520estimates%2520of%2520incidence%2520and%2520mortality%2520worldwide%2520for%252036%2520cancers%2520in%2520185%2520countries%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2018%26volume%3D68%26spage%3D394%26epage%3D424%26doi%3D10.3322%2Fcaac.21492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Agency for Healthcare Research
and Quality</span>. <span> </span><span class="NLM_article-title">Total expenditures
in millions by condition</span>, <span class="NLM_publisher-loc">U.S.</span>, <span class="NLM_year">2015</span>.  <i>Medical Expenditure Panel Survey</i>. <a href="https://www.meps.ahrq.gov/mepstrends/hc_cond/" class="extLink">https://www.meps.ahrq.gov/mepstrends/hc_cond/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Agency+for+Healthcare+Research%0Aand+Quality&title=Medical+Expenditure+Panel+Survey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DTotal%2520expenditures%250Ain%2520millions%2520by%2520condition%26date%3D2015%26btitle%3DMedical%2520Expenditure%2520Panel%2520Survey" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmarcher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilking, N.</span></span> <span> </span><span class="NLM_article-title">The cost and burden of cancer in the European Union 1995−2014</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2016.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.ejca.2016.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=27589247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BC2szmvVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=162-170&author=B.+Jonssonauthor=T.+Hofmarcherauthor=P.+Lindgrenauthor=N.+Wilking&title=The+cost+and+burden+of+cancer+in+the+European+Union+1995%E2%88%922014&doi=10.1016%2Fj.ejca.2016.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The cost and burden of cancer in the European Union 1995-2014</span></div><div class="casAuthors">Jonsson Bengt; Hofmarcher Thomas; Lindgren Peter; Wilking Nils</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cancer (Oxford, England : 1990)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">162-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is an intense debate about the cost of cancer and the value of new treatments.  However, there is limited data on the cost of cancer in the European Union (EU) and how costs relate to the burden of disease.  This paper presents new estimates on the development of the cost of cancer in the EU 1995-2014, with a focus on the major cost components: total health expenditure, cancer drugs, and production loss due to premature mortality.  METHODS:  Data on overall health expenditure were combined with national disease estimates to derive cancer-specific health expenditure.  Data on drug sales were obtained from IMS Health, and epidemiological data were used to calculate life years lost due to cancer.  FINDINGS:  Health expenditure on cancer increased continuously from .EURO.35.7 billion in 1995 to .EURO.83.2 billion in 2014 in the EU and spending on cancer drugs from .EURO.7.6 billion in 2005 to .EURO.19.1 billion in 2014 (current prices).  Yet the share of total health expenditure devoted to cancer was mostly constant (around 6 per cent).  While expenditures on cancer drugs increased in both absolute and relative terms, other expenditures were stable or decreased, despite increases in cancer incidence driven by a growing and ageing population.  Reductions in cancer mortality during working age resulted in decreasing production loss due to premature mortality.  INTERPRETATION:  Health spending on cancer as a share of total health expenditure is rather low and stable despite the growing incidence and relative burden of cancer.  Problems to reallocate funding in health care systems under economic pressure may be one explanation and shifting costs from inpatient to ambulatory care another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgkJlfSeKauDUE-swuRqsHfW6udTcc2eZMmKrKSgsIXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szmvVygtA%253D%253D&md5=3d538997967c9790503a7c7f73b71cca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2016.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2016.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DB.%26aulast%3DHofmarcher%26aufirst%3DT.%26aulast%3DLindgren%26aufirst%3DP.%26aulast%3DWilking%26aufirst%3DN.%26atitle%3DThe%2520cost%2520and%2520burden%2520of%2520cancer%2520in%2520the%2520European%2520Union%25201995%25E2%2588%25922014%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2016%26volume%3D66%26spage%3D162%26epage%3D170%26doi%3D10.1016%2Fj.ejca.2016.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Oxygen sensing, homeostasis, and disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1056/NEJMra1011165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1056%2FNEJMra1011165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=21830968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVars7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=537-547&author=G.+L.+Semenza&title=Oxygen+sensing%2C+homeostasis%2C+and+disease&doi=10.1056%2FNEJMra1011165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: oxygen sensing, homeostasis, and disease</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry90AK1l3p5LVg90H21EOLACvtfcHk0li2eDn4LQlOVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVars7nP&md5=2944fe18da77d2f5d74f8edd75661b51</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1011165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1011165%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DOxygen%2520sensing%252C%2520homeostasis%252C%2520and%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D537%26epage%3D547%26doi%3D10.1056%2FNEJMra1011165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rue, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O<sub>2</sub> tension</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">5510</span>– <span class="NLM_lpage">5514</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.12.5510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1073%2Fpnas.92.12.5510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=7539918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFOgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=5510-5514&author=G.+L.+Wangauthor=B.+H.+Jiangauthor=E.+A.+Rueauthor=G.+L.+Semenza&title=Hypoxia-inducible+factor+1+is+a+basic-helix-loop-helix-PAS+heterodimer+regulated+by+cellular+O2+tension&doi=10.1073%2Fpnas.92.12.5510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension</span></div><div class="casAuthors">Wang, Guang L.; Jiang, Bing-Hua; Rue, Elizabeth A.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5510-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is found in mammalian cells cultured under reduced O2 tension and is necessary for transcriptional activation mediated by the erythropoietin gene enhancer in hypoxic cells.  We show that both HIF-1 subunits are basic-helix-loop-helix proteins contg. a PAS domain, defined by its presence in the Drosophila Per and Sim proteins and in the mammalian ARNT and AHR proteins.  HIF-1α is most closely related to Sim.  HIF-1α and HIF-1β (ARNT) RNA and protein levels were induced in cells exposed to 1% O2 and decayed rapidly upon return of the cells to 20% O2, consistent with the role of HIF-1 as a mediator of transcriptional responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrijPeJeRyVcrVg90H21EOLACvtfcHk0li2eDn4LQlOVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFOgs7k%253D&md5=31e7aac200d3271870e8ad7dc06b4734</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.12.5510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.12.5510%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BL.%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DRue%26aufirst%3DE.%2BA.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factor%25201%2520is%2520a%2520basic-helix-loop-helix-PAS%2520heterodimer%2520regulated%2520by%2520cellular%2520O2%2520tension%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D5510%26epage%3D5514%26doi%3D10.1073%2Fpnas.92.12.5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lisy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span> <span> </span><span class="NLM_article-title">Turn me on: regulating HIF transcriptional activity</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">642</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4402315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1038%2Fsj.cdd.4402315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=18202699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtl2ju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=642-649&author=K.+Lisyauthor=D.+J.+Peet&title=Turn+me+on%3A+regulating+HIF+transcriptional+activity&doi=10.1038%2Fsj.cdd.4402315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Turn me on: regulating HIF transcriptional activity</span></div><div class="casAuthors">Lisy, K.; Peet, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">642-649</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The hypoxia-inducible factors (HIFs) are crit. for cellular adaptation to limiting oxygen and regulate a wide array of genes when cued by cellular oxygen-sensing mechanisms.  HIF is able to direct transcription from either of two transactivation domains, each of which is regulated by distinct mechanisms.  The oxygen-dependent asparaginyl hydroxylase factor-inhibiting HIF-1α (FIH-1) is a key regulator of the HIF C-terminal transactivation domain, and provides a direct link between oxygen sensation and HIF-mediated transcription.  Addnl., there are phosphorylation and nitrosylation events reported to modulate HIF transcriptional activity, as well as numerous transcriptional coactivators and other interacting proteins that together provide cell and tissue specificity of HIF target gene regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBRwIpomo01bVg90H21EOLACvtfcHk0lggfCDwFRnYIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtl2ju7c%253D&md5=59d0c2050f32bf5dfe3ab9ab68ae0b08</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402315%26sid%3Dliteratum%253Aachs%26aulast%3DLisy%26aufirst%3DK.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26atitle%3DTurn%2520me%2520on%253A%2520regulating%2520HIF%2520transcriptional%2520activity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2008%26volume%3D15%26spage%3D642%26epage%3D649%26doi%3D10.1038%2Fsj.cdd.4402315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, P.</span></span> <span> </span><span class="NLM_article-title">Tumor microenvironmental physiology and its implications for radiation oncology</span>. <i>Semin. Radiat. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1016/j.semradonc.2004.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.semradonc.2004.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=15254862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BD2czltFOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=198-206&author=P.+Vaupel&title=Tumor+microenvironmental+physiology+and+its+implications+for+radiation+oncology&doi=10.1016%2Fj.semradonc.2004.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor microenvironmental physiology and its implications for radiation oncology</span></div><div class="casAuthors">Vaupel Peter</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in radiation oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-206</span>
        ISSN:<span class="NLM_cas:issn">1053-4296</span>.
    </div><div class="casAbstract">The microenvironmental physiology of tumors is uniquely different from that of normal tissues.  It is characterized, inter alia, by O(2) depletion (hypoxia, anoxia), glucose and energy deprivation, high lactate levels, and extracellular acidosis, parameters that are anisotropically distributed within the tumor mass.  This hostile microenvironment is largely dictated by the abnormal tumor vasculature and heterogeneous microcirculation.  Hypoxia and other hostile microenvironmental parameters are known to directly or indirectly confer resistance to irradiation leading to treatment failure.  Hypoxia directly leads to a reduced "fixation" of radiation-induced DNA damage.  Indirect mechanisms include a restrained proliferation, changes in gene expression and alterations of the proteome (eg, elevated activity of DNA-repair enzymes and resistance-related proteins, increased transcription of growth factors), and genomic changes (genomic instability leading to clonal heterogeneity and selection of resistant clonal variants).  These changes, caused by the hostile microenvironment, can favor tumor progression and acquired treatment resistance, both resulting in poor clinical outcome and prognosis.  Pretreatment assessment of critical microenvironmental parameters is therefore needed to allow the selection of patients who could benefit from special treatment approaches (eg, hypoxia-targeting therapy).  Because of a relatively high risk of local relapse or distant metastasis, patients with hypoxic and/or "high-lactate" tumors should undergo close surveillance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUAShbi-bxLYxhnOQkIHOxfW6udTcc2eaNFhg3u5Wrp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltFOrsQ%253D%253D&md5=52dc30f316eac2b99d237f3e2ddbe064</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.semradonc.2004.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semradonc.2004.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DVaupel%26aufirst%3DP.%26atitle%3DTumor%2520microenvironmental%2520physiology%2520and%2520its%2520implications%2520for%2520radiation%2520oncology%26jtitle%3DSemin.%2520Radiat.%2520Oncol.%26date%3D2004%26volume%3D14%26spage%3D198%26epage%3D206%26doi%3D10.1016%2Fj.semradonc.2004.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laissue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djonov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Expression of hypoxia-inducible factor-1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2911</span>– <span class="NLM_lpage">2916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=11306467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2911-2916&author=D.+M.+Aebersoldauthor=P.+Burriauthor=K.+T.+Beerauthor=J.+Laissueauthor=V.+Djonovauthor=R.+H.+Greinerauthor=G.+L.+Semenza&title=Expression+of+hypoxia-inducible+factor-1a%3A+a+novel+predictive+and+prognostic+parameter+in+the+radiotherapy+of+oropharyngeal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer</span></div><div class="casAuthors">Aebersold, Daniel M.; Burri, Philipp; Beer, Karl T.; Laissue, Jean; Djonov, Valentin; Greiner, Richard H.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2911-2916</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia has long been recognized as detrimental to the successful treatment of malignant tumors with ionizing radiation.  Because hypoxia-inducible factor (HIF)-1α plays an essential role in oxygen homeostasis in vitro, we explored the predictive potential of this factor in a cohort of 98 patients with squamous cell cancer of the oropharynx, who were treated by curative radiation therapy.  Ninety-four % of the primary tumors showed overexpression of HIF-1α, relative to the surrounding tissue, as detd. by immunohistochem.  The degree of HIF-1α immunoreactivity correlated inversely with both the rate of complete remission of the primary tumor (odds ratio, 0.33; P = 0.03) and lymph node metastases (odds ratio, 0.34; P = 0.02) as well as with local failure-free survival (risk ratio, 2.15; P = 0.006), disease-free survival (risk ratio, 2.01; P = 0.008), and overall survival (risk ratio, 2.17; P = 0.002).  The multivariate anal. revealed the predictive power of HIF-1α to be independent of other covariables.  We conclude that HIF-1α is overexpressed in the vast majority of patients with squamous cell cancer of the oropharynx and that the degree of expression has predictive and prognostic significance in individuals undergoing curative radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQvUdKVgiYYrVg90H21EOLACvtfcHk0lggfCDwFRnYIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGqsr8%253D&md5=57fd3b52a292989d6c6548c5bbb25359</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAebersold%26aufirst%3DD.%2BM.%26aulast%3DBurri%26aufirst%3DP.%26aulast%3DBeer%26aufirst%3DK.%2BT.%26aulast%3DLaissue%26aufirst%3DJ.%26aulast%3DDjonov%26aufirst%3DV.%26aulast%3DGreiner%26aufirst%3DR.%2BH.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DExpression%2520of%2520hypoxia-inducible%2520factor-1a%253A%2520a%2520novel%2520predictive%2520and%2520prognostic%2520parameter%2520in%2520the%2520radiotherapy%2520of%2520oropharyngeal%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2911%26epage%3D2916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(04)00115-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS1535-6108%2804%2900115-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=15144951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-441&author=B.+J.+Moellerauthor=Y.+Caoauthor=C.+Y.+Liauthor=M.+W.+Dewhirst&title=Radiation+activates+HIF-1+to+regulate+vascular+radiosensitivity+in+tumors%3A+role+of+reoxygenation%2C+free+radicals%2C+and+stress+granules&doi=10.1016%2FS1535-6108%2804%2900115-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules</span></div><div class="casAuthors">Moeller, Benjamin J.; Cao, Yiting; Li, Chuan Y.; Dewhirst, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Through a poorly understood mechanism, tumors respond to radiation by secreting cytokines capable of inhibiting apoptosis in endothelial cells, thereby diminishing treatment response by minimizing vascular damage.  We reveal here that this pathway is governed by a major angiogenesis regulator, HIF-1.  Following radiotherapy, tumor reoxygenation leads to: (1) nuclear accumulation of HIF-1 in response to reactive oxygen, and (2) enhanced translation of HIF-1-regulated transcripts secondary to stress granule depolymn.  The resulting increase in HIF-1-regulated cytokines enhances endothelial cell radioresistance.  Inhibiting postradiation HIF-1 activation significantly increases tumor radiosensitivity as a result of enhanced vascular destruction.  These data describe novel pathways contributing significantly to our understanding of HIF-1 regulation which may be major determinants of tumor radiosensitization, potentially having high clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlGjDbjcgvbVg90H21EOLACvtfcHk0lgW8z8v5_CXAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7k%253D&md5=dfc296af70e9885fb40cb0fc7c1b918e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900115-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900115-1%26sid%3Dliteratum%253Aachs%26aulast%3DMoeller%26aufirst%3DB.%2BJ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DRadiation%2520activates%2520HIF-1%2520to%2520regulate%2520vascular%2520radiosensitivity%2520in%2520tumors%253A%2520role%2520of%2520reoxygenation%252C%2520free%2520radicals%252C%2520and%2520stress%2520granules%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D441%26doi%3D10.1016%2FS1535-6108%2804%2900115-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koukourakis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giatromanolaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivridis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talks, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatter, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1016/S0360-3016(02)02848-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0360-3016%2802%2902848-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=12128120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVKqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=1192-1202&author=M.+I.+Koukourakisauthor=A.+Giatromanolakiauthor=E.+Sivridisauthor=C.+Simopoulosauthor=H.+Turleyauthor=K.+Talksauthor=K.+C.+Gatterauthor=A.+L.+Harris&title=Hypoxia-inducible+factor+%28HIF1A+and+HIF2A%29%2C+angiogenesis%2C+and+chemoradiotherapy+outcome+of+squamous+cell+head-and-neck+cancer&doi=10.1016%2FS0360-3016%2802%2902848-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer</span></div><div class="casAuthors">Koukourakis, Michael I.; Giatromanolaki, Alexandra; Sivridis, Efthimios; Simopoulos, Constantinos; Turley, Helen; Talks, Kate; Gatter, Kevin C.; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1192-1202</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Purpose: Hypoxia-inducible factors HIF1α and HIF2α (HIFαs) regulate the expression of a variety of genes encoding proteins related to angiogenesis and to anaerobic metab. of cells exposed to hypoxic stress.  Their putative role as markers of clin. relevant hypoxia and, therefore, as predictors of response to chemoradiotherapy is herein examd.  Patients and Methods: Using immunohistochem., we assessed the expression of HIFαs in normal head-neck mucosa and in 75 cancer specimens from patients with locally advanced squamous cell head-and-neck cancer (SCHNC), treated with concurrent carboplatin chemoradiotherapy.  Results: Head-and-neck mucosa from normal individuals did not show any HIF1α or HIF2α reactivity.  SCHNC showed a varying expression of HIFαs ranging through neg. reactivity, to weak or focally strong cytoplasmic reactivity, or to strong diffuse cytoplasmic/nuclear reactivity.  Fifty-two percent and 33% of cancer samples showed the latter expression pattern for HIF1α and HIF2α, resp., and were considered to bear "high" HIF reactivity.  Bone/cartilage involvement was more frequent in tumors with high HIF1α expression (p = 0.05).  HIF1α and HIF2α overexpression were significantly assocd. with high microvessel d. (p = 0.002 and 0.02, resp.) and with VEGF expression (p = 0.01 and 0.005, resp.).  HIF1α was related to high thymidine phosphorylase expression (p = 0.03), whereas VEGF/KDR-activated tumor vasculature was significantly more frequent in HIF2α-overexpressing tumors (p = 0.02).  High HIF1α and HIF2α were assocd. with incomplete response to chemoradiation (p = 0.007 and p = 0.02, resp.).  In univariate anal., high HIF1α and HIF2α expression were significantly assocd. with poor local relapse-free survival (p = 0.003 and 0.003, resp.) and with poor overall survival (p = 0.05 and 0.001, resp.).  In multivariate models, HIF2α expression was an independent prognostic factor.  In biopsies performed after the delivery of 20 Gy of radiotherapy, upregulation of HIFαs was noted in some cases.  Conclusions: It is concluded that the overexpression of HIFαs in SCHNC is related to locally aggressive behavior, to intensification of angiogenesis, and to an important resistance to carboplatin chemoradiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonFIk55FiAtbVg90H21EOLACvtfcHk0lgW8z8v5_CXAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVKqs70%253D&md5=1b398079f84d1581734b57d2ee9223b1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2802%2902848-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252802%252902848-1%26sid%3Dliteratum%253Aachs%26aulast%3DKoukourakis%26aufirst%3DM.%2BI.%26aulast%3DGiatromanolaki%26aufirst%3DA.%26aulast%3DSivridis%26aufirst%3DE.%26aulast%3DSimopoulos%26aufirst%3DC.%26aulast%3DTurley%26aufirst%3DH.%26aulast%3DTalks%26aufirst%3DK.%26aulast%3DGatter%26aufirst%3DK.%2BC.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHypoxia-inducible%2520factor%2520%2528HIF1A%2520and%2520HIF2A%2529%252C%2520angiogenesis%252C%2520and%2520chemoradiotherapy%2520outcome%2520of%2520squamous%2520cell%2520head-and-neck%2520cancer%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2002%26volume%3D53%26spage%3D1192%26epage%3D1202%26doi%3D10.1016%2FS0360-3016%2802%2902848-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors: master regulators of cancer progression</span>. <i>Trends Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">758</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1016/j.trecan.2016.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.trecan.2016.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=28741521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BC1cfgvFansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=758-770&author=L.+Schitoauthor=G.+L.+Semenza&title=Hypoxia-inducible+factors%3A+master+regulators+of+cancer+progression&doi=10.1016%2Fj.trecan.2016.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-Inducible Factors: Master Regulators of Cancer Progression</span></div><div class="casAuthors">Schito Luana; Semenza Gregg L</div><div class="citationInfo"><span class="NLM_cas:title">Trends in cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">758-770</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Intratumoral hypoxia (reduced O2 availability) is a common finding in human cancer and leads to increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes that contribute to angiogenesis, metabolic reprogramming, extracellular matrix remodeling, epithelial-mesenchymal transition, motility, invasion, metastasis, cancer stem cell maintenance, immune evasion, and resistance to chemotherapy and radiation therapy.  Conventional anticancer therapies target well-oxygenated and proliferating cancer cells, whereas there are no approved therapies that target hypoxic cancer cells, despite growing clinical and experimental evidence indicating that intratumoral hypoxia is a critical microenvironmental factor driving cancer progression.  In this review, our current understanding of the consequences of HIF activity and the translational potential of targeting HIFs for cancer therapy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTd1_IJq-f2zlVwdslNBF-tfW6udTcc2eZ93sbSLRLEDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfgvFansA%253D%253D&md5=8aa53aef8e891394c0505b1c9fa9491e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.trecan.2016.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trecan.2016.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DSchito%26aufirst%3DL.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factors%253A%2520master%2520regulators%2520of%2520cancer%2520progression%26jtitle%3DTrends%2520Cancer%26date%3D2016%26volume%3D2%26spage%3D758%26epage%3D770%26doi%3D10.1016%2Fj.trecan.2016.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brizel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosnitz, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1016/S0360-3016(97)00101-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0360-3016%2897%2900101-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=9226314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADyaK2szmvFyksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=285-289&author=D.+M.+Brizelauthor=G.+S.+Sibleyauthor=L.+R.+Prosnitzauthor=R.+L.+Scherauthor=M.+W.+Dewhirst&title=Tumor+hypoxia+adversely+affects+the+prognosis+of+carcinoma+of+the+head+and+neck&doi=10.1016%2FS0360-3016%2897%2900101-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck</span></div><div class="casAuthors">Brizel D M; Sibley G S; Prosnitz L R; Scher R L; Dewhirst M W</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation oncology, biology, physics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-9</span>
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    </div><div class="casAbstract">PURPOSE:  Tumor hypoxia adversely affects short term clinical radiation response of head and neck cancer lymph node metastases and long term disease-free survival (DFS) in cervix carcinoma.  This study was performed to evaluate the relationship between tumor hypoxia and DFS in patients with squamous carcinoma of the head and neck (SCCHN).  METHODS AND MATERIALS:  Pretreatment tumor pO2 was assessed polarographically in SCCHN patients.  All patients were AJCC Stage IV and had pretreatment oxygen measurements taken from locally advanced primaries (T3 or T4) or neck nodes > or = 1.5 cm diameter.  Treatment consisted of once daily (2 Gy/day to 66-70 Gy) or twice daily irradiation (1.25 Gy B.I.D. to 70-75 Gy) +/- planned neck dissection (for > or = N2A disease) according to institutional treatment protocols.  RESULTS:  Twenty-eight patients underwent tumor pO2 measurement.  The average pre-treatment median pO2 was 11.2 mm Hg (range 0.4-60 mm Hg).  The DFS at 12 months was 42%.  The DFS was 78% for patients with median tumor pO2 > 10 mm Hg but only 22% for median pO2 < 10 mm Hg (p = 0.009).  The average tumor median pO2 for relapsing patients was 4.1 mm Hg and 17.1 mm Hg in non-relapsing (NED) patients (p = 0.007).  CONCLUSION:  Tumor hypoxia adversely affected the prognosis of patients in this study.  Understanding of the mechanistic relationship between hypoxia and treatment outcome will allow for the development of new and rational treatment programs in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOn2OYET779Z6KlWarZTAzfW6udTcc2eZ93sbSLRLEDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szmvFyksQ%253D%253D&md5=c0e5db4e5bea60615f7c5763afb8beda</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2897%2900101-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252897%252900101-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrizel%26aufirst%3DD.%2BM.%26aulast%3DSibley%26aufirst%3DG.%2BS.%26aulast%3DProsnitz%26aufirst%3DL.%2BR.%26aulast%3DScher%26aufirst%3DR.%2BL.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DTumor%2520hypoxia%2520adversely%2520affects%2520the%2520prognosis%2520of%2520carcinoma%2520of%2520the%2520head%2520and%2520neck%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D1997%26volume%3D38%26spage%3D285%26epage%3D289%26doi%3D10.1016%2FS0360-3016%2897%2900101-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hockel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aral, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, P.</span></span> <span> </span><span class="NLM_article-title">Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4509</span>– <span class="NLM_lpage">4915</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=8813149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADyaK28vgvVWjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=4509-4915&author=M.+Hockelauthor=K.+Schlengerauthor=B.+Aralauthor=M.+Mitzeauthor=U.+Schafferauthor=P.+Vaupel&title=Association+between+tumor+hypoxia+and+malignant+progression+in+advanced+cancer+of+the+uterine+cervix"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix</span></div><div class="casAuthors">Hockel M; Schlenger K; Aral B; Mitze M; Schaffer U; Vaupel P</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4509-15</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Experimental tumors contain a significant fraction of microregions that are chronically or transiently hypoxic.  Experimental evidence showing that hypoxia (and subsequent reoxygenation) may have a profound impact on malignant progression and on responsiveness to therapy is growing.  The clinical relevance of tumor oxygenation in human solid malignancies is under investigation.  We have developed and validated a clinically applicable method for measurement of tumor oxygenation in locally advanced cancer of the uterine cervix using a computerized polarographic electrode system.  Applying this procedure in patients with cervical cancers </= 3 cm in diameter, who gave informed consent, we have been studying the clinical relevance of tumor oxygenation prospectively since 1989.  As of June 1995, 103 patients with advanced cancers of the uterine cervix [Federation Internationale des Gynaecologistes et Obstetristes (FIGO) stages Ib, bulky (n = 13), IIa and IIb (n = 51), IIIa and IIIb (n = 34), and IVa and IVb (n = 5)] had entered the study.  Fifty % of the patients had carcinomas with median pO2 readings <10 mm Hg, referred to as hypoxic tumors.  Tumor oxygenation was found to be independent of various patient demographics and also of pretreatment tumor characteristics, such as clinical tumor stage and size, histological type, and differentiation.  However, histopathological examination of the surgical specimens following radical tumor resection in 47 patients showed that low-pO2 tumors exhibited larger tumor extensions and more frequent (occult) parametrial spread, as well as lymph-vascular space involvement, compared to well-oxygenated tumors of similar clinical stage and size.  Forty-two patients completing primary radiation therapy and 47 patients who underwent radical surgery were analyzed for treatment outcome after a median observation period of 28 months (range, 3-76 months).  Patients with hypoxic tumors had significantly worse disease-free and overall survival probabilities compared to patients with nonhypoxic tumors.  Cox regression analysis identified tumor oxygenation and FIGO stage as the most important independent prognostic factors.  The poorer outcome of the patients with hypoxic tumors was mainly due to locoregional failures with and without distant metastases, irrespective of whether surgery or radiation was applied as primary treatment.  Tumor oxygenation as measured with a standardized polarographic method proved to be a powerful new pretherapeutic prognostic parameter providing important information on malignant progression in terms of extracervical tumor spread and radioresistance in advanced cervical cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3e-bgelQZigqdek-gHSrIfW6udTcc2eZwShH12coUaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vgvVWjtg%253D%253D&md5=a0fc69874d7670a15d2e886ab9d629a9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHockel%26aufirst%3DM.%26aulast%3DSchlenger%26aufirst%3DK.%26aulast%3DAral%26aufirst%3DB.%26aulast%3DMitze%26aufirst%3DM.%26aulast%3DSchaffer%26aufirst%3DU.%26aulast%3DVaupel%26aufirst%3DP.%26atitle%3DAssociation%2520between%2520tumor%2520hypoxia%2520and%2520malignant%2520progression%2520in%2520advanced%2520cancer%2520of%2520the%2520uterine%2520cervix%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D4509%26epage%3D4915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1089%2Fars.2007.1623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=17571959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1237-1294&author=E.+J.+Moonauthor=D.+M.+Brizelauthor=J.+T.+Chiauthor=M.+W.+Dewhirst&title=The+potential+role+of+intrinsic+hypoxia+markers+as+prognostic+variables+in+cancer&doi=10.1089%2Fars.2007.1623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span></div><div class="casAuthors">Moon, Eui Jung; Brizel, David M.; Chi, Jen-Tsan Ashley; Dewhirst, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-1294</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia is related to tumor progression and therapy resistance, which leads to poor patient outcome.  It was suggested that measuring the hypoxic status of a tumor helps to predict patient outcome and to select more targeted treatment.  However, current methods using needle electrodes or exogenous markers have limitations due to their invasiveness or necessity for preinjection.  Recent studies showed that hypoxia-regulated genes could be alternatively used as endogenous hypoxia markers.  This is a review of 15 hypoxia-regulated genes, including hypoxia-inducible factor-1 and its targets, and their correlation with tumor hypoxia and patient outcome from 213 studies.  Though most of the studies showed significance of these genes in predicting prognosis, there was no definitive prognostic and hypoxia marker.  In conclusion, this review suggests the need for further studies with standardized methods to examine gene expression, as well as the use of multiple gene expressions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY758k83PGjbVg90H21EOLACvtfcHk0ljmKLTGn0Dpag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D&md5=61a4f08cd5644ffdc91b45634f96b8af</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1623%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DBrizel%26aufirst%3DD.%2BM.%26aulast%3DChi%26aufirst%3DJ.%2BT.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DThe%2520potential%2520role%2520of%2520intrinsic%2520hypoxia%2520markers%2520as%2520prognostic%2520variables%2520in%2520cancer%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D1237%26epage%3D1294%26doi%3D10.1089%2Fars.2007.1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wigerup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bexell, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.pharmthera.2016.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=27139518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2016&pages=152-169&author=C.+Wigerupauthor=S.+Pahlmanauthor=D.+Bexell&title=Therapeutic+targeting+of+hypoxia+and+hypoxia-inducible+factors+in+cancer&doi=10.1016%2Fj.pharmthera.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span></div><div class="casAuthors">Wigerup, Caroline; Paahlman, Sven; Bexell, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-169</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insufficient tissue oxygenation, or hypoxia, contributes to tumor aggressiveness and has a profound impact on clin. outcomes in cancer patients.  At decreased oxygen tensions, hypoxia-inducible factors (HIFs) 1 and 2 are stabilized and mediate a hypoxic response, primarily by acting as transcription factors.  HIFs exert differential effects on tumor growth and affect important cancer hallmarks including cell proliferation, apoptosis, differentiation, vascularization/angiogenesis, genetic instability, tumor metab., tumor immune responses, and invasion and metastasis.  As a consequence, HIFs mediate resistance to chemo- and radiotherapy and are assocd. with poor prognosis in cancer patients.  Intriguingly, perivascular tumor cells can also express HIF-2α, thereby forming a "pseudohypoxic" phenotype that further contributes to tumor aggressiveness.  Therefore, therapeutic targeting of HIFs in cancer has the potential to improve treatment efficacy.  Different strategies to target hypoxic cancer cells and/or HIFs include hypoxia-activated prodrugs and inhibition of HIF dimerization, mRNA or protein expression, DNA binding capacity, and transcriptional activity.  Here we review the functions of HIFs in the progression and treatment of malignant solid tumors.  We also highlight how HIFs may be targeted to improve the management of patients with therapy-resistant and metastatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcq5JPjcEkgLVg90H21EOLACvtfcHk0lhtbIIcxmN7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D&md5=dd665626b2d715b0222ca666f237a316</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DWigerup%26aufirst%3DC.%26aulast%3DPahlman%26aufirst%3DS.%26aulast%3DBexell%26aufirst%3DD.%26atitle%3DTherapeutic%2520targeting%2520of%2520hypoxia%2520and%2520hypoxia-inducible%2520factors%2520in%2520cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D164%26spage%3D152%26epage%3D169%26doi%3D10.1016%2Fj.pharmthera.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, F. M.</span></span> <span> </span><span class="NLM_article-title">Manassantins A/B and saucerneol: novel biologically active lignoids from <i>Saururus cernuus</i></span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4947</span>– <span class="NLM_lpage">4950</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)99818-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0040-4039%2801%2999818-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaL2cXkvVGltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1983&pages=4947-4950&author=K.+V.+Raoauthor=F.+M.+Alvarez&title=Manassantins+A%2FB+and+saucerneol%3A+novel+biologically+active+lignoids+from+Saururus+cernuus&doi=10.1016%2FS0040-4039%2801%2999818-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Manassantins A/B and saucerneol:  novel biologically active lignoids from Saururus cernuus</span></div><div class="casAuthors">Rao, Koppaka V.; Alvarez, Francisco M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">4947-50</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">From the ext. of S. cernuus, 2 toxic principles, manassantin A (I) and B (II) and a related substance, saucerneol (III) were isolated.  They have novel dineolignan or sesquineolignan type structures.  Although toxic, I showed potential neuroleptic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBdRijfJ6O1LVg90H21EOLACvtfcHk0lhtbIIcxmN7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvVGltg%253D%253D&md5=b979046ba5e7fb5c0c6ecadd99ceeec0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2999818-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252999818-1%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DAlvarez%26aufirst%3DF.%2BM.%26atitle%3DManassantins%2520A%252FB%2520and%2520saucerneol%253A%2520novel%2520biologically%2520active%2520lignoids%2520from%2520Saururus%2520cernuus%26jtitle%3DTetrahedron%2520Lett.%26date%3D1983%26volume%3D24%26spage%3D4947%26epage%3D4950%26doi%3D10.1016%2FS0040-4039%2801%2999818-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span> <span> </span><span class="NLM_article-title">Molecular-targeted antitumor agents: the <i>Saururus cernuus</i> dineolignans manassantin B and 4-<i>O</i>-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1021/np030514m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np030514m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=767-771&author=T.+W.+Hodgesauthor=C.+F.+Hossainauthor=Y.+P.+Kimauthor=Y.+D.+Zhouauthor=D.+G.+Nagle&title=Molecular-targeted+antitumor+agents%3A+the+Saururus+cernuus+dineolignans+manassantin+B+and+4-O-demethylmanassantin+B+are+potent+inhibitors+of+hypoxia-activated+HIF-1&doi=10.1021%2Fnp030514m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular-Targeted Antitumor Agents: The Saururus cernuus Dineolignans Manassantin B and 4-O-Demethylmanassantin B Are Potent Inhibitors of Hypoxia-Activated HIF-1</span></div><div class="casAuthors">Hodges, Tyler W.; Hossain, Chowdhury Faiz; Kim, Yong-Pil; Zhou, Yu-Dong; Nagle, Dale G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-771</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key regulator of tumor cell adaptation and survival under hypoxic conditions.  Selective HIF-1 inhibitors represent an important new class of potential mol.-targeted antitumor therapeutic agents.  Exts. of plants and marine organisms were evaluated using a T47D human breast tumor cell-based reporter assay for HIF-1 inhibitors.  Bioassay-guided fractionation of the lipid ext. of Saururus cernuus resulted in the isolation of manassantin B (1) and a new compd., 4-O-demethylmanassantin B (2).  The structure of 2 was detd. spectroscopically.  The abs. configurations of manassantin-type dineolignans have not been previously reported.  Therefore, the abs. configurations of the chiral centers in each side chain were deduced from spectroscopic anal. of the Mosher MTPA ester derivs. of 1.  Both 1 and 2 are among the most potent small mol. HIF-1 inhibitors discovered, to date, with IC50 values of 3 and 30 nM, resp.  Compds. 1 and 2 selectively inhibited hypoxia-activated HIF-1 in contrast to iron chelator-activated HIF-1.  Compds. 1 and 2 also inhibited hypoxic induction of the angiogenic factor VEGF.  Further study revealed that 1 selectively blocked the induction of HIF-1α protein, the oxygen regulated HIF-1 subunit that dets. HIF-1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8c4Zw-95rF7Vg90H21EOLACvtfcHk0lhHoZ0zUI-94Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFSrtLc%253D&md5=56b5c0f02729d5fb1d79514107ac6758</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fnp030514m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp030514m%26sid%3Dliteratum%253Aachs%26aulast%3DHodges%26aufirst%3DT.%2BW.%26aulast%3DHossain%26aufirst%3DC.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BP.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26atitle%3DMolecular-targeted%2520antitumor%2520agents%253A%2520the%2520Saururus%2520cernuus%2520dineolignans%2520manassantin%2520B%2520and%25204-O-demethylmanassantin%2520B%2520are%2520potent%2520inhibitors%2520of%2520hypoxia-activated%2520HIF-1%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D767%26epage%3D771%26doi%3D10.1021%2Fnp030514m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baerson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span> <span> </span><span class="NLM_article-title"><i>Saururus cernuus</i> lignanslpotent small molecule inhibitors of hypoxia-inducible factor-1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">1026</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.05.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.bbrc.2005.05.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=15967416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVensb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2005&pages=1026-1033&author=C.+F.+Hossainauthor=Y.+P.+Kimauthor=S.+R.+Baersonauthor=L.+Zhangauthor=R.+K.+Bruickauthor=K.+A.+Mohammedauthor=A.+K.+Agarwalauthor=D.+G.+Nagleauthor=Y.+D.+Zhou&title=Saururus+cernuus+lignanslpotent+small+molecule+inhibitors+of+hypoxia-inducible+factor-1&doi=10.1016%2Fj.bbrc.2005.05.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Saururus cernuus lignans-Potent small molecule inhibitors of hypoxia-inducible factor-1</span></div><div class="casAuthors">Hossain, Chowdhury Faiz; Kim, Yong-Pil; Baerson, Scott R.; Zhang, Lei; Bruick, Richard K.; Mohammed, Kaleem A.; Agarwal, Ameeta K.; Nagle, Dale G.; Zhou, Yu-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1026-1033</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) represents an important tumor-selective therapeutic target for solid tumors.  In search of novel small mol. HIF-1 inhibitors, 5400 natural product-rich exts. from plants, marine organisms, and microbes were examd. for HIF-1 inhibitory activities using a cell-based reporter assay.  Bioassay-guided fractionation and isolation, followed by structure elucidation, yielded three potent natural product-derived HIF-1 inhibitors and two structurally related inactive compds.  In a T47D cell-based reporter assay, manassantin B1, manassantin A, and 4-O-methylsaucerneol inhibited hypoxia-induced HIF-1 activation with IC50 values of 3, 3, and 20 nM, resp.  All three compds. are relatively hypoxia-specific inhibitors of HIF-1 activation, in comparison to other stimuli.  The hypoxic induction of HIF-1 target genes CDKN1A, VEGF, and GLUT-1 were also inhibited.  These compds. inhibit HIF-1 by blocking hypoxia-induced nuclear HIF-1α protein accumulation without affecting HIF-1α mRNA levels.  In addn., preliminary structure-activity studies suggest specific structural requirements for this class of HIF-1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-b893wiUXx7Vg90H21EOLACvtfcHk0lhHoZ0zUI-94Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVensb4%253D&md5=29100e0ff47d515b9738573fb0a6ed38</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.05.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.05.191%26sid%3Dliteratum%253Aachs%26aulast%3DHossain%26aufirst%3DC.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BP.%26aulast%3DBaerson%26aufirst%3DS.%2BR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DMohammed%26aufirst%3DK.%2BA.%26aulast%3DAgarwal%26aufirst%3DA.%2BK.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26atitle%3DSaururus%2520cernuus%2520lignanslpotent%2520small%2520molecule%2520inhibitors%2520of%2520hypoxia-inducible%2520factor-1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D333%26spage%3D1026%26epage%3D1033%26doi%3D10.1016%2Fj.bbrc.2005.05.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Nucleophilic addition of organozinc reagents to 2-sulfonyl cyclic ethers: stereoselective synthesis of manassantins A and B</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1021/ol8024617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8024617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=89-92&author=H.+Kimauthor=A.+C.+Kasperauthor=E.+J.+Moonauthor=Y.+Parkauthor=C.+M.+Wootenauthor=M.+W.+Dewhirstauthor=J.+Hong&title=Nucleophilic+addition+of+organozinc+reagents+to+2-sulfonyl+cyclic+ethers%3A+stereoselective+synthesis+of+manassantins+A+and+B&doi=10.1021%2Fol8024617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleophilic Addition of Organozinc Reagents to 2-Sulfonyl Cyclic Ethers: Stereoselective Synthesis of Manassantins A and B</span></div><div class="casAuthors">Kim, Hyoungsu; Kasper, Amanda C.; Moon, Eui Jung; Park, Yongho; Wooten, Ceshea M.; Dewhirst, Mark W.; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-92</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A convergent route to the synthesis of manassantins A (I) and B (II), potent inhibitors of HIF-1, is described.  Central to the synthesis is a stereoselective addn. of an organozinc reagent to a 2-benzenesulfonyl cyclic ether to achieve the 2,3-cis-3,4-trans-4,5-cis-tetrahydrofuran of the natural products.  Preliminary structure-activity relationships suggested that the (R)-configuration at C-7 and C-7''' is not crit. for HIF-1 inhibition.  In addn., the hydroxyl group at C-7 and C-7''' can be replaced with a carbonyl group without loss of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooK8kpL0vwKrVg90H21EOLACvtfcHk0lhHoZ0zUI-94Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7%252FK&md5=6b4667db29fc0658040438186aacab46</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fol8024617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8024617%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DWooten%26aufirst%3DC.%2BM.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DNucleophilic%2520addition%2520of%2520organozinc%2520reagents%2520to%25202-sulfonyl%2520cyclic%2520ethers%253A%2520stereoselective%2520synthesis%2520of%2520manassantins%2520A%2520and%2520B%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D89%26epage%3D92%26doi%3D10.1021%2Fol8024617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitzel, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of manassantin analogues for hypoxia-inducible factor 1alpha inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7659</span>– <span class="NLM_lpage">7671</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7659-7671&author=D.+Y.+Kwonauthor=H.+E.+Leeauthor=D.+H.+Weitzelauthor=K.+Parkauthor=S.+H.+Leeauthor=C.+T.+Leeauthor=T.+N.+Stephensonauthor=H.+Parkauthor=M.+C.+Fitzgeraldauthor=J.+T.+Chiauthor=R.+A.+Mookauthor=M.+W.+Dewhirstauthor=Y.+M.+Leeauthor=J.+Hong&title=Synthesis+and+biological+evaluation+of+manassantin+analogues+for+hypoxia-inducible+factor+1alpha+inhibition&doi=10.1021%2Facs.jmedchem.5b01220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition</span></div><div class="casAuthors">Kwon, Do-Yeon; Lee, Hye Eun; Weitzel, Douglas H.; Park, Kyunghye; Lee, Sun Hee; Lee, Chen-Ting; Stephenson, Tesia N.; Park, Hyeri; Fitzgerald, Michael C.; Chi, Jen-Tsan; Mook, Robert A., Jr.; Dewhirst, Mark W.; Lee, You Mie; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7659-7671</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To cope with hypoxia, tumor cells have developed a no. of adaptive mechanisms mediated by hypoxia-inducible factor 1 (HIF-1) to promote angiogenesis and cell survival.  Due to significant roles of HIF-1 in the initiation, progression, metastasis, and resistance to treatment of most solid tumors, a considerable amt. of effort has been made to identify HIF-1 inhibitors for treatment of cancer.  Isolated from Saururus cernuus, manassantins A (I) and B (II) are potent inhibitors of HIF-1 activity.  To define the structural requirements of manassantins for HIF-1 inhibition, we prepd. and evaluated a series of manassantin analogs.  Our SAR studies examd. key regions of manassantin's structure in order to understand the impact of these regions on biol. activity and to define modifications that can lead to improved performance and drug-like properties.  Our efforts identified several manassantin analogs with reduced structural complexity as potential lead compds. for further development.  Some analogs, e.g., III, down-regulated hypoxia-induced expression of the HIF-1α protein and reduced the levels of HIF-1 target genes, including cyclin-dependent kinase 6 (Cdk6) and vascular endothelial growth factor (VEGF).  These findings provide an important framework to design potent and selective HIF-1α inhibitors, which is necessary to aid translation of manassantin-derived natural products to the clinic as novel therapeutics for cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4LzA8xQ0-LbVg90H21EOLACvtfcHk0lgyrirMVsGXTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM&md5=95a898b0ab734a00a2d7b2e685c816a8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01220%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DWeitzel%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DStephenson%26aufirst%3DT.%2BN.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DFitzgerald%26aufirst%3DM.%2BC.%26aulast%3DChi%26aufirst%3DJ.%2BT.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520manassantin%2520analogues%2520for%2520hypoxia-inducible%2520factor%25201alpha%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7659%26epage%3D7671%26doi%3D10.1021%2Facs.jmedchem.5b01220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3783</span>– <span class="NLM_lpage">3786</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.bmcl.2009.04.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=19423348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3783-3786&author=A.+C.+Kasperauthor=E.+J.+Moonauthor=X.+Huauthor=Y.+Parkauthor=C.+M.+Wootenauthor=H.+Kimauthor=W.+Yangauthor=M.+W.+Dewhirstauthor=J.+Hong&title=Analysis+of+HIF-1+inhibition+by+manassantin+A+and+analogues+with+modified+tetrahydrofuran+configurations&doi=10.1016%2Fj.bmcl.2009.04.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations</span></div><div class="casAuthors">Kasper, Amanda C.; Moon, Eui Jung; Hu, Xiangqian; Park, Yongho; Wooten, Ceshea M.; Kim, Hyoungsu; Yang, Weitao; Dewhirst, Mark W.; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3783-3786</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have shown that manassantin A downregulated the HIF-1α expression and inhibited the secretion of VEGF.  The authors have also demonstrated that the 2,3-cis-3,4-trans-4,5-cis-configuration of the THF is crit. to the HIF-1 inhibition of manassantin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsGegjOvL0WLVg90H21EOLACvtfcHk0lgyrirMVsGXTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGns7w%253D&md5=d2e53ba8945df484928063c932a5095b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.071%26sid%3Dliteratum%253Aachs%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DWooten%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DAnalysis%2520of%2520HIF-1%2520inhibition%2520by%2520manassantin%2520A%2520and%2520analogues%2520with%2520modified%2520tetrahydrofuran%2520configurations%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3783%26epage%3D3786%26doi%3D10.1016%2Fj.bmcl.2009.04.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauke, S.</span></span> <span> </span><span class="NLM_article-title">Cross metathesis of allyl alcohols: how to suppress and how to promote double bond isomerization</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4194</span>– <span class="NLM_lpage">4206</span>, <span class="refDoi"> DOI: 10.1039/c3ob40167g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2Fc3ob40167g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=23676990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=4194-4206&author=B.+Schmidtauthor=S.+Hauke&title=Cross+metathesis+of+allyl+alcohols%3A+how+to+suppress+and+how+to+promote+double+bond+isomerization&doi=10.1039%2Fc3ob40167g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cross metathesis of allyl alcohols: how to suppress and how to promote double bond isomerization</span></div><div class="casAuthors">Schmidt, Bernd; Hauke, Sylvia</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4194-4206</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Under std. conditions the cross metathesis of allyl alcs. and Me acrylate is accompanied by the formation of ketones, resulting from uncontrolled and undesired double bond isomerization.  By conducting the CM in the presence of phenol, the catalyst loading and the reaction time required for quant. conversion can be reduced, and isomerization can be suppressed.  On the other hand, consecutive isomerization can be deliberately promoted by evapg. excess Me acrylate after completing cross metathesis and by adding a base or silane as chem. triggers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqjn4qD5Zz7Vg90H21EOLACvtfcHk0ljxbcY483xgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWktL4%253D&md5=54f8a207282d8702d0ed5682a21f2ba0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2Fc3ob40167g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob40167g%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DHauke%26aufirst%3DS.%26atitle%3DCross%2520metathesis%2520of%2520allyl%2520alcohols%253A%2520how%2520to%2520suppress%2520and%2520how%2520to%2520promote%2520double%2520bond%2520isomerization%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D4194%26epage%3D4206%26doi%3D10.1039%2Fc3ob40167g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strych, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauner, D.</span></span> <span> </span><span class="NLM_article-title">Biomimetic synthesis of santalin A, B and santarubin A, B, the major colorants of red sandalwood</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">9509</span>– <span class="NLM_lpage">9512</span>, <span class="refDoi"> DOI: 10.1002/anie.201302317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1002%2Fanie.201302317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFCrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=9509-9512&author=S.+Strychauthor=D.+Trauner&title=Biomimetic+synthesis+of+santalin+A%2C+B+and+santarubin+A%2C+B%2C+the+major+colorants+of+red+sandalwood&doi=10.1002%2Fanie.201302317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic Synthesis of Santalin A,B and Santarubin A,B, the Major Colorants of Red Sandalwood</span></div><div class="casAuthors">Strych, Sebastian; Trauner, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">9509-9512</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a unified synthetic approach to Santalin A,B and Santarubin A,B, the major dyes of red sandalwood.  It is yet another demonstration that complex mol. scaffolds, not easily accessible with other methods, can be assembled along biosynthetic lines without the necessity of enzymic catalysis.  The final reaction sequence appears to be general and our conditions are mild, which raises the question whether the cycloaddn./oxidn. cascade could spontaneously occur in nature as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqhS8VyHD-g7Vg90H21EOLACvtfcHk0ljxbcY483xgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFCrurw%253D&md5=d79b920df57c2ea10269365d76fb90ac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fanie.201302317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201302317%26sid%3Dliteratum%253Aachs%26aulast%3DStrych%26aufirst%3DS.%26aulast%3DTrauner%26aufirst%3DD.%26atitle%3DBiomimetic%2520synthesis%2520of%2520santalin%2520A%252C%2520B%2520and%2520santarubin%2520A%252C%2520B%252C%2520the%2520major%2520colorants%2520of%2520red%2520sandalwood%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D9509%26epage%3D9512%26doi%3D10.1002%2Fanie.201302317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span> <span> </span><span class="NLM_article-title">Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. mechanism and synthetic implications</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5551</span>– <span class="NLM_lpage">5553</span>, <span class="refDoi"> DOI: 10.1021/ja00252a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00252a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaL2sXlslGlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5551-5553&author=E.+Coreyauthor=R.+K.+Bakshiauthor=S.+Shibata&title=Highly+enantioselective+borane+reduction+of+ketones+catalyzed+by+chiral+oxazaborolidines.+mechanism+and+synthetic+implications&doi=10.1021%2Fja00252a056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines.  Mechanism and synthetic implications</span></div><div class="casAuthors">Corey, E. J.; Bakshi, Raman K.; Shibata, Saizo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5551-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">An enantioselective redn. of ketones to secondary alcs.,e.g., PhCOMe to (R)-PhMeCHOH, by vic-amino alcs. and BH3-THF is reported.  Two key reaction intermediates involved in a catalytic redn. with BH3.THF as the stoichiometric reductant.  (S)-Diphenylprolinol reacts with BH3.THF upon heating to form oxazaborolidine I, which is a catalyst for these redns.  I forms a complex II.  Amino alc. III similarly effects enantioselective redn. of ketones.  I and II are the most effective reducing agents found to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr0FOvqDo-BLVg90H21EOLACvtfcHk0ljxbcY483xgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlslGlsrs%253D&md5=e52d09fe788534f0f5d8168d2ad93e4f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00252a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00252a056%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DShibata%26aufirst%3DS.%26atitle%3DHighly%2520enantioselective%2520borane%2520reduction%2520of%2520ketones%2520catalyzed%2520by%2520chiral%2520oxazaborolidines.%2520mechanism%2520and%2520synthetic%2520implications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D5551%26epage%3D5553%26doi%3D10.1021%2Fja00252a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">The enantiomeric excess of <b>7</b> was determined by Mosher ester analysis. See the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghavimi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnus, P.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of 8,14-dihydromorphinandienone alkaloids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1708</span>– <span class="NLM_lpage">1711</span>, <span class="refDoi"> DOI: 10.1021/ol500368p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol500368p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Grtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1708-1711&author=B.+Ghavimiauthor=P.+Magnus&title=Total+synthesis+of+8%2C14-dihydromorphinandienone+alkaloids&doi=10.1021%2Fol500368p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of 8,14-Dihydromorphinandienone Alkaloids</span></div><div class="casAuthors">Ghavimi, Bahman; Magnus, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1708-1711</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A collective synthesis of 8,14-dihydronorsalutaridine, 8,14-dihydrosalutaridine, norisosinomenine, and isosinomenine is reported.  The strategy provides direct access to the correct oxidn. level of the products.  The combination of an organocatalyst guanidine superbase, a tertiary amine base, and a dehydrating agent was necessary for the successful Henry-Michael-dehydration cascade to form the phenanthrene motif.  The required selective aliph. nitro redn. could only be achieved under heterogeneous transfer-hydrogenation conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGE8awZcit57Vg90H21EOLACvtfcHk0lijRJB76mQRhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Grtrk%253D&md5=f314c67e030f0a79bf1b19d7bb71489c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol500368p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol500368p%26sid%3Dliteratum%253Aachs%26aulast%3DGhavimi%26aufirst%3DB.%26aulast%3DMagnus%26aufirst%3DP.%26atitle%3DTotal%2520synthesis%2520of%25208%252C14-dihydromorphinandienone%2520alkaloids%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D1708%26epage%3D1711%26doi%3D10.1021%2Fol500368p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, F.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Z.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis of <i>rac</i>-(8<i>R</i>,13<i>S</i>,14<i>S</i>)-7-oxa-estra-4,9-diene-3,17-dione</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">9021</span>– <span class="NLM_lpage">9024</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.10.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.tetlet.2006.10.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=9021-9024&author=F.-A.+Kangauthor=N.+Jainauthor=Z.+Sui&title=Stereoselective+synthesis+of+rac-%288R%2C13S%2C14S%29-7-oxa-estra-4%2C9-diene-3%2C17-dione&doi=10.1016%2Fj.tetlet.2006.10.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis of rac-(8R,13S,14S)-7-oxa-estra-4,9-diene-3,17-dione</span></div><div class="casAuthors">Kang, Fu-An; Jain, Nareshkumar; Sui, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">9021-9024</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The first synthesis of a novel oxa-steroid, rac-(8R,13S,14S)-7-oxa-estra-4,9-diene-3,17-dione I has been achieved via stereoselective catalytic hydrogenation of the tetra-substituted indene intermediate II, whose structure was confirmed by X-ray crystallog.  In contrast to the previous reports of similar indene systems, it was found that catalytic hydrogenation of indenes with a large substituent at the C-2 position and a bulky β-oriented protective group at the C-6 position resulted in cis-indanes instead of trans-indanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhSJWitp9IaLVg90H21EOLACvtfcHk0lijRJB76mQRhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrzF&md5=c523b7afeca4d2cc53e8a2de093d8ea7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.10.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.10.098%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DF.-A.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DStereoselective%2520synthesis%2520of%2520rac-%25288R%252C13S%252C14S%2529-7-oxa-estra-4%252C9-diene-3%252C17-dione%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D9021%26epage%3D9024%26doi%3D10.1016%2Fj.tetlet.2006.10.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wills, M.</span></span> <span> </span><span class="NLM_article-title">Gold-catalysed cyclic ether formation from diols</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">9828</span>– <span class="NLM_lpage">9834</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2010.10.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.tet.2010.10.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2rs7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=9828-9834&author=X.+Jiangauthor=E.+K.+Londonauthor=D.+J.+Morrisauthor=G.+J.+Clarksonauthor=M.+Wills&title=Gold-catalysed+cyclic+ether+formation+from+diols&doi=10.1016%2Fj.tet.2010.10.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Gold-catalysed cyclic ether formation from diols</span></div><div class="casAuthors">Jiang, Xiaolu; London, Emma K.; Morris, David J.; Clarkson, Guy J.; Wills, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">9828-9834</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gold(I) and (III) salts have been found to be highly effective at the catalysis of ether formation from alcs.  Intramol. ether formation of a 1,5-diol was also achieved to give cyclic ethers, e.g. 2-phenyltetrahydropyran, with a stereoselectivity that indicates that an SN1 mechanism predominates.  In an attempt to form a seven-membered ring, a stable 14-membered dimer product was also formed.  Attempts to control the diastereoselectivity of the reaction using a chiral anionic counterion did not give products with a high de.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTpVjq84CV8rVg90H21EOLACvtfcHk0lijRJB76mQRhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2rs7zK&md5=3e06e826b14dc383dac10cda59ea9751</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.10.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.10.068%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DLondon%26aufirst%3DE.%2BK.%26aulast%3DMorris%26aufirst%3DD.%2BJ.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DWills%26aufirst%3DM.%26atitle%3DGold-catalysed%2520cyclic%2520ether%2520formation%2520from%2520diols%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D9828%26epage%3D9834%26doi%3D10.1016%2Fj.tet.2010.10.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchigami, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4-iodotetrahydropyran-containing polymers via TMSI-promoted Prins cyclization</span>. <i>Polym. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1039/C2PY20890C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2FC2PY20890C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1221-1227&author=S.+Inagiauthor=N.+Takeiauthor=T.+Fuchigami&title=Synthesis+of+4-iodotetrahydropyran-containing+polymers+via+TMSI-promoted+Prins+cyclization&doi=10.1039%2FC2PY20890C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-iodotetrahydropyran-containing polymers via TMSI-promoted Prins cyclization</span></div><div class="casAuthors">Inagi, Shinsuke; Takei, Naoko; Fuchigami, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Polymer Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1221-1227</span>CODEN:
                <span class="NLM_cas:coden">PCOHC2</span>;
        ISSN:<span class="NLM_cas:issn">1759-9962</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">4-Iodotetrahydropyran (THP)-contg. polymers were synthesized via Prins cyclization of monomers with an aldehyde moiety and a homoallylic alc. moiety.  The progress of polymn. was confirmed by NMR and GPC anal.  The deiodination of the THP in the polymer structure was carried out by reductive hydrogenation using AIBN and tributyltin hydride.  Thermogravimetric anal. (TGA) was performed for the THP-contg. polymers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb6ly81rWEb7Vg90H21EOLACvtfcHk0lgT70v3Nvvysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlemurk%253D&md5=18845956b4d46b49667c1ead48dc4c1a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC2PY20890C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2PY20890C%26sid%3Dliteratum%253Aachs%26aulast%3DInagi%26aufirst%3DS.%26aulast%3DTakei%26aufirst%3DN.%26aulast%3DFuchigami%26aufirst%3DT.%26atitle%3DSynthesis%2520of%25204-iodotetrahydropyran-containing%2520polymers%2520via%2520TMSI-promoted%2520Prins%2520cyclization%26jtitle%3DPolym.%2520Chem.%26date%3D2013%26volume%3D4%26spage%3D1221%26epage%3D1227%26doi%3D10.1039%2FC2PY20890C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, S. V.</span></span> <span> </span><span class="NLM_article-title">Substitution reactions of 2-benzenesulphonyl cyclic ethers with carbon nucleophiles</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4293</span>– <span class="NLM_lpage">4308</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)81323-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0040-4020%2801%2981323-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaK3cXpvVehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=4293-4308&author=D.+S.+Brownauthor=M.+Brunoauthor=R.+J.+Davenportauthor=S.+V.+Ley&title=Substitution+reactions+of+2-benzenesulphonyl+cyclic+ethers+with+carbon+nucleophiles&doi=10.1016%2FS0040-4020%2801%2981323-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Substitution reactions of 2-benzenesulfonyl cyclic ethers with carbon nucleophiles</span></div><div class="casAuthors">Brown, Dearg S.; Bruno, Maurizio; Davenport, Raymond J.; Ley, Steven V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4293-308</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The direct substitution of 2-benzenesulfonyl cyclic ethers I (R = H, Ph, MeO, Bu, AcOCH2) was studied by using a variety of nucleophiles such as silyl enol ethers, silyl ketene acetals, allylsilanes, or Me3SiCN in the presence of AlCl3 or organozinc reagents.  A general selectivity for the formation of trans products was seen for I.  E.g., the reaction of trans-I (R = AcOCH2) with Me2C:C(OMe)OSiMe3 in the presence of AlCl3 gave 33% Me cis-6-(acetoxymethyl)-α,α-dimethyl-2H-pyran-2-acetate (cis-II) and 64% trans-II.  Treatment of I (R = Ph; cis-trans = 57:43) with MgBr2.OEt2 and Et3N gave 89% 3,4-dihydro-2-phenyl-2H-pyran.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtrWOJcuXXrVg90H21EOLACvtfcHk0lgT70v3Nvvysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXpvVehug%253D%253D&md5=6542a3344bfca1b47f4208c9bb1bafaa</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2981323-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252981323-5%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BS.%26aulast%3DBruno%26aufirst%3DM.%26aulast%3DDavenport%26aufirst%3DR.%2BJ.%26aulast%3DLey%26aufirst%3DS.%2BV.%26atitle%3DSubstitution%2520reactions%2520of%25202-benzenesulphonyl%2520cyclic%2520ethers%2520with%2520carbon%2520nucleophiles%26jtitle%3DTetrahedron%26date%3D1989%26volume%3D45%26spage%3D4293%26epage%3D4308%26doi%3D10.1016%2FS0040-4020%2801%2981323-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. J.</span></span> <span> </span><span class="NLM_article-title">Sequential kinetic resolution of <i>C</i><sub>2</sub>-symmetric compounds as a key step in two-directional synthesis: structural requirements for efficient resolution of difuryl diols</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2403</span>– <span class="NLM_lpage">2413</span>, <span class="refDoi"> DOI: 10.1039/b206478b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2Fb206478b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=2403-2413&author=M.+Hardingauthor=R.+Hodgsonauthor=A.+J.+Nelson&title=Sequential+kinetic+resolution+of+C2-symmetric+compounds+as+a+key+step+in+two-directional+synthesis%3A+structural+requirements+for+efficient+resolution+of+difuryl+diols&doi=10.1039%2Fb206478b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fb206478b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb206478b%26sid%3Dliteratum%253Aachs%26aulast%3DHarding%26aufirst%3DM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DA.%2BJ.%26atitle%3DSequential%2520kinetic%2520resolution%2520of%2520C2-symmetric%2520compounds%2520as%2520a%2520key%2520step%2520in%2520two-directional%2520synthesis%253A%2520structural%2520requirements%2520for%2520efficient%2520resolution%2520of%2520difuryl%2520diols%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D2002%26volume%3D21%26spage%3D2403%26epage%3D2413%26doi%3D10.1039%2Fb206478b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasdemir, B.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of some chiral aryl and hetero aryl-substituted β-, γ-, δ-hydroxy esters</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1080/00397911.2014.1003353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1080%2F00397911.2014.1003353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVyntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=1082-1088&author=B.+Hasdemir&title=Asymmetric+synthesis+of+some+chiral+aryl+and+hetero+aryl-substituted+%CE%B2-%2C+%CE%B3-%2C+%CE%B4-hydroxy+esters&doi=10.1080%2F00397911.2014.1003353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Some Chiral Aryl and Hetero Aryl-Substituted β-, γ-, δ-Hydroxy Esters</span></div><div class="casAuthors">Hasdemir, Belma</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1082-1088</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Sixteen chiral β-, γ-, and δ-hydroxy esters with aryl, substituted aryl, and heteroaryl groups were synthesized by the asym. redn. of their corresponding keto esters as chiral pure ref. compds. and starting materials.  The asym. redn. was achieved by (R)-Me-CBS-oxazaborolidine.  Ten new chiral γ- and δ-hydroxy esters , and were obtained with high ee values and characterized by IR, NMR (1H and 13C), mass spectrometry, chiral high-performance liq. chromatog., and sp. rotation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd11Lr4QeoObVg90H21EOLACvtfcHk0lgVxj5VjeosgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVyntb4%253D&md5=3095a10854028f79f9f10e247bb49fd0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F00397911.2014.1003353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2014.1003353%26sid%3Dliteratum%253Aachs%26aulast%3DHasdemir%26aufirst%3DB.%26atitle%3DAsymmetric%2520synthesis%2520of%2520some%2520chiral%2520aryl%2520and%2520hetero%2520aryl-substituted%2520%25CE%25B2-%252C%2520%25CE%25B3-%252C%2520%25CE%25B4-hydroxy%2520esters%26jtitle%3DSynth.%2520Commun.%26date%3D2015%26volume%3D45%26spage%3D1082%26epage%3D1088%26doi%3D10.1080%2F00397911.2014.1003353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span> <span> </span><span class="NLM_article-title">Base-promoted/gold-catalyzed intramolecular highly selective and controllable detosylative cyclization</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">12871</span>– <span class="NLM_lpage">12875</span>, <span class="refDoi"> DOI: 10.1002/chem.201502073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1002%2Fchem.201502073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=26223908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gls77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=12871-12875&author=C.+Zhuauthor=L.+Qiuauthor=G.+Xuauthor=J.+Liauthor=J.+Sun&title=Base-promoted%2Fgold-catalyzed+intramolecular+highly+selective+and+controllable+detosylative+cyclization&doi=10.1002%2Fchem.201502073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Base-Promoted/Gold-Catalyzed Intramolecular Highly Selective and Controllable Detosylative Cyclization</span></div><div class="casAuthors">Zhu, Chenghao; Qiu, Lin; Xu, Guangyang; Li, Jian; Sun, Jiangtao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12871-12875</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly selective, controllable and synthetically useful base-promoted intramol. detosylative cyclization of bis-N-tosylhydrazones was achieved, affording N-contg. heterocycles and cyclic olefins under transition-metal-free or gold-catalyzed procedures, resp.  For example, the bis N-tosylhydrazone of 1,5-diphenyl-1,5-pentanedione gave either I or II.  An effective and practical metal-free or gold-catalyzed approach to synthesize polycyclic arom. compds. was also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48vzjudwAcbVg90H21EOLACvtfcHk0lgVxj5VjeosgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gls77K&md5=f86022046cb4c6b41b3f5d9347e3c488</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502073%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26atitle%3DBase-promoted%252Fgold-catalyzed%2520intramolecular%2520highly%2520selective%2520and%2520controllable%2520detosylative%2520cyclization%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D12871%26epage%3D12875%26doi%3D10.1002%2Fchem.201502073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (±)-isocombretastatins AC</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1080/00397918708063944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1080%2F00397918708063944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1Oiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=877-892&author=S.+B.+Singhauthor=G.+R.+Pettit&title=Synthesis+of+%28%C2%B1%29-isocombretastatins+AC&doi=10.1080%2F00397918708063944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents.  Part 125.  Synthesis of (±)-isocombretastatins A-C</span></div><div class="casAuthors">Singh, Sheo Bux; Pettit, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">877-92</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Isocombretastatins A and C (I, R = Me, R1 = R3 = H, R2 = OH; R = R3 = H, R1 = Me, R2 = OH) were prepd. from 3,4,5-(MeO)3C6H2CH2Br and 3,4- or 4,3-Me3CSiMe2O(MeO)C6H3CHO resp.  Isocombretastatin B (I, R = R2 = H, R1 = Me, R3 = OH) was obtained from 4,3-Me3CSiMe2O(MeO)C6H3CH2OH and 3,4,5-(MeO)3C6H2CHO.  (±)-I (R = Me, R1 = R3 = H, R2 = OH) had a ED50 of 0.19-0.25 μg/mL against leukemia P388.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN_CQAmKqLHLVg90H21EOLACvtfcHk0lgVxj5VjeosgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1Oiurs%253D&md5=6a537ce2dc7853108518cb70f55bb622</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F00397918708063944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918708063944%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26atitle%3DSynthesis%2520of%2520%2528%25C2%25B1%2529-isocombretastatins%2520AC%26jtitle%3DSynth.%2520Commun.%26date%3D1987%26volume%3D17%26spage%3D877%26epage%3D892%26doi%3D10.1080%2F00397918708063944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crutizat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivès, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marat, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalko-Csiba, M.</span></span> <span> </span><span class="NLM_article-title">Flash-metathesis for the coupling of sustainable (poly) hydroxyl β-methylstyrenes from essential oils</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3756</span>– <span class="NLM_lpage">3761</span>, <span class="refDoi"> DOI: 10.1039/C5GC00759C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2FC5GC00759C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=3756-3761&author=J.+Hitceauthor=M.+Crutizatauthor=C.+Bourdonauthor=A.+Viv%C3%A8sauthor=X.+Maratauthor=M.+Dalko-Csiba&title=Flash-metathesis+for+the+coupling+of+sustainable+%28poly%29+hydroxyl+%CE%B2-methylstyrenes+from+essential+oils&doi=10.1039%2FC5GC00759C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Flash-metathesis for the coupling of sustainable (poly)hydroxyl β-methylstyrenes from essential oils</span></div><div class="casAuthors">Hitce, J.; Crutizat, M.; Bourdon, C.; Vives, A.; Marat, X.; Dalko-Csiba, M.</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3756-3761</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A cross-metathesis procedure was developed to synthesize sym. and non sym. stilbenes from sustainable resources.  The reaction proceeds under solvent-free conditions and at low catalyst loading (down to 0.01 mol%) within a couple of minutes only (TOF up to 6.9 s-1), on multi-gram scale.  The highly reactive β-methylstyrene substrates were homo-coupled not only as pure synthons but also as components of essential oils that were reacted directly in order to eliminate prior substrate isolation from the overall process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFTWMyXAdWHrVg90H21EOLACvtfcHk0ljxhtVuh4cGUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVyqsbs%253D&md5=aae817203ee122fcd081b6d07850c9df</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2FC5GC00759C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5GC00759C%26sid%3Dliteratum%253Aachs%26aulast%3DHitce%26aufirst%3DJ.%26aulast%3DCrutizat%26aufirst%3DM.%26aulast%3DBourdon%26aufirst%3DC.%26aulast%3DViv%25C3%25A8s%26aufirst%3DA.%26aulast%3DMarat%26aufirst%3DX.%26aulast%3DDalko-Csiba%26aufirst%3DM.%26atitle%3DFlash-metathesis%2520for%2520the%2520coupling%2520of%2520sustainable%2520%2528poly%2529%2520hydroxyl%2520%25CE%25B2-methylstyrenes%2520from%2520essential%2520oils%26jtitle%3DGreen%2520Chem.%26date%3D2015%26volume%3D17%26spage%3D3756%26epage%3D3761%26doi%3D10.1039%2FC5GC00759C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">To avoid any unnecessary complications and/or exaggeration by the flexible side chains, truncated structures of <b>1</b>, <b>11</b>, and <b>25b</b> were used instead of the full structures.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy combined or sequenced with targeted therapy in the treatment of solid tumors: current perspectives</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>, <span class="NLM_elocation-id">djv414</span> <span class="refDoi"> DOI: 10.1093/jnci/djv414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1093%2Fjnci%2Fdjv414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=26839346" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&author=M.+B.+Atkinsauthor=J.+Larkin&title=Immunotherapy+combined+or+sequenced+with+targeted+therapy+in+the+treatment+of+solid+tumors%3A+current+perspectives&doi=10.1093%2Fjnci%2Fdjv414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjv414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjv414%26sid%3Dliteratum%253Aachs%26aulast%3DAtkins%26aufirst%3DM.%2BB.%26aulast%3DLarkin%26aufirst%3DJ.%26atitle%3DImmunotherapy%2520combined%2520or%2520sequenced%2520with%2520targeted%2520therapy%2520in%2520the%2520treatment%2520of%2520solid%2520tumors%253A%2520current%2520perspectives%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2016%26volume%3D108%26doi%3D10.1093%2Fjnci%2Fdjv414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. C.</span></span> <span> </span><span class="NLM_article-title">Changing strategies for target therapy in gastric cancer</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.3748/wjg.v22.i3.1179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.3748%2Fwjg.v22.i3.1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=26811656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2mt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1179-1189&author=S.+Y.+Leeauthor=S.+C.+Oh&title=Changing+strategies+for+target+therapy+in+gastric+cancer&doi=10.3748%2Fwjg.v22.i3.1179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Changing strategies for target therapy in gastric cancer</span></div><div class="casAuthors">Lee, Suk-young; Oh, Sang Cheul</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1189</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">2219-2840</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still remains one of the leading causes of cancer mortality.  Great efforts have been made to improve treatment outcomes in patients with metastatic gastric cancer, and the introduction of trastuzumab has greatly improved the overall survival.  The trastuzumab treatment took its first step in opening the era of mol. targeted therapy, however several issues still need to be resolved to increase the efficacy of targeted therapy.  Firstly, many patients with metastatic gastric cancer who receive trastuzumab in combination with chemotherapeutic agents develop resistance to the targeted therapy.  Secondly, many clin. trials testing novel mol. targeted agents with demonstrated efficacy in other malignancies have failed to show benefit in patients with metastatic gastric cancer, suggesting the importance of the selection of appropriate indications according to mol. characteristics in application of targeted agents.  Herein, we review the mol. targeted agents currently approved and in use, and clin. trials in patients with metastatic gastric cancer, and demonstrate the limitations and future direction in treatment of advanced gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7g9zy4-hJPbVg90H21EOLACvtfcHk0ljxhtVuh4cGUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2mt7bI&md5=14e36dfc51376b3edc60bd3b0586cbb8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v22.i3.1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v22.i3.1179%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DOh%26aufirst%3DS.%2BC.%26atitle%3DChanging%2520strategies%2520for%2520target%2520therapy%2520in%2520gastric%2520cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2016%26volume%3D22%26spage%3D1179%26epage%3D1189%26doi%3D10.3748%2Fwjg.v22.i3.1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camidge, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sequist, L. V.</span></span> <span> </span><span class="NLM_article-title">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2014.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1038%2Fnrclinonc.2014.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=24981256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=473-481&author=D.+R.+Camidgeauthor=W.+Paoauthor=L.+V.+Sequist&title=Acquired+resistance+to+TKIs+in+solid+tumours%3A+learning+from+lung+cancer&doi=10.1038%2Fnrclinonc.2014.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span></div><div class="casAuthors">Camidge, D. Ross; Pao, William; Sequist, Lecia V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The use of advanced mol. profiling to direct the use of targeted therapy, such as tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer (NSCLC), has revolutionized the treatment of this disease.  However, acquired resistance, defined as progression after initial benefit, to targeted therapies inevitably occurs.  This Review explores breakthroughs in the understanding and treatment of acquired resistance in NSCLC, focusing on EGFR mutant and ALK rearrangement-pos. disease, which may be relevant across multiple different solid malignancies with oncogene-addicted subtypes.  Mechanisms of acquired resistance may be pharmacol. (i.e., failure of delivery of the drug to its target) or biol., resulting from evolutionary selection on molecularly diverse tumors.  A no. of clin. approaches can maintain control of the disease in the acquired resistance setting, including the use of radiation to treat isolated areas of progression and adding or switching to cytotoxic chemotherapy.  Furthermore, novel approaches that have already proven successful include the development of second-generation and third-generation inhibitors and the combination of some of these inhibitors with antibodies directed against the same target.  With our increased understanding of the spectrum of acquired resistance, major changes in how we conduct clin. research in this setting are now underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp00ixSKYoDuLVg90H21EOLACvtfcHk0lgSyoof2jMslg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL&md5=13cc2f49f7ef320ad54f7e84f5102816</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2014.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2014.104%26sid%3Dliteratum%253Aachs%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26atitle%3DAcquired%2520resistance%2520to%2520TKIs%2520in%2520solid%2520tumours%253A%2520learning%2520from%2520lung%2520cancer%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D11%26spage%3D473%26epage%3D481%26doi%3D10.1038%2Fnrclinonc.2014.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherwood, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkman, J.</span></span> <span> </span><span class="NLM_article-title">Tumor angiogenesis: therapeutic implications</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1186</span>, <span class="refDoi"> DOI: 10.1056/NEJM197111182852108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1056%2FNEJM197111182852108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=4938153" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&author=L.+M.+Sherwoodauthor=E.+E.+Parrisauthor=J.+Folkman&title=Tumor+angiogenesis%3A+therapeutic+implications&doi=10.1056%2FNEJM197111182852108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1056%2FNEJM197111182852108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197111182852108%26sid%3Dliteratum%253Aachs%26aulast%3DSherwood%26aufirst%3DL.%2BM.%26aulast%3DParris%26aufirst%3DE.%2BE.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DTumor%2520angiogenesis%253A%2520therapeutic%2520implications%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1182%26epage%3D1186%26doi%3D10.1056%2FNEJM197111182852108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in cancer and other diseases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1038/35025220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1038%2F35025220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=11001068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&author=P.+Carmelietauthor=R.+K.+Jain&title=Angiogenesis+in+cancer+and+other+diseases&doi=10.1038%2F35025220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Carmeliet, Peter; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 75 refs.  Pathol. angiogenesis is a hallmark of cancer and various ischemic and inflammatory diseases.  Concd. efforts in this area of research are leading to the discovery of a growing no. of pro- and anti-angiogenic mols., some of which are already in clin. trials.  The complex interactions among these mols. and how they affect vascular structure and function in different environments are now beginning to be elucidated.  This integrated understanding is leading to the development of a no. of exciting and bold approaches to treat cancer and other diseases.  But owing to several unanswered questions, caution is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQMelW0OMYbVg90H21EOLACvtfcHk0lgSyoof2jMslg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D&md5=703cbcdbd32292a9238f0394220c853c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F35025220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025220%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D249%26epage%3D257%26doi%3D10.1038%2F35025220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">A synthetic manassantin A derivative inhibits hypoxia-inducible factor 1 and tumor growth</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e99584</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0099584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1371%2Fjournal.pone.0099584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=24925080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eksrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=L.+Langauthor=X.+Liuauthor=Y.+Liauthor=Q.+Zhouauthor=P.+Xieauthor=C.+Yanauthor=X.+Chen&title=A+synthetic+manassantin+A+derivative+inhibits+hypoxia-inducible+factor+1+and+tumor+growth&doi=10.1371%2Fjournal.pone.0099584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A synthetic manassantin A derivative inhibits hypoxia-inducible factor 1 and tumor growth</span></div><div class="casAuthors">Lang, Liwei; Liu, Xiaoyu; Li, Yan; Zhou, Qing; Xie, Ping; Yan, Chunhong; Chen, Xiaoguang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e99584/1-e99584/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The dineolignan manassantin A from Saururaceae was recently identified as a hypoxia-inducible factor 1 (HIF-1) inhibitor, but its in-vivo anti-tumor effect has not been explored.  We synthesized a series of manassantin A derivs., and found that replacing the central THF moiety with a cyclopentane ring yielded a compd. (LXY6006) with increased HIF-1-inhibitory activity yet decreased stereochem. complexity amenable to a simplified synthesis scheme.  LXY6006 inhibited HIF-1α nuclear accumulation induced by hypoxia, and inhibited cancer cell growth as a consequence of G2/M arrest.  Oral administration of LXY6006 significantly inhibited growth of breast, lung, and pancreatic tumors implanted in nude mice.  These results indicate that LXY6006 represents a novel class of agents targeting a broad range of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5X_SZSQ_DxrVg90H21EOLACvtfcHk0lgSyoof2jMslg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eksrzN&md5=d0860462a3eb9514577ac95bc01af0e0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0099584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0099584%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DA%2520synthetic%2520manassantin%2520A%2520derivative%2520inhibits%2520hypoxia-inducible%2520factor%25201%2520and%2520tumor%2520growth%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0099584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span> <span> </span><span class="NLM_article-title">X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells <i>in vitro</i> and <i>in vivo.</i></span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3115</span>– <span class="NLM_lpage">3120</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.3729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.3892%2Fmmr.2015.3729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=25954853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWks77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3115-3120&author=J.+Liauthor=K.+Zhaoauthor=F.+Wangauthor=J.+Caiauthor=Z.+Liauthor=L.+Zou&title=X609%2C+a+novel+manassantin+A+derivative%2C+exhibits+antitumor+activity+in+MG-63+human+osteosarcoma+cells+in+vitro+and+in+vivo.&doi=10.3892%2Fmmr.2015.3729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo</span></div><div class="casAuthors">Li, Ji; Zhao, Kongbo; Wang, Fu; Cai, Jinfang; Li, Zongyu; Zou, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2, Pt. B</span>),
    <span class="NLM_cas:pages">3115-3120</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Manassantin A has been well-established as an inhibitor of HIF-1.  In the present study, a new manasantin A deriv., X609, with decreased stereochem. complexity, rendering it amenable to a simplified synthesis scheme, was synthesized and was found to increase HIF-1 inhibitory activity.  X609 exhibited antiproliferative activity in a broad spectrum of tumor cell lines, via HIF-1-dependent mechanisms.  X609 may induce apoptosis in MG-63 cells through activation of the mitochondrial pathway.  Oral administration of X609 significantly inhibited the growth of human osteosarcomas implanted into nude mice.  In light of the results of the present study, it may be possible to develop X609 for use as a novel antitumor agent, which targets human osteosarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzfqx5aXXni7Vg90H21EOLACvtfcHk0liZjis1KsTJbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWks77I&md5=71987ca285d244e0957418fa3820c527</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.3729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.3729%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZou%26aufirst%3DL.%26atitle%3DX609%252C%2520a%2520novel%2520manassantin%2520A%2520derivative%252C%2520exhibits%2520antitumor%2520activity%2520in%2520MG-63%2520human%2520osteosarcoma%2520cells%2520in%2520vitro%2520and%2520in%2520vivo.%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D3115%26epage%3D3120%26doi%3D10.3892%2Fmmr.2015.3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">LXY6090 - a novel manassantin A derivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibition</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3829</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.2147/OTT.S106925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.2147%2FOTT.S106925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=27445487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFymtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=3829-3840&author=F.+Laiauthor=Q.+Liuauthor=X.+Liuauthor=M.+Jiauthor=P.+Xieauthor=X.+Chen&title=LXY6090+-+a+novel+manassantin+A+derivative+-+limits+breast+cancer+growth+through+hypoxia-inducible+factor-1+inhibition&doi=10.2147%2FOTT.S106925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">LXY6090 - a novel manassantin Aderivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibition</span></div><div class="casAuthors">Lai, Fangfang; Liu, Qian; Liu, Xiaoyu; Ji, Ming; Xie, Ping; Chen, Xiaoguang</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3829-3840</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) represents a novel antitumor target owing to its involvement in vital processes considered hallmarks of cancer phenotypes.  Manassantin A (MA) derived from Saururus cernuus has been reported as a selective HIF-1 inhibitor.  Herein, the structure of MA was optimized to achieve new derivs. with simple chem. properties while retaining its activity.  LXY6090 was designed to replace the central THF moiety of MA with a cyclopentane ring and was identified as a potent HIF-1 inhibitor with an IC50 value of 4.11 nM.  It not only inhibited the activity of HIF-1 in breast cancer cells but also downregulated the protein level of HIF-1α, which depended on von Hippel-Lindau for proteasome degrdn.  The related biol. evaluation showed that the activity of HIF-1 target genes, VEGF and IGF-2, was decreased by LXY6090 in breast cancer cell lines.  LXY6090 presented potent antitumor activity in vitro.  Furthermore, LXY6090 showed in vivo anticancer efficacy by decreasing the HIF-1α expression in nude mice bearing MX-1 tumor xenografts.  In conclusion, our data provide a basis for the future development of the novel compd. LXY6090 as a potential therapeutic agent for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohMbMg-vgShLVg90H21EOLACvtfcHk0liZjis1KsTJbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFymtb8%253D&md5=d89249dc79aa7bc8f9ce572155e2439c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2147%2FOTT.S106925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S106925%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DLXY6090%2520-%2520a%2520novel%2520manassantin%2520A%2520derivative%2520-%2520limits%2520breast%2520cancer%2520growth%2520through%2520hypoxia-inducible%2520factor-1%2520inhibition%26jtitle%3DOncoTargets%2520Ther.%26date%3D2016%26volume%3D9%26spage%3D3829%26epage%3D3840%26doi%3D10.2147%2FOTT.S106925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':[],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhikun  Liu</span>, <span class="hlFld-ContribAuthor ">Shengjin  Xia</span>, <span class="hlFld-ContribAuthor ">Qingqing  Liu</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113300. <a href="https://doi.org/10.1016/j.ejmech.2021.113300" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113300%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsulfamoylphenyl-quinazoline%252Bderivatives%252Bas%252Bpotential%252BEGFR%25252FCAIX%252Bdual%252Binhibitors%26aulast%3DZhang%26aufirst%3DBin%26date%3D2021%26volume%3D216%26spage%3D113300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and SAR plan of manassantin A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Analogues <b>4</b>, <b>11</b>, <b>15</b>, <b>20a</b>, and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd/C, H<sub>2</sub>, EtOAc/EtOH, 25 °C, 24 h, 71%; (b) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 83%; (c) methyl acrylate, Grubbs’ II, PMHS, toluene, 110 °C, 30 min, 130 °C, 12 h, 45%; (d) (<i>R</i>)-2-Me-CBS-oxazaborolidine, BH<sub>3</sub>·SMe<sub>2</sub>, THF, 0 °C, 30 min, 58%, 80% ee; (e) PPTS, toluene, 70 °C, 12 h, 86%; (f) <b>9</b>, <i>t</i>-BuLi, THF, −78 °C, 1 h, 20%; (g) BF<sub>3</sub>·OEt<sub>2</sub>, NaBH<sub>3</sub>CN, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>CN, −78 °C, 1 h, 49%; (h) TBAF, THF, 0–25 °C, 1 h, 88%; (i) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 25 °C, 1 h, 73%; (j) <b>9</b>, <i>n</i>-BuLi, THF, −78 °C, 4 h, 64%; (k) LiAlH<sub>4</sub>, THF, 0 to 25 °C, 10 min, 56%; (l) AuCl<sub>3</sub>, CH<sub>3</sub>CN, 25 °C, 10 min, 57%; (m) TBAF, THF, 0–25 °C, 10 min, 47%; (n) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1.5 h, 76%; (o) <b>9</b>, <i>t</i>-BuLi, THF, −78 °C, 6 h, 40%; (p) (<i>S</i>)-α,α-diphenyl-2-pyrrolidinemethanol, B(OMe)<sub>3</sub>, BH<sub>3</sub>·SMe<sub>2</sub>, THF, 25 °C, 1 h, 80%, 97% ee; (q) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, −20 °C, 3 h; (r) RNH<sub>2</sub>, 25 °C, 12 h, (<b>19a</b>) 73%, (<b>19b</b>) 64%; (s) TBAF, THF, 0 to 25 °C, 10 min (R = allyl, 55%; R = Bn, 82%); (t) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 25 °C, 1 h, (<b>20a</b>) 72%, (<b>20b</b>) 26%; (u) Pd/C, H<sub>2</sub>, HOAc, 25 °C, 24 h, 50%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Analogues <b>25a</b>, <b>25b</b>, <b>28</b>, <b>33</b>, and <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>23</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 2–4 h, (<b>24a</b>) 99%, (<b>24b</b>) 8%; (b) Pd/C, H<sub>2</sub>, EtOH, 25 °C, 24 h, X = C: 34%, X = N: 89%; (c) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, (<b>25a</b>) 27%, (<b>25b</b>) 43%; (d) TsNHNH<sub>2</sub>, MeOH, 60 °C, 15 h, quant.; (e) <i>t</i>-BuXphosAuCl, LiO<i>t</i>-Bu, NaBArF, 1,2-dichloroethane, reflux, 16 h, 13%; (f) TBAF, THF, 0–25 °C, 1 h, 88%; (g) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 73%; (h) <b>30</b>, <i>n</i>-BuLi, THF, −78 °C, 1 h, 39%; (i) <b>30</b>, <i>t</i>-BuLi, THF/HMPA, −78 °C, 1 h, 63%; (j) TBAF, THF, 0–25 °C, 40 min, 79%; (k) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 86%; (l) PPh<sub>3</sub>, toluene, reflux, 2 h, 60%; (m) <b>36</b>, LHMDS, THF, −78 to 0 °C, 5.5 h, 8.4%; (n) TBAF, THF, 0–25 °C, 1 h, 55%; (o) <b>3</b>, BEMP, CH<sub>2</sub>Cl<sub>2</sub>, 0–25 °C, 1 h, 45%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activity of manassantin A (ManA) and analogues for HIF-1 inhibition. HEK-293T cells were transfected with pGL3-5HRE-VEGF-luciferase and pRL-SV40 plasmids, and treated with 0, 0.01, 0.1, and 1 μM of ManA (manassantin A) and analogues or 10 μM of 17-AAG (17-(allylamino)-17-demethoxygeldanamycin), as a positive control under hypoxia for 24 h. Relative luciferase activity was determined after normalized to the Renilla luciferase activity. Three independent experiments were performed. # <i>P</i> < 0.0001 versus vehicle control group, % <i>P</i> < 0.001 versus vehicle control group, $ <i>P</i> < 0.01 versus vehicle control group, and * <i>P</i> < 0.1 versus vehicle control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlays of optimized conformations of manassantin A (<b>1</b>) and analogues (<b>11</b> and <b>25b</b>). To avoid any unnecessary complications and/or exaggeration by the flexible side chains, truncated structures of <b>1</b>, <b>11</b>, and <b>25b</b> were used instead of the full structures. Initial geometries were determined by conformational search based on MMFF and OPLS3. (A and B) Superimposition of an active manassantin A analog (gray: <b>1</b>; green: <b>11</b>). (C and D) Superimposition of an inactive manassantin A analog (gray: <b>1</b>; sky blue: <b>25b</b>). (E) Truncated structures <b>1</b>, <b>11</b>, and <b>25b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/medium/jm0c00151_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Manassantin A (ManA) cooperatively inhibits tumor growth in combination with an EGFR inhibitor, gefitinib (Gef). Lewis lung carcinoma cells (2 × 10<sup>5</sup>) were inoculated into both flanks of C57Bl/6 mice (Day 0). From two days after inoculation, mice (<i>n</i> = 5 per group) were treated intraperitoneally with manassantin A (5 mg/kg body weight) and/or gefitinib (5 mg/kg body weight) three times a week for 17 days and then sacrificed. Tumor size (A) and tumor weight (B) were measured three times a week and on the final day, respectively. Tumor masses were photographed and shown in a box right the graph. * <i>P</i> < 0.05 versus vehicle control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00151/20200701/images/large/jm0c00151_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00151&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torre, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.3322/caac.21492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.3322%2Fcaac.21492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=30207593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=394-424&author=F.+Brayauthor=J.+Ferlayauthor=I.+Soerjomataramauthor=R.+L.+Siegelauthor=L.+A.+Torreauthor=A.+Jemal&title=Global+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countries&doi=10.3322%2Fcaac.21492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span></div><div class="casAuthors">Bray Freddie; Ferlay Jacques; Soerjomataram Isabelle; Siegel Rebecca L; Torre Lindsey A; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">394-424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.  There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018.  In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality.  Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality).  Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality.  The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors.  It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries.  The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts.  CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaW5wv8ocuhLxanA7vODO6fW6udTcc2ebSs_fXSp_WN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D&md5=48529f8f794092779d70a27eec5c9017</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21492%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DF.%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DTorre%26aufirst%3DL.%2BA.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DGlobal%2520cancer%2520statistics%25202018%253A%2520GLOBOCAN%2520estimates%2520of%2520incidence%2520and%2520mortality%2520worldwide%2520for%252036%2520cancers%2520in%2520185%2520countries%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2018%26volume%3D68%26spage%3D394%26epage%3D424%26doi%3D10.3322%2Fcaac.21492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Agency for Healthcare Research
and Quality</span>. <span> </span><span class="NLM_article-title">Total expenditures
in millions by condition</span>, <span class="NLM_publisher-loc">U.S.</span>, <span class="NLM_year">2015</span>.  <i>Medical Expenditure Panel Survey</i>. <a href="https://www.meps.ahrq.gov/mepstrends/hc_cond/" class="extLink">https://www.meps.ahrq.gov/mepstrends/hc_cond/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Agency+for+Healthcare+Research%0Aand+Quality&title=Medical+Expenditure+Panel+Survey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DTotal%2520expenditures%250Ain%2520millions%2520by%2520condition%26date%3D2015%26btitle%3DMedical%2520Expenditure%2520Panel%2520Survey" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmarcher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilking, N.</span></span> <span> </span><span class="NLM_article-title">The cost and burden of cancer in the European Union 1995−2014</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2016.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.ejca.2016.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=27589247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BC2szmvVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=162-170&author=B.+Jonssonauthor=T.+Hofmarcherauthor=P.+Lindgrenauthor=N.+Wilking&title=The+cost+and+burden+of+cancer+in+the+European+Union+1995%E2%88%922014&doi=10.1016%2Fj.ejca.2016.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The cost and burden of cancer in the European Union 1995-2014</span></div><div class="casAuthors">Jonsson Bengt; Hofmarcher Thomas; Lindgren Peter; Wilking Nils</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cancer (Oxford, England : 1990)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">162-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is an intense debate about the cost of cancer and the value of new treatments.  However, there is limited data on the cost of cancer in the European Union (EU) and how costs relate to the burden of disease.  This paper presents new estimates on the development of the cost of cancer in the EU 1995-2014, with a focus on the major cost components: total health expenditure, cancer drugs, and production loss due to premature mortality.  METHODS:  Data on overall health expenditure were combined with national disease estimates to derive cancer-specific health expenditure.  Data on drug sales were obtained from IMS Health, and epidemiological data were used to calculate life years lost due to cancer.  FINDINGS:  Health expenditure on cancer increased continuously from .EURO.35.7 billion in 1995 to .EURO.83.2 billion in 2014 in the EU and spending on cancer drugs from .EURO.7.6 billion in 2005 to .EURO.19.1 billion in 2014 (current prices).  Yet the share of total health expenditure devoted to cancer was mostly constant (around 6 per cent).  While expenditures on cancer drugs increased in both absolute and relative terms, other expenditures were stable or decreased, despite increases in cancer incidence driven by a growing and ageing population.  Reductions in cancer mortality during working age resulted in decreasing production loss due to premature mortality.  INTERPRETATION:  Health spending on cancer as a share of total health expenditure is rather low and stable despite the growing incidence and relative burden of cancer.  Problems to reallocate funding in health care systems under economic pressure may be one explanation and shifting costs from inpatient to ambulatory care another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgkJlfSeKauDUE-swuRqsHfW6udTcc2ebSs_fXSp_WN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szmvVygtA%253D%253D&md5=3d538997967c9790503a7c7f73b71cca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2016.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2016.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DB.%26aulast%3DHofmarcher%26aufirst%3DT.%26aulast%3DLindgren%26aufirst%3DP.%26aulast%3DWilking%26aufirst%3DN.%26atitle%3DThe%2520cost%2520and%2520burden%2520of%2520cancer%2520in%2520the%2520European%2520Union%25201995%25E2%2588%25922014%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2016%26volume%3D66%26spage%3D162%26epage%3D170%26doi%3D10.1016%2Fj.ejca.2016.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Oxygen sensing, homeostasis, and disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1056/NEJMra1011165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1056%2FNEJMra1011165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=21830968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVars7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=537-547&author=G.+L.+Semenza&title=Oxygen+sensing%2C+homeostasis%2C+and+disease&doi=10.1056%2FNEJMra1011165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: oxygen sensing, homeostasis, and disease</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry90AK1l3p5LVg90H21EOLACvtfcHk0lhsaQsYmykkcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVars7nP&md5=2944fe18da77d2f5d74f8edd75661b51</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1011165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1011165%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DOxygen%2520sensing%252C%2520homeostasis%252C%2520and%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D537%26epage%3D547%26doi%3D10.1056%2FNEJMra1011165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rue, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O<sub>2</sub> tension</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">5510</span>– <span class="NLM_lpage">5514</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.12.5510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1073%2Fpnas.92.12.5510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=7539918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFOgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=5510-5514&author=G.+L.+Wangauthor=B.+H.+Jiangauthor=E.+A.+Rueauthor=G.+L.+Semenza&title=Hypoxia-inducible+factor+1+is+a+basic-helix-loop-helix-PAS+heterodimer+regulated+by+cellular+O2+tension&doi=10.1073%2Fpnas.92.12.5510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension</span></div><div class="casAuthors">Wang, Guang L.; Jiang, Bing-Hua; Rue, Elizabeth A.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5510-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is found in mammalian cells cultured under reduced O2 tension and is necessary for transcriptional activation mediated by the erythropoietin gene enhancer in hypoxic cells.  We show that both HIF-1 subunits are basic-helix-loop-helix proteins contg. a PAS domain, defined by its presence in the Drosophila Per and Sim proteins and in the mammalian ARNT and AHR proteins.  HIF-1α is most closely related to Sim.  HIF-1α and HIF-1β (ARNT) RNA and protein levels were induced in cells exposed to 1% O2 and decayed rapidly upon return of the cells to 20% O2, consistent with the role of HIF-1 as a mediator of transcriptional responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrijPeJeRyVcrVg90H21EOLACvtfcHk0liasQPfYD10PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFOgs7k%253D&md5=31e7aac200d3271870e8ad7dc06b4734</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.12.5510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.12.5510%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BL.%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DRue%26aufirst%3DE.%2BA.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factor%25201%2520is%2520a%2520basic-helix-loop-helix-PAS%2520heterodimer%2520regulated%2520by%2520cellular%2520O2%2520tension%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D5510%26epage%3D5514%26doi%3D10.1073%2Fpnas.92.12.5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lisy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span> <span> </span><span class="NLM_article-title">Turn me on: regulating HIF transcriptional activity</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">642</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4402315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1038%2Fsj.cdd.4402315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=18202699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtl2ju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=642-649&author=K.+Lisyauthor=D.+J.+Peet&title=Turn+me+on%3A+regulating+HIF+transcriptional+activity&doi=10.1038%2Fsj.cdd.4402315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Turn me on: regulating HIF transcriptional activity</span></div><div class="casAuthors">Lisy, K.; Peet, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">642-649</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The hypoxia-inducible factors (HIFs) are crit. for cellular adaptation to limiting oxygen and regulate a wide array of genes when cued by cellular oxygen-sensing mechanisms.  HIF is able to direct transcription from either of two transactivation domains, each of which is regulated by distinct mechanisms.  The oxygen-dependent asparaginyl hydroxylase factor-inhibiting HIF-1α (FIH-1) is a key regulator of the HIF C-terminal transactivation domain, and provides a direct link between oxygen sensation and HIF-mediated transcription.  Addnl., there are phosphorylation and nitrosylation events reported to modulate HIF transcriptional activity, as well as numerous transcriptional coactivators and other interacting proteins that together provide cell and tissue specificity of HIF target gene regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBRwIpomo01bVg90H21EOLACvtfcHk0liasQPfYD10PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtl2ju7c%253D&md5=59d0c2050f32bf5dfe3ab9ab68ae0b08</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402315%26sid%3Dliteratum%253Aachs%26aulast%3DLisy%26aufirst%3DK.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26atitle%3DTurn%2520me%2520on%253A%2520regulating%2520HIF%2520transcriptional%2520activity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2008%26volume%3D15%26spage%3D642%26epage%3D649%26doi%3D10.1038%2Fsj.cdd.4402315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, P.</span></span> <span> </span><span class="NLM_article-title">Tumor microenvironmental physiology and its implications for radiation oncology</span>. <i>Semin. Radiat. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1016/j.semradonc.2004.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.semradonc.2004.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=15254862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BD2czltFOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=198-206&author=P.+Vaupel&title=Tumor+microenvironmental+physiology+and+its+implications+for+radiation+oncology&doi=10.1016%2Fj.semradonc.2004.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor microenvironmental physiology and its implications for radiation oncology</span></div><div class="casAuthors">Vaupel Peter</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in radiation oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-206</span>
        ISSN:<span class="NLM_cas:issn">1053-4296</span>.
    </div><div class="casAbstract">The microenvironmental physiology of tumors is uniquely different from that of normal tissues.  It is characterized, inter alia, by O(2) depletion (hypoxia, anoxia), glucose and energy deprivation, high lactate levels, and extracellular acidosis, parameters that are anisotropically distributed within the tumor mass.  This hostile microenvironment is largely dictated by the abnormal tumor vasculature and heterogeneous microcirculation.  Hypoxia and other hostile microenvironmental parameters are known to directly or indirectly confer resistance to irradiation leading to treatment failure.  Hypoxia directly leads to a reduced "fixation" of radiation-induced DNA damage.  Indirect mechanisms include a restrained proliferation, changes in gene expression and alterations of the proteome (eg, elevated activity of DNA-repair enzymes and resistance-related proteins, increased transcription of growth factors), and genomic changes (genomic instability leading to clonal heterogeneity and selection of resistant clonal variants).  These changes, caused by the hostile microenvironment, can favor tumor progression and acquired treatment resistance, both resulting in poor clinical outcome and prognosis.  Pretreatment assessment of critical microenvironmental parameters is therefore needed to allow the selection of patients who could benefit from special treatment approaches (eg, hypoxia-targeting therapy).  Because of a relatively high risk of local relapse or distant metastasis, patients with hypoxic and/or "high-lactate" tumors should undergo close surveillance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUAShbi-bxLYxhnOQkIHOxfW6udTcc2eZNYt1e04oUF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltFOrsQ%253D%253D&md5=52dc30f316eac2b99d237f3e2ddbe064</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.semradonc.2004.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semradonc.2004.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DVaupel%26aufirst%3DP.%26atitle%3DTumor%2520microenvironmental%2520physiology%2520and%2520its%2520implications%2520for%2520radiation%2520oncology%26jtitle%3DSemin.%2520Radiat.%2520Oncol.%26date%3D2004%26volume%3D14%26spage%3D198%26epage%3D206%26doi%3D10.1016%2Fj.semradonc.2004.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laissue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djonov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Expression of hypoxia-inducible factor-1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2911</span>– <span class="NLM_lpage">2916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=11306467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2911-2916&author=D.+M.+Aebersoldauthor=P.+Burriauthor=K.+T.+Beerauthor=J.+Laissueauthor=V.+Djonovauthor=R.+H.+Greinerauthor=G.+L.+Semenza&title=Expression+of+hypoxia-inducible+factor-1a%3A+a+novel+predictive+and+prognostic+parameter+in+the+radiotherapy+of+oropharyngeal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer</span></div><div class="casAuthors">Aebersold, Daniel M.; Burri, Philipp; Beer, Karl T.; Laissue, Jean; Djonov, Valentin; Greiner, Richard H.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2911-2916</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia has long been recognized as detrimental to the successful treatment of malignant tumors with ionizing radiation.  Because hypoxia-inducible factor (HIF)-1α plays an essential role in oxygen homeostasis in vitro, we explored the predictive potential of this factor in a cohort of 98 patients with squamous cell cancer of the oropharynx, who were treated by curative radiation therapy.  Ninety-four % of the primary tumors showed overexpression of HIF-1α, relative to the surrounding tissue, as detd. by immunohistochem.  The degree of HIF-1α immunoreactivity correlated inversely with both the rate of complete remission of the primary tumor (odds ratio, 0.33; P = 0.03) and lymph node metastases (odds ratio, 0.34; P = 0.02) as well as with local failure-free survival (risk ratio, 2.15; P = 0.006), disease-free survival (risk ratio, 2.01; P = 0.008), and overall survival (risk ratio, 2.17; P = 0.002).  The multivariate anal. revealed the predictive power of HIF-1α to be independent of other covariables.  We conclude that HIF-1α is overexpressed in the vast majority of patients with squamous cell cancer of the oropharynx and that the degree of expression has predictive and prognostic significance in individuals undergoing curative radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQvUdKVgiYYrVg90H21EOLACvtfcHk0liSUo45xAr5mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGqsr8%253D&md5=57fd3b52a292989d6c6548c5bbb25359</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAebersold%26aufirst%3DD.%2BM.%26aulast%3DBurri%26aufirst%3DP.%26aulast%3DBeer%26aufirst%3DK.%2BT.%26aulast%3DLaissue%26aufirst%3DJ.%26aulast%3DDjonov%26aufirst%3DV.%26aulast%3DGreiner%26aufirst%3DR.%2BH.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DExpression%2520of%2520hypoxia-inducible%2520factor-1a%253A%2520a%2520novel%2520predictive%2520and%2520prognostic%2520parameter%2520in%2520the%2520radiotherapy%2520of%2520oropharyngeal%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2911%26epage%3D2916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(04)00115-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS1535-6108%2804%2900115-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=15144951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-441&author=B.+J.+Moellerauthor=Y.+Caoauthor=C.+Y.+Liauthor=M.+W.+Dewhirst&title=Radiation+activates+HIF-1+to+regulate+vascular+radiosensitivity+in+tumors%3A+role+of+reoxygenation%2C+free+radicals%2C+and+stress+granules&doi=10.1016%2FS1535-6108%2804%2900115-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules</span></div><div class="casAuthors">Moeller, Benjamin J.; Cao, Yiting; Li, Chuan Y.; Dewhirst, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Through a poorly understood mechanism, tumors respond to radiation by secreting cytokines capable of inhibiting apoptosis in endothelial cells, thereby diminishing treatment response by minimizing vascular damage.  We reveal here that this pathway is governed by a major angiogenesis regulator, HIF-1.  Following radiotherapy, tumor reoxygenation leads to: (1) nuclear accumulation of HIF-1 in response to reactive oxygen, and (2) enhanced translation of HIF-1-regulated transcripts secondary to stress granule depolymn.  The resulting increase in HIF-1-regulated cytokines enhances endothelial cell radioresistance.  Inhibiting postradiation HIF-1 activation significantly increases tumor radiosensitivity as a result of enhanced vascular destruction.  These data describe novel pathways contributing significantly to our understanding of HIF-1 regulation which may be major determinants of tumor radiosensitization, potentially having high clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlGjDbjcgvbVg90H21EOLACvtfcHk0liSUo45xAr5mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7k%253D&md5=dfc296af70e9885fb40cb0fc7c1b918e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900115-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900115-1%26sid%3Dliteratum%253Aachs%26aulast%3DMoeller%26aufirst%3DB.%2BJ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DRadiation%2520activates%2520HIF-1%2520to%2520regulate%2520vascular%2520radiosensitivity%2520in%2520tumors%253A%2520role%2520of%2520reoxygenation%252C%2520free%2520radicals%252C%2520and%2520stress%2520granules%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D441%26doi%3D10.1016%2FS1535-6108%2804%2900115-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koukourakis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giatromanolaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivridis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talks, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatter, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1016/S0360-3016(02)02848-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0360-3016%2802%2902848-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=12128120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVKqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=1192-1202&author=M.+I.+Koukourakisauthor=A.+Giatromanolakiauthor=E.+Sivridisauthor=C.+Simopoulosauthor=H.+Turleyauthor=K.+Talksauthor=K.+C.+Gatterauthor=A.+L.+Harris&title=Hypoxia-inducible+factor+%28HIF1A+and+HIF2A%29%2C+angiogenesis%2C+and+chemoradiotherapy+outcome+of+squamous+cell+head-and-neck+cancer&doi=10.1016%2FS0360-3016%2802%2902848-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer</span></div><div class="casAuthors">Koukourakis, Michael I.; Giatromanolaki, Alexandra; Sivridis, Efthimios; Simopoulos, Constantinos; Turley, Helen; Talks, Kate; Gatter, Kevin C.; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1192-1202</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Purpose: Hypoxia-inducible factors HIF1α and HIF2α (HIFαs) regulate the expression of a variety of genes encoding proteins related to angiogenesis and to anaerobic metab. of cells exposed to hypoxic stress.  Their putative role as markers of clin. relevant hypoxia and, therefore, as predictors of response to chemoradiotherapy is herein examd.  Patients and Methods: Using immunohistochem., we assessed the expression of HIFαs in normal head-neck mucosa and in 75 cancer specimens from patients with locally advanced squamous cell head-and-neck cancer (SCHNC), treated with concurrent carboplatin chemoradiotherapy.  Results: Head-and-neck mucosa from normal individuals did not show any HIF1α or HIF2α reactivity.  SCHNC showed a varying expression of HIFαs ranging through neg. reactivity, to weak or focally strong cytoplasmic reactivity, or to strong diffuse cytoplasmic/nuclear reactivity.  Fifty-two percent and 33% of cancer samples showed the latter expression pattern for HIF1α and HIF2α, resp., and were considered to bear "high" HIF reactivity.  Bone/cartilage involvement was more frequent in tumors with high HIF1α expression (p = 0.05).  HIF1α and HIF2α overexpression were significantly assocd. with high microvessel d. (p = 0.002 and 0.02, resp.) and with VEGF expression (p = 0.01 and 0.005, resp.).  HIF1α was related to high thymidine phosphorylase expression (p = 0.03), whereas VEGF/KDR-activated tumor vasculature was significantly more frequent in HIF2α-overexpressing tumors (p = 0.02).  High HIF1α and HIF2α were assocd. with incomplete response to chemoradiation (p = 0.007 and p = 0.02, resp.).  In univariate anal., high HIF1α and HIF2α expression were significantly assocd. with poor local relapse-free survival (p = 0.003 and 0.003, resp.) and with poor overall survival (p = 0.05 and 0.001, resp.).  In multivariate models, HIF2α expression was an independent prognostic factor.  In biopsies performed after the delivery of 20 Gy of radiotherapy, upregulation of HIFαs was noted in some cases.  Conclusions: It is concluded that the overexpression of HIFαs in SCHNC is related to locally aggressive behavior, to intensification of angiogenesis, and to an important resistance to carboplatin chemoradiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonFIk55FiAtbVg90H21EOLACvtfcHk0liSUo45xAr5mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVKqs70%253D&md5=1b398079f84d1581734b57d2ee9223b1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2802%2902848-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252802%252902848-1%26sid%3Dliteratum%253Aachs%26aulast%3DKoukourakis%26aufirst%3DM.%2BI.%26aulast%3DGiatromanolaki%26aufirst%3DA.%26aulast%3DSivridis%26aufirst%3DE.%26aulast%3DSimopoulos%26aufirst%3DC.%26aulast%3DTurley%26aufirst%3DH.%26aulast%3DTalks%26aufirst%3DK.%26aulast%3DGatter%26aufirst%3DK.%2BC.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHypoxia-inducible%2520factor%2520%2528HIF1A%2520and%2520HIF2A%2529%252C%2520angiogenesis%252C%2520and%2520chemoradiotherapy%2520outcome%2520of%2520squamous%2520cell%2520head-and-neck%2520cancer%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2002%26volume%3D53%26spage%3D1192%26epage%3D1202%26doi%3D10.1016%2FS0360-3016%2802%2902848-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors: master regulators of cancer progression</span>. <i>Trends Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">758</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1016/j.trecan.2016.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.trecan.2016.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=28741521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADC%252BC1cfgvFansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=758-770&author=L.+Schitoauthor=G.+L.+Semenza&title=Hypoxia-inducible+factors%3A+master+regulators+of+cancer+progression&doi=10.1016%2Fj.trecan.2016.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-Inducible Factors: Master Regulators of Cancer Progression</span></div><div class="casAuthors">Schito Luana; Semenza Gregg L</div><div class="citationInfo"><span class="NLM_cas:title">Trends in cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">758-770</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Intratumoral hypoxia (reduced O2 availability) is a common finding in human cancer and leads to increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes that contribute to angiogenesis, metabolic reprogramming, extracellular matrix remodeling, epithelial-mesenchymal transition, motility, invasion, metastasis, cancer stem cell maintenance, immune evasion, and resistance to chemotherapy and radiation therapy.  Conventional anticancer therapies target well-oxygenated and proliferating cancer cells, whereas there are no approved therapies that target hypoxic cancer cells, despite growing clinical and experimental evidence indicating that intratumoral hypoxia is a critical microenvironmental factor driving cancer progression.  In this review, our current understanding of the consequences of HIF activity and the translational potential of targeting HIFs for cancer therapy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTd1_IJq-f2zlVwdslNBF-tfW6udTcc2ebPp16p1EZFJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfgvFansA%253D%253D&md5=8aa53aef8e891394c0505b1c9fa9491e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.trecan.2016.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trecan.2016.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DSchito%26aufirst%3DL.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factors%253A%2520master%2520regulators%2520of%2520cancer%2520progression%26jtitle%3DTrends%2520Cancer%26date%3D2016%26volume%3D2%26spage%3D758%26epage%3D770%26doi%3D10.1016%2Fj.trecan.2016.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brizel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosnitz, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1016/S0360-3016(97)00101-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0360-3016%2897%2900101-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=9226314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADyaK2szmvFyksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=285-289&author=D.+M.+Brizelauthor=G.+S.+Sibleyauthor=L.+R.+Prosnitzauthor=R.+L.+Scherauthor=M.+W.+Dewhirst&title=Tumor+hypoxia+adversely+affects+the+prognosis+of+carcinoma+of+the+head+and+neck&doi=10.1016%2FS0360-3016%2897%2900101-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck</span></div><div class="casAuthors">Brizel D M; Sibley G S; Prosnitz L R; Scher R L; Dewhirst M W</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation oncology, biology, physics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-9</span>
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    </div><div class="casAbstract">PURPOSE:  Tumor hypoxia adversely affects short term clinical radiation response of head and neck cancer lymph node metastases and long term disease-free survival (DFS) in cervix carcinoma.  This study was performed to evaluate the relationship between tumor hypoxia and DFS in patients with squamous carcinoma of the head and neck (SCCHN).  METHODS AND MATERIALS:  Pretreatment tumor pO2 was assessed polarographically in SCCHN patients.  All patients were AJCC Stage IV and had pretreatment oxygen measurements taken from locally advanced primaries (T3 or T4) or neck nodes > or = 1.5 cm diameter.  Treatment consisted of once daily (2 Gy/day to 66-70 Gy) or twice daily irradiation (1.25 Gy B.I.D. to 70-75 Gy) +/- planned neck dissection (for > or = N2A disease) according to institutional treatment protocols.  RESULTS:  Twenty-eight patients underwent tumor pO2 measurement.  The average pre-treatment median pO2 was 11.2 mm Hg (range 0.4-60 mm Hg).  The DFS at 12 months was 42%.  The DFS was 78% for patients with median tumor pO2 > 10 mm Hg but only 22% for median pO2 < 10 mm Hg (p = 0.009).  The average tumor median pO2 for relapsing patients was 4.1 mm Hg and 17.1 mm Hg in non-relapsing (NED) patients (p = 0.007).  CONCLUSION:  Tumor hypoxia adversely affected the prognosis of patients in this study.  Understanding of the mechanistic relationship between hypoxia and treatment outcome will allow for the development of new and rational treatment programs in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOn2OYET779Z6KlWarZTAzfW6udTcc2ebPp16p1EZFJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szmvFyksQ%253D%253D&md5=c0e5db4e5bea60615f7c5763afb8beda</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2897%2900101-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252897%252900101-6%26sid%3Dliteratum%253Aachs%26aulast%3DBrizel%26aufirst%3DD.%2BM.%26aulast%3DSibley%26aufirst%3DG.%2BS.%26aulast%3DProsnitz%26aufirst%3DL.%2BR.%26aulast%3DScher%26aufirst%3DR.%2BL.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DTumor%2520hypoxia%2520adversely%2520affects%2520the%2520prognosis%2520of%2520carcinoma%2520of%2520the%2520head%2520and%2520neck%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D1997%26volume%3D38%26spage%3D285%26epage%3D289%26doi%3D10.1016%2FS0360-3016%2897%2900101-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hockel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aral, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaupel, P.</span></span> <span> </span><span class="NLM_article-title">Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4509</span>– <span class="NLM_lpage">4915</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=8813149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A280%3ADyaK28vgvVWjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=4509-4915&author=M.+Hockelauthor=K.+Schlengerauthor=B.+Aralauthor=M.+Mitzeauthor=U.+Schafferauthor=P.+Vaupel&title=Association+between+tumor+hypoxia+and+malignant+progression+in+advanced+cancer+of+the+uterine+cervix"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix</span></div><div class="casAuthors">Hockel M; Schlenger K; Aral B; Mitze M; Schaffer U; Vaupel P</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4509-15</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Experimental tumors contain a significant fraction of microregions that are chronically or transiently hypoxic.  Experimental evidence showing that hypoxia (and subsequent reoxygenation) may have a profound impact on malignant progression and on responsiveness to therapy is growing.  The clinical relevance of tumor oxygenation in human solid malignancies is under investigation.  We have developed and validated a clinically applicable method for measurement of tumor oxygenation in locally advanced cancer of the uterine cervix using a computerized polarographic electrode system.  Applying this procedure in patients with cervical cancers </= 3 cm in diameter, who gave informed consent, we have been studying the clinical relevance of tumor oxygenation prospectively since 1989.  As of June 1995, 103 patients with advanced cancers of the uterine cervix [Federation Internationale des Gynaecologistes et Obstetristes (FIGO) stages Ib, bulky (n = 13), IIa and IIb (n = 51), IIIa and IIIb (n = 34), and IVa and IVb (n = 5)] had entered the study.  Fifty % of the patients had carcinomas with median pO2 readings <10 mm Hg, referred to as hypoxic tumors.  Tumor oxygenation was found to be independent of various patient demographics and also of pretreatment tumor characteristics, such as clinical tumor stage and size, histological type, and differentiation.  However, histopathological examination of the surgical specimens following radical tumor resection in 47 patients showed that low-pO2 tumors exhibited larger tumor extensions and more frequent (occult) parametrial spread, as well as lymph-vascular space involvement, compared to well-oxygenated tumors of similar clinical stage and size.  Forty-two patients completing primary radiation therapy and 47 patients who underwent radical surgery were analyzed for treatment outcome after a median observation period of 28 months (range, 3-76 months).  Patients with hypoxic tumors had significantly worse disease-free and overall survival probabilities compared to patients with nonhypoxic tumors.  Cox regression analysis identified tumor oxygenation and FIGO stage as the most important independent prognostic factors.  The poorer outcome of the patients with hypoxic tumors was mainly due to locoregional failures with and without distant metastases, irrespective of whether surgery or radiation was applied as primary treatment.  Tumor oxygenation as measured with a standardized polarographic method proved to be a powerful new pretherapeutic prognostic parameter providing important information on malignant progression in terms of extracervical tumor spread and radioresistance in advanced cervical cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3e-bgelQZigqdek-gHSrIfW6udTcc2eaFNY1FV_S_kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vgvVWjtg%253D%253D&md5=a0fc69874d7670a15d2e886ab9d629a9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHockel%26aufirst%3DM.%26aulast%3DSchlenger%26aufirst%3DK.%26aulast%3DAral%26aufirst%3DB.%26aulast%3DMitze%26aufirst%3DM.%26aulast%3DSchaffer%26aufirst%3DU.%26aulast%3DVaupel%26aufirst%3DP.%26atitle%3DAssociation%2520between%2520tumor%2520hypoxia%2520and%2520malignant%2520progression%2520in%2520advanced%2520cancer%2520of%2520the%2520uterine%2520cervix%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D4509%26epage%3D4915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1089%2Fars.2007.1623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=17571959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1237-1294&author=E.+J.+Moonauthor=D.+M.+Brizelauthor=J.+T.+Chiauthor=M.+W.+Dewhirst&title=The+potential+role+of+intrinsic+hypoxia+markers+as+prognostic+variables+in+cancer&doi=10.1089%2Fars.2007.1623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span></div><div class="casAuthors">Moon, Eui Jung; Brizel, David M.; Chi, Jen-Tsan Ashley; Dewhirst, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-1294</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia is related to tumor progression and therapy resistance, which leads to poor patient outcome.  It was suggested that measuring the hypoxic status of a tumor helps to predict patient outcome and to select more targeted treatment.  However, current methods using needle electrodes or exogenous markers have limitations due to their invasiveness or necessity for preinjection.  Recent studies showed that hypoxia-regulated genes could be alternatively used as endogenous hypoxia markers.  This is a review of 15 hypoxia-regulated genes, including hypoxia-inducible factor-1 and its targets, and their correlation with tumor hypoxia and patient outcome from 213 studies.  Though most of the studies showed significance of these genes in predicting prognosis, there was no definitive prognostic and hypoxia marker.  In conclusion, this review suggests the need for further studies with standardized methods to examine gene expression, as well as the use of multiple gene expressions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY758k83PGjbVg90H21EOLACvtfcHk0lg4GHfHdF5ACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D&md5=61a4f08cd5644ffdc91b45634f96b8af</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1623%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DBrizel%26aufirst%3DD.%2BM.%26aulast%3DChi%26aufirst%3DJ.%2BT.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DThe%2520potential%2520role%2520of%2520intrinsic%2520hypoxia%2520markers%2520as%2520prognostic%2520variables%2520in%2520cancer%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D1237%26epage%3D1294%26doi%3D10.1089%2Fars.2007.1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wigerup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bexell, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.pharmthera.2016.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=27139518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2016&pages=152-169&author=C.+Wigerupauthor=S.+Pahlmanauthor=D.+Bexell&title=Therapeutic+targeting+of+hypoxia+and+hypoxia-inducible+factors+in+cancer&doi=10.1016%2Fj.pharmthera.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span></div><div class="casAuthors">Wigerup, Caroline; Paahlman, Sven; Bexell, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-169</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insufficient tissue oxygenation, or hypoxia, contributes to tumor aggressiveness and has a profound impact on clin. outcomes in cancer patients.  At decreased oxygen tensions, hypoxia-inducible factors (HIFs) 1 and 2 are stabilized and mediate a hypoxic response, primarily by acting as transcription factors.  HIFs exert differential effects on tumor growth and affect important cancer hallmarks including cell proliferation, apoptosis, differentiation, vascularization/angiogenesis, genetic instability, tumor metab., tumor immune responses, and invasion and metastasis.  As a consequence, HIFs mediate resistance to chemo- and radiotherapy and are assocd. with poor prognosis in cancer patients.  Intriguingly, perivascular tumor cells can also express HIF-2α, thereby forming a "pseudohypoxic" phenotype that further contributes to tumor aggressiveness.  Therefore, therapeutic targeting of HIFs in cancer has the potential to improve treatment efficacy.  Different strategies to target hypoxic cancer cells and/or HIFs include hypoxia-activated prodrugs and inhibition of HIF dimerization, mRNA or protein expression, DNA binding capacity, and transcriptional activity.  Here we review the functions of HIFs in the progression and treatment of malignant solid tumors.  We also highlight how HIFs may be targeted to improve the management of patients with therapy-resistant and metastatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcq5JPjcEkgLVg90H21EOLACvtfcHk0lg4GHfHdF5ACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D&md5=dd665626b2d715b0222ca666f237a316</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DWigerup%26aufirst%3DC.%26aulast%3DPahlman%26aufirst%3DS.%26aulast%3DBexell%26aufirst%3DD.%26atitle%3DTherapeutic%2520targeting%2520of%2520hypoxia%2520and%2520hypoxia-inducible%2520factors%2520in%2520cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D164%26spage%3D152%26epage%3D169%26doi%3D10.1016%2Fj.pharmthera.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, F. M.</span></span> <span> </span><span class="NLM_article-title">Manassantins A/B and saucerneol: novel biologically active lignoids from <i>Saururus cernuus</i></span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4947</span>– <span class="NLM_lpage">4950</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)99818-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0040-4039%2801%2999818-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaL2cXkvVGltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1983&pages=4947-4950&author=K.+V.+Raoauthor=F.+M.+Alvarez&title=Manassantins+A%2FB+and+saucerneol%3A+novel+biologically+active+lignoids+from+Saururus+cernuus&doi=10.1016%2FS0040-4039%2801%2999818-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Manassantins A/B and saucerneol:  novel biologically active lignoids from Saururus cernuus</span></div><div class="casAuthors">Rao, Koppaka V.; Alvarez, Francisco M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">4947-50</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">From the ext. of S. cernuus, 2 toxic principles, manassantin A (I) and B (II) and a related substance, saucerneol (III) were isolated.  They have novel dineolignan or sesquineolignan type structures.  Although toxic, I showed potential neuroleptic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBdRijfJ6O1LVg90H21EOLACvtfcHk0liDrRKcVap7LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvVGltg%253D%253D&md5=b979046ba5e7fb5c0c6ecadd99ceeec0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2999818-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252999818-1%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DAlvarez%26aufirst%3DF.%2BM.%26atitle%3DManassantins%2520A%252FB%2520and%2520saucerneol%253A%2520novel%2520biologically%2520active%2520lignoids%2520from%2520Saururus%2520cernuus%26jtitle%3DTetrahedron%2520Lett.%26date%3D1983%26volume%3D24%26spage%3D4947%26epage%3D4950%26doi%3D10.1016%2FS0040-4039%2801%2999818-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span> <span> </span><span class="NLM_article-title">Molecular-targeted antitumor agents: the <i>Saururus cernuus</i> dineolignans manassantin B and 4-<i>O</i>-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">771</span>, <span class="refDoi"> DOI: 10.1021/np030514m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np030514m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=767-771&author=T.+W.+Hodgesauthor=C.+F.+Hossainauthor=Y.+P.+Kimauthor=Y.+D.+Zhouauthor=D.+G.+Nagle&title=Molecular-targeted+antitumor+agents%3A+the+Saururus+cernuus+dineolignans+manassantin+B+and+4-O-demethylmanassantin+B+are+potent+inhibitors+of+hypoxia-activated+HIF-1&doi=10.1021%2Fnp030514m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular-Targeted Antitumor Agents: The Saururus cernuus Dineolignans Manassantin B and 4-O-Demethylmanassantin B Are Potent Inhibitors of Hypoxia-Activated HIF-1</span></div><div class="casAuthors">Hodges, Tyler W.; Hossain, Chowdhury Faiz; Kim, Yong-Pil; Zhou, Yu-Dong; Nagle, Dale G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-771</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key regulator of tumor cell adaptation and survival under hypoxic conditions.  Selective HIF-1 inhibitors represent an important new class of potential mol.-targeted antitumor therapeutic agents.  Exts. of plants and marine organisms were evaluated using a T47D human breast tumor cell-based reporter assay for HIF-1 inhibitors.  Bioassay-guided fractionation of the lipid ext. of Saururus cernuus resulted in the isolation of manassantin B (1) and a new compd., 4-O-demethylmanassantin B (2).  The structure of 2 was detd. spectroscopically.  The abs. configurations of manassantin-type dineolignans have not been previously reported.  Therefore, the abs. configurations of the chiral centers in each side chain were deduced from spectroscopic anal. of the Mosher MTPA ester derivs. of 1.  Both 1 and 2 are among the most potent small mol. HIF-1 inhibitors discovered, to date, with IC50 values of 3 and 30 nM, resp.  Compds. 1 and 2 selectively inhibited hypoxia-activated HIF-1 in contrast to iron chelator-activated HIF-1.  Compds. 1 and 2 also inhibited hypoxic induction of the angiogenic factor VEGF.  Further study revealed that 1 selectively blocked the induction of HIF-1α protein, the oxygen regulated HIF-1 subunit that dets. HIF-1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8c4Zw-95rF7Vg90H21EOLACvtfcHk0liDrRKcVap7LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFSrtLc%253D&md5=56b5c0f02729d5fb1d79514107ac6758</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fnp030514m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp030514m%26sid%3Dliteratum%253Aachs%26aulast%3DHodges%26aufirst%3DT.%2BW.%26aulast%3DHossain%26aufirst%3DC.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BP.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26atitle%3DMolecular-targeted%2520antitumor%2520agents%253A%2520the%2520Saururus%2520cernuus%2520dineolignans%2520manassantin%2520B%2520and%25204-O-demethylmanassantin%2520B%2520are%2520potent%2520inhibitors%2520of%2520hypoxia-activated%2520HIF-1%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D767%26epage%3D771%26doi%3D10.1021%2Fnp030514m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baerson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span> <span> </span><span class="NLM_article-title"><i>Saururus cernuus</i> lignanslpotent small molecule inhibitors of hypoxia-inducible factor-1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>333</i></span>,  <span class="NLM_fpage">1026</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.05.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.bbrc.2005.05.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=15967416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVensb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2005&pages=1026-1033&author=C.+F.+Hossainauthor=Y.+P.+Kimauthor=S.+R.+Baersonauthor=L.+Zhangauthor=R.+K.+Bruickauthor=K.+A.+Mohammedauthor=A.+K.+Agarwalauthor=D.+G.+Nagleauthor=Y.+D.+Zhou&title=Saururus+cernuus+lignanslpotent+small+molecule+inhibitors+of+hypoxia-inducible+factor-1&doi=10.1016%2Fj.bbrc.2005.05.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Saururus cernuus lignans-Potent small molecule inhibitors of hypoxia-inducible factor-1</span></div><div class="casAuthors">Hossain, Chowdhury Faiz; Kim, Yong-Pil; Baerson, Scott R.; Zhang, Lei; Bruick, Richard K.; Mohammed, Kaleem A.; Agarwal, Ameeta K.; Nagle, Dale G.; Zhou, Yu-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1026-1033</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) represents an important tumor-selective therapeutic target for solid tumors.  In search of novel small mol. HIF-1 inhibitors, 5400 natural product-rich exts. from plants, marine organisms, and microbes were examd. for HIF-1 inhibitory activities using a cell-based reporter assay.  Bioassay-guided fractionation and isolation, followed by structure elucidation, yielded three potent natural product-derived HIF-1 inhibitors and two structurally related inactive compds.  In a T47D cell-based reporter assay, manassantin B1, manassantin A, and 4-O-methylsaucerneol inhibited hypoxia-induced HIF-1 activation with IC50 values of 3, 3, and 20 nM, resp.  All three compds. are relatively hypoxia-specific inhibitors of HIF-1 activation, in comparison to other stimuli.  The hypoxic induction of HIF-1 target genes CDKN1A, VEGF, and GLUT-1 were also inhibited.  These compds. inhibit HIF-1 by blocking hypoxia-induced nuclear HIF-1α protein accumulation without affecting HIF-1α mRNA levels.  In addn., preliminary structure-activity studies suggest specific structural requirements for this class of HIF-1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-b893wiUXx7Vg90H21EOLACvtfcHk0liDrRKcVap7LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVensb4%253D&md5=29100e0ff47d515b9738573fb0a6ed38</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.05.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.05.191%26sid%3Dliteratum%253Aachs%26aulast%3DHossain%26aufirst%3DC.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BP.%26aulast%3DBaerson%26aufirst%3DS.%2BR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DMohammed%26aufirst%3DK.%2BA.%26aulast%3DAgarwal%26aufirst%3DA.%2BK.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26atitle%3DSaururus%2520cernuus%2520lignanslpotent%2520small%2520molecule%2520inhibitors%2520of%2520hypoxia-inducible%2520factor-1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D333%26spage%3D1026%26epage%3D1033%26doi%3D10.1016%2Fj.bbrc.2005.05.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Nucleophilic addition of organozinc reagents to 2-sulfonyl cyclic ethers: stereoselective synthesis of manassantins A and B</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1021/ol8024617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8024617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=89-92&author=H.+Kimauthor=A.+C.+Kasperauthor=E.+J.+Moonauthor=Y.+Parkauthor=C.+M.+Wootenauthor=M.+W.+Dewhirstauthor=J.+Hong&title=Nucleophilic+addition+of+organozinc+reagents+to+2-sulfonyl+cyclic+ethers%3A+stereoselective+synthesis+of+manassantins+A+and+B&doi=10.1021%2Fol8024617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleophilic Addition of Organozinc Reagents to 2-Sulfonyl Cyclic Ethers: Stereoselective Synthesis of Manassantins A and B</span></div><div class="casAuthors">Kim, Hyoungsu; Kasper, Amanda C.; Moon, Eui Jung; Park, Yongho; Wooten, Ceshea M.; Dewhirst, Mark W.; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-92</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A convergent route to the synthesis of manassantins A (I) and B (II), potent inhibitors of HIF-1, is described.  Central to the synthesis is a stereoselective addn. of an organozinc reagent to a 2-benzenesulfonyl cyclic ether to achieve the 2,3-cis-3,4-trans-4,5-cis-tetrahydrofuran of the natural products.  Preliminary structure-activity relationships suggested that the (R)-configuration at C-7 and C-7''' is not crit. for HIF-1 inhibition.  In addn., the hydroxyl group at C-7 and C-7''' can be replaced with a carbonyl group without loss of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooK8kpL0vwKrVg90H21EOLACvtfcHk0lhx8W7WgU9ryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7%252FK&md5=6b4667db29fc0658040438186aacab46</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fol8024617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8024617%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DWooten%26aufirst%3DC.%2BM.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DNucleophilic%2520addition%2520of%2520organozinc%2520reagents%2520to%25202-sulfonyl%2520cyclic%2520ethers%253A%2520stereoselective%2520synthesis%2520of%2520manassantins%2520A%2520and%2520B%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D89%26epage%3D92%26doi%3D10.1021%2Fol8024617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitzel, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of manassantin analogues for hypoxia-inducible factor 1alpha inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7659</span>– <span class="NLM_lpage">7671</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7659-7671&author=D.+Y.+Kwonauthor=H.+E.+Leeauthor=D.+H.+Weitzelauthor=K.+Parkauthor=S.+H.+Leeauthor=C.+T.+Leeauthor=T.+N.+Stephensonauthor=H.+Parkauthor=M.+C.+Fitzgeraldauthor=J.+T.+Chiauthor=R.+A.+Mookauthor=M.+W.+Dewhirstauthor=Y.+M.+Leeauthor=J.+Hong&title=Synthesis+and+biological+evaluation+of+manassantin+analogues+for+hypoxia-inducible+factor+1alpha+inhibition&doi=10.1021%2Facs.jmedchem.5b01220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition</span></div><div class="casAuthors">Kwon, Do-Yeon; Lee, Hye Eun; Weitzel, Douglas H.; Park, Kyunghye; Lee, Sun Hee; Lee, Chen-Ting; Stephenson, Tesia N.; Park, Hyeri; Fitzgerald, Michael C.; Chi, Jen-Tsan; Mook, Robert A., Jr.; Dewhirst, Mark W.; Lee, You Mie; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7659-7671</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To cope with hypoxia, tumor cells have developed a no. of adaptive mechanisms mediated by hypoxia-inducible factor 1 (HIF-1) to promote angiogenesis and cell survival.  Due to significant roles of HIF-1 in the initiation, progression, metastasis, and resistance to treatment of most solid tumors, a considerable amt. of effort has been made to identify HIF-1 inhibitors for treatment of cancer.  Isolated from Saururus cernuus, manassantins A (I) and B (II) are potent inhibitors of HIF-1 activity.  To define the structural requirements of manassantins for HIF-1 inhibition, we prepd. and evaluated a series of manassantin analogs.  Our SAR studies examd. key regions of manassantin's structure in order to understand the impact of these regions on biol. activity and to define modifications that can lead to improved performance and drug-like properties.  Our efforts identified several manassantin analogs with reduced structural complexity as potential lead compds. for further development.  Some analogs, e.g., III, down-regulated hypoxia-induced expression of the HIF-1α protein and reduced the levels of HIF-1 target genes, including cyclin-dependent kinase 6 (Cdk6) and vascular endothelial growth factor (VEGF).  These findings provide an important framework to design potent and selective HIF-1α inhibitors, which is necessary to aid translation of manassantin-derived natural products to the clinic as novel therapeutics for cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4LzA8xQ0-LbVg90H21EOLACvtfcHk0lhx8W7WgU9ryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM&md5=95a898b0ab734a00a2d7b2e685c816a8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01220%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DWeitzel%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DStephenson%26aufirst%3DT.%2BN.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DFitzgerald%26aufirst%3DM.%2BC.%26aulast%3DChi%26aufirst%3DJ.%2BT.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520manassantin%2520analogues%2520for%2520hypoxia-inducible%2520factor%25201alpha%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7659%26epage%3D7671%26doi%3D10.1021%2Facs.jmedchem.5b01220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wooten, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3783</span>– <span class="NLM_lpage">3786</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.bmcl.2009.04.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=19423348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3783-3786&author=A.+C.+Kasperauthor=E.+J.+Moonauthor=X.+Huauthor=Y.+Parkauthor=C.+M.+Wootenauthor=H.+Kimauthor=W.+Yangauthor=M.+W.+Dewhirstauthor=J.+Hong&title=Analysis+of+HIF-1+inhibition+by+manassantin+A+and+analogues+with+modified+tetrahydrofuran+configurations&doi=10.1016%2Fj.bmcl.2009.04.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations</span></div><div class="casAuthors">Kasper, Amanda C.; Moon, Eui Jung; Hu, Xiangqian; Park, Yongho; Wooten, Ceshea M.; Kim, Hyoungsu; Yang, Weitao; Dewhirst, Mark W.; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3783-3786</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have shown that manassantin A downregulated the HIF-1α expression and inhibited the secretion of VEGF.  The authors have also demonstrated that the 2,3-cis-3,4-trans-4,5-cis-configuration of the THF is crit. to the HIF-1 inhibition of manassantin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsGegjOvL0WLVg90H21EOLACvtfcHk0lhx8W7WgU9ryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGns7w%253D&md5=d2e53ba8945df484928063c932a5095b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.071%26sid%3Dliteratum%253Aachs%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DWooten%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DAnalysis%2520of%2520HIF-1%2520inhibition%2520by%2520manassantin%2520A%2520and%2520analogues%2520with%2520modified%2520tetrahydrofuran%2520configurations%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3783%26epage%3D3786%26doi%3D10.1016%2Fj.bmcl.2009.04.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauke, S.</span></span> <span> </span><span class="NLM_article-title">Cross metathesis of allyl alcohols: how to suppress and how to promote double bond isomerization</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4194</span>– <span class="NLM_lpage">4206</span>, <span class="refDoi"> DOI: 10.1039/c3ob40167g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2Fc3ob40167g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=23676990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=4194-4206&author=B.+Schmidtauthor=S.+Hauke&title=Cross+metathesis+of+allyl+alcohols%3A+how+to+suppress+and+how+to+promote+double+bond+isomerization&doi=10.1039%2Fc3ob40167g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cross metathesis of allyl alcohols: how to suppress and how to promote double bond isomerization</span></div><div class="casAuthors">Schmidt, Bernd; Hauke, Sylvia</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4194-4206</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Under std. conditions the cross metathesis of allyl alcs. and Me acrylate is accompanied by the formation of ketones, resulting from uncontrolled and undesired double bond isomerization.  By conducting the CM in the presence of phenol, the catalyst loading and the reaction time required for quant. conversion can be reduced, and isomerization can be suppressed.  On the other hand, consecutive isomerization can be deliberately promoted by evapg. excess Me acrylate after completing cross metathesis and by adding a base or silane as chem. triggers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqjn4qD5Zz7Vg90H21EOLACvtfcHk0lhq7B-bH-ZH_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWktL4%253D&md5=54f8a207282d8702d0ed5682a21f2ba0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2Fc3ob40167g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob40167g%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DHauke%26aufirst%3DS.%26atitle%3DCross%2520metathesis%2520of%2520allyl%2520alcohols%253A%2520how%2520to%2520suppress%2520and%2520how%2520to%2520promote%2520double%2520bond%2520isomerization%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D4194%26epage%3D4206%26doi%3D10.1039%2Fc3ob40167g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strych, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauner, D.</span></span> <span> </span><span class="NLM_article-title">Biomimetic synthesis of santalin A, B and santarubin A, B, the major colorants of red sandalwood</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">9509</span>– <span class="NLM_lpage">9512</span>, <span class="refDoi"> DOI: 10.1002/anie.201302317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1002%2Fanie.201302317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFCrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=9509-9512&author=S.+Strychauthor=D.+Trauner&title=Biomimetic+synthesis+of+santalin+A%2C+B+and+santarubin+A%2C+B%2C+the+major+colorants+of+red+sandalwood&doi=10.1002%2Fanie.201302317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic Synthesis of Santalin A,B and Santarubin A,B, the Major Colorants of Red Sandalwood</span></div><div class="casAuthors">Strych, Sebastian; Trauner, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">9509-9512</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a unified synthetic approach to Santalin A,B and Santarubin A,B, the major dyes of red sandalwood.  It is yet another demonstration that complex mol. scaffolds, not easily accessible with other methods, can be assembled along biosynthetic lines without the necessity of enzymic catalysis.  The final reaction sequence appears to be general and our conditions are mild, which raises the question whether the cycloaddn./oxidn. cascade could spontaneously occur in nature as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqhS8VyHD-g7Vg90H21EOLACvtfcHk0lhq7B-bH-ZH_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFCrurw%253D&md5=d79b920df57c2ea10269365d76fb90ac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fanie.201302317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201302317%26sid%3Dliteratum%253Aachs%26aulast%3DStrych%26aufirst%3DS.%26aulast%3DTrauner%26aufirst%3DD.%26atitle%3DBiomimetic%2520synthesis%2520of%2520santalin%2520A%252C%2520B%2520and%2520santarubin%2520A%252C%2520B%252C%2520the%2520major%2520colorants%2520of%2520red%2520sandalwood%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D9509%26epage%3D9512%26doi%3D10.1002%2Fanie.201302317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span> <span> </span><span class="NLM_article-title">Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. mechanism and synthetic implications</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5551</span>– <span class="NLM_lpage">5553</span>, <span class="refDoi"> DOI: 10.1021/ja00252a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00252a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaL2sXlslGlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5551-5553&author=E.+Coreyauthor=R.+K.+Bakshiauthor=S.+Shibata&title=Highly+enantioselective+borane+reduction+of+ketones+catalyzed+by+chiral+oxazaborolidines.+mechanism+and+synthetic+implications&doi=10.1021%2Fja00252a056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines.  Mechanism and synthetic implications</span></div><div class="casAuthors">Corey, E. J.; Bakshi, Raman K.; Shibata, Saizo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5551-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">An enantioselective redn. of ketones to secondary alcs.,e.g., PhCOMe to (R)-PhMeCHOH, by vic-amino alcs. and BH3-THF is reported.  Two key reaction intermediates involved in a catalytic redn. with BH3.THF as the stoichiometric reductant.  (S)-Diphenylprolinol reacts with BH3.THF upon heating to form oxazaborolidine I, which is a catalyst for these redns.  I forms a complex II.  Amino alc. III similarly effects enantioselective redn. of ketones.  I and II are the most effective reducing agents found to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr0FOvqDo-BLVg90H21EOLACvtfcHk0lgolVmjlImR9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlslGlsrs%253D&md5=e52d09fe788534f0f5d8168d2ad93e4f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00252a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00252a056%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DShibata%26aufirst%3DS.%26atitle%3DHighly%2520enantioselective%2520borane%2520reduction%2520of%2520ketones%2520catalyzed%2520by%2520chiral%2520oxazaborolidines.%2520mechanism%2520and%2520synthetic%2520implications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D5551%26epage%3D5553%26doi%3D10.1021%2Fja00252a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">The enantiomeric excess of <b>7</b> was determined by Mosher ester analysis. See the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghavimi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnus, P.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of 8,14-dihydromorphinandienone alkaloids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1708</span>– <span class="NLM_lpage">1711</span>, <span class="refDoi"> DOI: 10.1021/ol500368p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol500368p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Grtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1708-1711&author=B.+Ghavimiauthor=P.+Magnus&title=Total+synthesis+of+8%2C14-dihydromorphinandienone+alkaloids&doi=10.1021%2Fol500368p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of 8,14-Dihydromorphinandienone Alkaloids</span></div><div class="casAuthors">Ghavimi, Bahman; Magnus, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1708-1711</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A collective synthesis of 8,14-dihydronorsalutaridine, 8,14-dihydrosalutaridine, norisosinomenine, and isosinomenine is reported.  The strategy provides direct access to the correct oxidn. level of the products.  The combination of an organocatalyst guanidine superbase, a tertiary amine base, and a dehydrating agent was necessary for the successful Henry-Michael-dehydration cascade to form the phenanthrene motif.  The required selective aliph. nitro redn. could only be achieved under heterogeneous transfer-hydrogenation conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGE8awZcit57Vg90H21EOLACvtfcHk0ljl5PeE5922Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Grtrk%253D&md5=f314c67e030f0a79bf1b19d7bb71489c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol500368p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol500368p%26sid%3Dliteratum%253Aachs%26aulast%3DGhavimi%26aufirst%3DB.%26aulast%3DMagnus%26aufirst%3DP.%26atitle%3DTotal%2520synthesis%2520of%25208%252C14-dihydromorphinandienone%2520alkaloids%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D1708%26epage%3D1711%26doi%3D10.1021%2Fol500368p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, F.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Z.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis of <i>rac</i>-(8<i>R</i>,13<i>S</i>,14<i>S</i>)-7-oxa-estra-4,9-diene-3,17-dione</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">9021</span>– <span class="NLM_lpage">9024</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.10.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.tetlet.2006.10.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=9021-9024&author=F.-A.+Kangauthor=N.+Jainauthor=Z.+Sui&title=Stereoselective+synthesis+of+rac-%288R%2C13S%2C14S%29-7-oxa-estra-4%2C9-diene-3%2C17-dione&doi=10.1016%2Fj.tetlet.2006.10.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis of rac-(8R,13S,14S)-7-oxa-estra-4,9-diene-3,17-dione</span></div><div class="casAuthors">Kang, Fu-An; Jain, Nareshkumar; Sui, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">9021-9024</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The first synthesis of a novel oxa-steroid, rac-(8R,13S,14S)-7-oxa-estra-4,9-diene-3,17-dione I has been achieved via stereoselective catalytic hydrogenation of the tetra-substituted indene intermediate II, whose structure was confirmed by X-ray crystallog.  In contrast to the previous reports of similar indene systems, it was found that catalytic hydrogenation of indenes with a large substituent at the C-2 position and a bulky β-oriented protective group at the C-6 position resulted in cis-indanes instead of trans-indanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhSJWitp9IaLVg90H21EOLACvtfcHk0ljl5PeE5922Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrzF&md5=c523b7afeca4d2cc53e8a2de093d8ea7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.10.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.10.098%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DF.-A.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DStereoselective%2520synthesis%2520of%2520rac-%25288R%252C13S%252C14S%2529-7-oxa-estra-4%252C9-diene-3%252C17-dione%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D9021%26epage%3D9024%26doi%3D10.1016%2Fj.tetlet.2006.10.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wills, M.</span></span> <span> </span><span class="NLM_article-title">Gold-catalysed cyclic ether formation from diols</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">9828</span>– <span class="NLM_lpage">9834</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2010.10.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2Fj.tet.2010.10.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2rs7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=9828-9834&author=X.+Jiangauthor=E.+K.+Londonauthor=D.+J.+Morrisauthor=G.+J.+Clarksonauthor=M.+Wills&title=Gold-catalysed+cyclic+ether+formation+from+diols&doi=10.1016%2Fj.tet.2010.10.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Gold-catalysed cyclic ether formation from diols</span></div><div class="casAuthors">Jiang, Xiaolu; London, Emma K.; Morris, David J.; Clarkson, Guy J.; Wills, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">9828-9834</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gold(I) and (III) salts have been found to be highly effective at the catalysis of ether formation from alcs.  Intramol. ether formation of a 1,5-diol was also achieved to give cyclic ethers, e.g. 2-phenyltetrahydropyran, with a stereoselectivity that indicates that an SN1 mechanism predominates.  In an attempt to form a seven-membered ring, a stable 14-membered dimer product was also formed.  Attempts to control the diastereoselectivity of the reaction using a chiral anionic counterion did not give products with a high de.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTpVjq84CV8rVg90H21EOLACvtfcHk0ljl5PeE5922Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2rs7zK&md5=3e06e826b14dc383dac10cda59ea9751</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.10.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.10.068%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DLondon%26aufirst%3DE.%2BK.%26aulast%3DMorris%26aufirst%3DD.%2BJ.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DWills%26aufirst%3DM.%26atitle%3DGold-catalysed%2520cyclic%2520ether%2520formation%2520from%2520diols%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D9828%26epage%3D9834%26doi%3D10.1016%2Fj.tet.2010.10.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchigami, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4-iodotetrahydropyran-containing polymers via TMSI-promoted Prins cyclization</span>. <i>Polym. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1039/C2PY20890C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2FC2PY20890C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1221-1227&author=S.+Inagiauthor=N.+Takeiauthor=T.+Fuchigami&title=Synthesis+of+4-iodotetrahydropyran-containing+polymers+via+TMSI-promoted+Prins+cyclization&doi=10.1039%2FC2PY20890C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4-iodotetrahydropyran-containing polymers via TMSI-promoted Prins cyclization</span></div><div class="casAuthors">Inagi, Shinsuke; Takei, Naoko; Fuchigami, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Polymer Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1221-1227</span>CODEN:
                <span class="NLM_cas:coden">PCOHC2</span>;
        ISSN:<span class="NLM_cas:issn">1759-9962</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">4-Iodotetrahydropyran (THP)-contg. polymers were synthesized via Prins cyclization of monomers with an aldehyde moiety and a homoallylic alc. moiety.  The progress of polymn. was confirmed by NMR and GPC anal.  The deiodination of the THP in the polymer structure was carried out by reductive hydrogenation using AIBN and tributyltin hydride.  Thermogravimetric anal. (TGA) was performed for the THP-contg. polymers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb6ly81rWEb7Vg90H21EOLACvtfcHk0lhYLEL7-Ek_Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlemurk%253D&md5=18845956b4d46b49667c1ead48dc4c1a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC2PY20890C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2PY20890C%26sid%3Dliteratum%253Aachs%26aulast%3DInagi%26aufirst%3DS.%26aulast%3DTakei%26aufirst%3DN.%26aulast%3DFuchigami%26aufirst%3DT.%26atitle%3DSynthesis%2520of%25204-iodotetrahydropyran-containing%2520polymers%2520via%2520TMSI-promoted%2520Prins%2520cyclization%26jtitle%3DPolym.%2520Chem.%26date%3D2013%26volume%3D4%26spage%3D1221%26epage%3D1227%26doi%3D10.1039%2FC2PY20890C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, S. V.</span></span> <span> </span><span class="NLM_article-title">Substitution reactions of 2-benzenesulphonyl cyclic ethers with carbon nucleophiles</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4293</span>– <span class="NLM_lpage">4308</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)81323-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1016%2FS0040-4020%2801%2981323-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaK3cXpvVehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=4293-4308&author=D.+S.+Brownauthor=M.+Brunoauthor=R.+J.+Davenportauthor=S.+V.+Ley&title=Substitution+reactions+of+2-benzenesulphonyl+cyclic+ethers+with+carbon+nucleophiles&doi=10.1016%2FS0040-4020%2801%2981323-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Substitution reactions of 2-benzenesulfonyl cyclic ethers with carbon nucleophiles</span></div><div class="casAuthors">Brown, Dearg S.; Bruno, Maurizio; Davenport, Raymond J.; Ley, Steven V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4293-308</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The direct substitution of 2-benzenesulfonyl cyclic ethers I (R = H, Ph, MeO, Bu, AcOCH2) was studied by using a variety of nucleophiles such as silyl enol ethers, silyl ketene acetals, allylsilanes, or Me3SiCN in the presence of AlCl3 or organozinc reagents.  A general selectivity for the formation of trans products was seen for I.  E.g., the reaction of trans-I (R = AcOCH2) with Me2C:C(OMe)OSiMe3 in the presence of AlCl3 gave 33% Me cis-6-(acetoxymethyl)-α,α-dimethyl-2H-pyran-2-acetate (cis-II) and 64% trans-II.  Treatment of I (R = Ph; cis-trans = 57:43) with MgBr2.OEt2 and Et3N gave 89% 3,4-dihydro-2-phenyl-2H-pyran.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtrWOJcuXXrVg90H21EOLACvtfcHk0lhYLEL7-Ek_Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXpvVehug%253D%253D&md5=6542a3344bfca1b47f4208c9bb1bafaa</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2981323-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252981323-5%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BS.%26aulast%3DBruno%26aufirst%3DM.%26aulast%3DDavenport%26aufirst%3DR.%2BJ.%26aulast%3DLey%26aufirst%3DS.%2BV.%26atitle%3DSubstitution%2520reactions%2520of%25202-benzenesulphonyl%2520cyclic%2520ethers%2520with%2520carbon%2520nucleophiles%26jtitle%3DTetrahedron%26date%3D1989%26volume%3D45%26spage%3D4293%26epage%3D4308%26doi%3D10.1016%2FS0040-4020%2801%2981323-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. J.</span></span> <span> </span><span class="NLM_article-title">Sequential kinetic resolution of <i>C</i><sub>2</sub>-symmetric compounds as a key step in two-directional synthesis: structural requirements for efficient resolution of difuryl diols</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2403</span>– <span class="NLM_lpage">2413</span>, <span class="refDoi"> DOI: 10.1039/b206478b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2Fb206478b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=2403-2413&author=M.+Hardingauthor=R.+Hodgsonauthor=A.+J.+Nelson&title=Sequential+kinetic+resolution+of+C2-symmetric+compounds+as+a+key+step+in+two-directional+synthesis%3A+structural+requirements+for+efficient+resolution+of+difuryl+diols&doi=10.1039%2Fb206478b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fb206478b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb206478b%26sid%3Dliteratum%253Aachs%26aulast%3DHarding%26aufirst%3DM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DA.%2BJ.%26atitle%3DSequential%2520kinetic%2520resolution%2520of%2520C2-symmetric%2520compounds%2520as%2520a%2520key%2520step%2520in%2520two-directional%2520synthesis%253A%2520structural%2520requirements%2520for%2520efficient%2520resolution%2520of%2520difuryl%2520diols%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D2002%26volume%3D21%26spage%3D2403%26epage%3D2413%26doi%3D10.1039%2Fb206478b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasdemir, B.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of some chiral aryl and hetero aryl-substituted β-, γ-, δ-hydroxy esters</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1080/00397911.2014.1003353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1080%2F00397911.2014.1003353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVyntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=1082-1088&author=B.+Hasdemir&title=Asymmetric+synthesis+of+some+chiral+aryl+and+hetero+aryl-substituted+%CE%B2-%2C+%CE%B3-%2C+%CE%B4-hydroxy+esters&doi=10.1080%2F00397911.2014.1003353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Some Chiral Aryl and Hetero Aryl-Substituted β-, γ-, δ-Hydroxy Esters</span></div><div class="casAuthors">Hasdemir, Belma</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1082-1088</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Sixteen chiral β-, γ-, and δ-hydroxy esters with aryl, substituted aryl, and heteroaryl groups were synthesized by the asym. redn. of their corresponding keto esters as chiral pure ref. compds. and starting materials.  The asym. redn. was achieved by (R)-Me-CBS-oxazaborolidine.  Ten new chiral γ- and δ-hydroxy esters , and were obtained with high ee values and characterized by IR, NMR (1H and 13C), mass spectrometry, chiral high-performance liq. chromatog., and sp. rotation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd11Lr4QeoObVg90H21EOLACvtfcHk0ljp3lqtdvUKHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVyntb4%253D&md5=3095a10854028f79f9f10e247bb49fd0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1080%2F00397911.2014.1003353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2014.1003353%26sid%3Dliteratum%253Aachs%26aulast%3DHasdemir%26aufirst%3DB.%26atitle%3DAsymmetric%2520synthesis%2520of%2520some%2520chiral%2520aryl%2520and%2520hetero%2520aryl-substituted%2520%25CE%25B2-%252C%2520%25CE%25B3-%252C%2520%25CE%25B4-hydroxy%2520esters%26jtitle%3DSynth.%2520Commun.%26date%3D2015%26volume%3D45%26spage%3D1082%26epage%3D1088%26doi%3D10.1080%2F00397911.2014.1003353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span> <span> </span><span class="NLM_article-title">Base-promoted/gold-catalyzed intramolecular highly selective and controllable detosylative cyclization</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">12871</span>– <span class="NLM_lpage">12875</span>, <span class="refDoi"> DOI: 10.1002/chem.201502073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1002%2Fchem.201502073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=26223908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gls77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=12871-12875&author=C.+Zhuauthor=L.+Qiuauthor=G.+Xuauthor=J.+Liauthor=J.+Sun&title=Base-promoted%2Fgold-catalyzed+intramolecular+highly+selective+and+controllable+detosylative+cyclization&doi=10.1002%2Fchem.201502073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Base-Promoted/Gold-Catalyzed Intramolecular Highly Selective and Controllable Detosylative Cyclization</span></div><div class="casAuthors">Zhu, Chenghao; Qiu, Lin; Xu, Guangyang; Li, Jian; Sun, Jiangtao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12871-12875</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly selective, controllable and synthetically useful base-promoted intramol. detosylative cyclization of bis-N-tosylhydrazones was achieved, affording N-contg. heterocycles and cyclic olefins under transition-metal-free or gold-catalyzed procedures, resp.  For example, the bis N-tosylhydrazone of 1,5-diphenyl-1,5-pentanedione gave either I or II.  An effective and practical metal-free or gold-catalyzed approach to synthesize polycyclic arom. compds. was also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48vzjudwAcbVg90H21EOLACvtfcHk0ljp3lqtdvUKHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gls77K&md5=f86022046cb4c6b41b3f5d9347e3c488</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fchem.201502073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201502073%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26atitle%3DBase-promoted%252Fgold-catalyzed%2520intramolecular%2520highly%2520selective%2520and%2520controllable%2520detosylative%2520cyclization%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D12871%26epage%3D12875%26doi%3D10.1002%2Fchem.201502073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (±)-isocombretastatins AC</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1080/00397918708063944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1080%2F00397918708063944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1Oiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=877-892&author=S.+B.+Singhauthor=G.+R.+Pettit&title=Synthesis+of+%28%C2%B1%29-isocombretastatins+AC&doi=10.1080%2F00397918708063944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents.  Part 125.  Synthesis of (±)-isocombretastatins A-C</span></div><div class="casAuthors">Singh, Sheo Bux; Pettit, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">877-92</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Isocombretastatins A and C (I, R = Me, R1 = R3 = H, R2 = OH; R = R3 = H, R1 = Me, R2 = OH) were prepd. from 3,4,5-(MeO)3C6H2CH2Br and 3,4- or 4,3-Me3CSiMe2O(MeO)C6H3CHO resp.  Isocombretastatin B (I, R = R2 = H, R1 = Me, R3 = OH) was obtained from 4,3-Me3CSiMe2O(MeO)C6H3CH2OH and 3,4,5-(MeO)3C6H2CHO.  (±)-I (R = Me, R1 = R3 = H, R2 = OH) had a ED50 of 0.19-0.25 μg/mL against leukemia P388.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN_CQAmKqLHLVg90H21EOLACvtfcHk0ljp3lqtdvUKHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1Oiurs%253D&md5=6a537ce2dc7853108518cb70f55bb622</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F00397918708063944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918708063944%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26atitle%3DSynthesis%2520of%2520%2528%25C2%25B1%2529-isocombretastatins%2520AC%26jtitle%3DSynth.%2520Commun.%26date%3D1987%26volume%3D17%26spage%3D877%26epage%3D892%26doi%3D10.1080%2F00397918708063944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crutizat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivès, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marat, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalko-Csiba, M.</span></span> <span> </span><span class="NLM_article-title">Flash-metathesis for the coupling of sustainable (poly) hydroxyl β-methylstyrenes from essential oils</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3756</span>– <span class="NLM_lpage">3761</span>, <span class="refDoi"> DOI: 10.1039/C5GC00759C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1039%2FC5GC00759C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=3756-3761&author=J.+Hitceauthor=M.+Crutizatauthor=C.+Bourdonauthor=A.+Viv%C3%A8sauthor=X.+Maratauthor=M.+Dalko-Csiba&title=Flash-metathesis+for+the+coupling+of+sustainable+%28poly%29+hydroxyl+%CE%B2-methylstyrenes+from+essential+oils&doi=10.1039%2FC5GC00759C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Flash-metathesis for the coupling of sustainable (poly)hydroxyl β-methylstyrenes from essential oils</span></div><div class="casAuthors">Hitce, J.; Crutizat, M.; Bourdon, C.; Vives, A.; Marat, X.; Dalko-Csiba, M.</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3756-3761</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A cross-metathesis procedure was developed to synthesize sym. and non sym. stilbenes from sustainable resources.  The reaction proceeds under solvent-free conditions and at low catalyst loading (down to 0.01 mol%) within a couple of minutes only (TOF up to 6.9 s-1), on multi-gram scale.  The highly reactive β-methylstyrene substrates were homo-coupled not only as pure synthons but also as components of essential oils that were reacted directly in order to eliminate prior substrate isolation from the overall process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFTWMyXAdWHrVg90H21EOLACvtfcHk0liZE-jQMeKK6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVyqsbs%253D&md5=aae817203ee122fcd081b6d07850c9df</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2FC5GC00759C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5GC00759C%26sid%3Dliteratum%253Aachs%26aulast%3DHitce%26aufirst%3DJ.%26aulast%3DCrutizat%26aufirst%3DM.%26aulast%3DBourdon%26aufirst%3DC.%26aulast%3DViv%25C3%25A8s%26aufirst%3DA.%26aulast%3DMarat%26aufirst%3DX.%26aulast%3DDalko-Csiba%26aufirst%3DM.%26atitle%3DFlash-metathesis%2520for%2520the%2520coupling%2520of%2520sustainable%2520%2528poly%2529%2520hydroxyl%2520%25CE%25B2-methylstyrenes%2520from%2520essential%2520oils%26jtitle%3DGreen%2520Chem.%26date%3D2015%26volume%3D17%26spage%3D3756%26epage%3D3761%26doi%3D10.1039%2FC5GC00759C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">To avoid any unnecessary complications and/or exaggeration by the flexible side chains, truncated structures of <b>1</b>, <b>11</b>, and <b>25b</b> were used instead of the full structures.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy combined or sequenced with targeted therapy in the treatment of solid tumors: current perspectives</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>, <span class="NLM_elocation-id">djv414</span> <span class="refDoi"> DOI: 10.1093/jnci/djv414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1093%2Fjnci%2Fdjv414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=26839346" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&author=M.+B.+Atkinsauthor=J.+Larkin&title=Immunotherapy+combined+or+sequenced+with+targeted+therapy+in+the+treatment+of+solid+tumors%3A+current+perspectives&doi=10.1093%2Fjnci%2Fdjv414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjv414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjv414%26sid%3Dliteratum%253Aachs%26aulast%3DAtkins%26aufirst%3DM.%2BB.%26aulast%3DLarkin%26aufirst%3DJ.%26atitle%3DImmunotherapy%2520combined%2520or%2520sequenced%2520with%2520targeted%2520therapy%2520in%2520the%2520treatment%2520of%2520solid%2520tumors%253A%2520current%2520perspectives%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2016%26volume%3D108%26doi%3D10.1093%2Fjnci%2Fdjv414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. C.</span></span> <span> </span><span class="NLM_article-title">Changing strategies for target therapy in gastric cancer</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.3748/wjg.v22.i3.1179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.3748%2Fwjg.v22.i3.1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=26811656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2mt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1179-1189&author=S.+Y.+Leeauthor=S.+C.+Oh&title=Changing+strategies+for+target+therapy+in+gastric+cancer&doi=10.3748%2Fwjg.v22.i3.1179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Changing strategies for target therapy in gastric cancer</span></div><div class="casAuthors">Lee, Suk-young; Oh, Sang Cheul</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1189</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">2219-2840</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still remains one of the leading causes of cancer mortality.  Great efforts have been made to improve treatment outcomes in patients with metastatic gastric cancer, and the introduction of trastuzumab has greatly improved the overall survival.  The trastuzumab treatment took its first step in opening the era of mol. targeted therapy, however several issues still need to be resolved to increase the efficacy of targeted therapy.  Firstly, many patients with metastatic gastric cancer who receive trastuzumab in combination with chemotherapeutic agents develop resistance to the targeted therapy.  Secondly, many clin. trials testing novel mol. targeted agents with demonstrated efficacy in other malignancies have failed to show benefit in patients with metastatic gastric cancer, suggesting the importance of the selection of appropriate indications according to mol. characteristics in application of targeted agents.  Herein, we review the mol. targeted agents currently approved and in use, and clin. trials in patients with metastatic gastric cancer, and demonstrate the limitations and future direction in treatment of advanced gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7g9zy4-hJPbVg90H21EOLACvtfcHk0liZE-jQMeKK6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2mt7bI&md5=14e36dfc51376b3edc60bd3b0586cbb8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v22.i3.1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v22.i3.1179%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DOh%26aufirst%3DS.%2BC.%26atitle%3DChanging%2520strategies%2520for%2520target%2520therapy%2520in%2520gastric%2520cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2016%26volume%3D22%26spage%3D1179%26epage%3D1189%26doi%3D10.3748%2Fwjg.v22.i3.1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camidge, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sequist, L. V.</span></span> <span> </span><span class="NLM_article-title">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2014.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1038%2Fnrclinonc.2014.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=24981256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=473-481&author=D.+R.+Camidgeauthor=W.+Paoauthor=L.+V.+Sequist&title=Acquired+resistance+to+TKIs+in+solid+tumours%3A+learning+from+lung+cancer&doi=10.1038%2Fnrclinonc.2014.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span></div><div class="casAuthors">Camidge, D. Ross; Pao, William; Sequist, Lecia V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The use of advanced mol. profiling to direct the use of targeted therapy, such as tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer (NSCLC), has revolutionized the treatment of this disease.  However, acquired resistance, defined as progression after initial benefit, to targeted therapies inevitably occurs.  This Review explores breakthroughs in the understanding and treatment of acquired resistance in NSCLC, focusing on EGFR mutant and ALK rearrangement-pos. disease, which may be relevant across multiple different solid malignancies with oncogene-addicted subtypes.  Mechanisms of acquired resistance may be pharmacol. (i.e., failure of delivery of the drug to its target) or biol., resulting from evolutionary selection on molecularly diverse tumors.  A no. of clin. approaches can maintain control of the disease in the acquired resistance setting, including the use of radiation to treat isolated areas of progression and adding or switching to cytotoxic chemotherapy.  Furthermore, novel approaches that have already proven successful include the development of second-generation and third-generation inhibitors and the combination of some of these inhibitors with antibodies directed against the same target.  With our increased understanding of the spectrum of acquired resistance, major changes in how we conduct clin. research in this setting are now underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp00ixSKYoDuLVg90H21EOLACvtfcHk0liZE-jQMeKK6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL&md5=13cc2f49f7ef320ad54f7e84f5102816</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2014.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2014.104%26sid%3Dliteratum%253Aachs%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26atitle%3DAcquired%2520resistance%2520to%2520TKIs%2520in%2520solid%2520tumours%253A%2520learning%2520from%2520lung%2520cancer%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D11%26spage%3D473%26epage%3D481%26doi%3D10.1038%2Fnrclinonc.2014.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherwood, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkman, J.</span></span> <span> </span><span class="NLM_article-title">Tumor angiogenesis: therapeutic implications</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1186</span>, <span class="refDoi"> DOI: 10.1056/NEJM197111182852108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1056%2FNEJM197111182852108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=4938153" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&author=L.+M.+Sherwoodauthor=E.+E.+Parrisauthor=J.+Folkman&title=Tumor+angiogenesis%3A+therapeutic+implications&doi=10.1056%2FNEJM197111182852108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1056%2FNEJM197111182852108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197111182852108%26sid%3Dliteratum%253Aachs%26aulast%3DSherwood%26aufirst%3DL.%2BM.%26aulast%3DParris%26aufirst%3DE.%2BE.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DTumor%2520angiogenesis%253A%2520therapeutic%2520implications%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1182%26epage%3D1186%26doi%3D10.1056%2FNEJM197111182852108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in cancer and other diseases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>407</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1038/35025220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1038%2F35025220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=11001068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&author=P.+Carmelietauthor=R.+K.+Jain&title=Angiogenesis+in+cancer+and+other+diseases&doi=10.1038%2F35025220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Carmeliet, Peter; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 75 refs.  Pathol. angiogenesis is a hallmark of cancer and various ischemic and inflammatory diseases.  Concd. efforts in this area of research are leading to the discovery of a growing no. of pro- and anti-angiogenic mols., some of which are already in clin. trials.  The complex interactions among these mols. and how they affect vascular structure and function in different environments are now beginning to be elucidated.  This integrated understanding is leading to the development of a no. of exciting and bold approaches to treat cancer and other diseases.  But owing to several unanswered questions, caution is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQMelW0OMYbVg90H21EOLACvtfcHk0lh_zy7kA5tk2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D&md5=703cbcdbd32292a9238f0394220c853c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F35025220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025220%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D249%26epage%3D257%26doi%3D10.1038%2F35025220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">A synthetic manassantin A derivative inhibits hypoxia-inducible factor 1 and tumor growth</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e99584</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0099584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.1371%2Fjournal.pone.0099584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=24925080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eksrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=L.+Langauthor=X.+Liuauthor=Y.+Liauthor=Q.+Zhouauthor=P.+Xieauthor=C.+Yanauthor=X.+Chen&title=A+synthetic+manassantin+A+derivative+inhibits+hypoxia-inducible+factor+1+and+tumor+growth&doi=10.1371%2Fjournal.pone.0099584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A synthetic manassantin A derivative inhibits hypoxia-inducible factor 1 and tumor growth</span></div><div class="casAuthors">Lang, Liwei; Liu, Xiaoyu; Li, Yan; Zhou, Qing; Xie, Ping; Yan, Chunhong; Chen, Xiaoguang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e99584/1-e99584/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The dineolignan manassantin A from Saururaceae was recently identified as a hypoxia-inducible factor 1 (HIF-1) inhibitor, but its in-vivo anti-tumor effect has not been explored.  We synthesized a series of manassantin A derivs., and found that replacing the central THF moiety with a cyclopentane ring yielded a compd. (LXY6006) with increased HIF-1-inhibitory activity yet decreased stereochem. complexity amenable to a simplified synthesis scheme.  LXY6006 inhibited HIF-1α nuclear accumulation induced by hypoxia, and inhibited cancer cell growth as a consequence of G2/M arrest.  Oral administration of LXY6006 significantly inhibited growth of breast, lung, and pancreatic tumors implanted in nude mice.  These results indicate that LXY6006 represents a novel class of agents targeting a broad range of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5X_SZSQ_DxrVg90H21EOLACvtfcHk0lh_zy7kA5tk2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eksrzN&md5=d0860462a3eb9514577ac95bc01af0e0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0099584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0099584%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DA%2520synthetic%2520manassantin%2520A%2520derivative%2520inhibits%2520hypoxia-inducible%2520factor%25201%2520and%2520tumor%2520growth%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0099584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span> <span> </span><span class="NLM_article-title">X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells <i>in vitro</i> and <i>in vivo.</i></span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3115</span>– <span class="NLM_lpage">3120</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.3729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.3892%2Fmmr.2015.3729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=25954853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWks77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3115-3120&author=J.+Liauthor=K.+Zhaoauthor=F.+Wangauthor=J.+Caiauthor=Z.+Liauthor=L.+Zou&title=X609%2C+a+novel+manassantin+A+derivative%2C+exhibits+antitumor+activity+in+MG-63+human+osteosarcoma+cells+in+vitro+and+in+vivo.&doi=10.3892%2Fmmr.2015.3729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo</span></div><div class="casAuthors">Li, Ji; Zhao, Kongbo; Wang, Fu; Cai, Jinfang; Li, Zongyu; Zou, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2, Pt. B</span>),
    <span class="NLM_cas:pages">3115-3120</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Manassantin A has been well-established as an inhibitor of HIF-1.  In the present study, a new manasantin A deriv., X609, with decreased stereochem. complexity, rendering it amenable to a simplified synthesis scheme, was synthesized and was found to increase HIF-1 inhibitory activity.  X609 exhibited antiproliferative activity in a broad spectrum of tumor cell lines, via HIF-1-dependent mechanisms.  X609 may induce apoptosis in MG-63 cells through activation of the mitochondrial pathway.  Oral administration of X609 significantly inhibited the growth of human osteosarcomas implanted into nude mice.  In light of the results of the present study, it may be possible to develop X609 for use as a novel antitumor agent, which targets human osteosarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzfqx5aXXni7Vg90H21EOLACvtfcHk0lh_zy7kA5tk2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWks77I&md5=71987ca285d244e0957418fa3820c527</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.3729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.3729%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZou%26aufirst%3DL.%26atitle%3DX609%252C%2520a%2520novel%2520manassantin%2520A%2520derivative%252C%2520exhibits%2520antitumor%2520activity%2520in%2520MG-63%2520human%2520osteosarcoma%2520cells%2520in%2520vitro%2520and%2520in%2520vivo.%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D3115%26epage%3D3120%26doi%3D10.3892%2Fmmr.2015.3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">LXY6090 - a novel manassantin A derivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibition</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3829</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.2147/OTT.S106925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=10.2147%2FOTT.S106925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=27445487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFymtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=3829-3840&author=F.+Laiauthor=Q.+Liuauthor=X.+Liuauthor=M.+Jiauthor=P.+Xieauthor=X.+Chen&title=LXY6090+-+a+novel+manassantin+A+derivative+-+limits+breast+cancer+growth+through+hypoxia-inducible+factor-1+inhibition&doi=10.2147%2FOTT.S106925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">LXY6090 - a novel manassantin Aderivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibition</span></div><div class="casAuthors">Lai, Fangfang; Liu, Qian; Liu, Xiaoyu; Ji, Ming; Xie, Ping; Chen, Xiaoguang</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3829-3840</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) represents a novel antitumor target owing to its involvement in vital processes considered hallmarks of cancer phenotypes.  Manassantin A (MA) derived from Saururus cernuus has been reported as a selective HIF-1 inhibitor.  Herein, the structure of MA was optimized to achieve new derivs. with simple chem. properties while retaining its activity.  LXY6090 was designed to replace the central THF moiety of MA with a cyclopentane ring and was identified as a potent HIF-1 inhibitor with an IC50 value of 4.11 nM.  It not only inhibited the activity of HIF-1 in breast cancer cells but also downregulated the protein level of HIF-1α, which depended on von Hippel-Lindau for proteasome degrdn.  The related biol. evaluation showed that the activity of HIF-1 target genes, VEGF and IGF-2, was decreased by LXY6090 in breast cancer cell lines.  LXY6090 presented potent antitumor activity in vitro.  Furthermore, LXY6090 showed in vivo anticancer efficacy by decreasing the HIF-1α expression in nude mice bearing MX-1 tumor xenografts.  In conclusion, our data provide a basis for the future development of the novel compd. LXY6090 as a potential therapeutic agent for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohMbMg-vgShLVg90H21EOLACvtfcHk0liVqJBvuhB-3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFymtb8%253D&md5=d89249dc79aa7bc8f9ce572155e2439c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2147%2FOTT.S106925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S106925%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DLXY6090%2520-%2520a%2520novel%2520manassantin%2520A%2520derivative%2520-%2520limits%2520breast%2520cancer%2520growth%2520through%2520hypoxia-inducible%2520factor-1%2520inhibition%26jtitle%3DOncoTargets%2520Ther.%26date%3D2016%26volume%3D9%26spage%3D3829%26epage%3D3840%26doi%3D10.2147%2FOTT.S106925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00151">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16287"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00151?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00151</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Determination of enantiomeric excess of <b>7</b> and <b>18</b>, body weight, and HPLC traces of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES representations and relative luciferase activity (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_001.pdf">jm0c00151_si_001.pdf (928.84 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00151/suppl_file/jm0c00151_si_002.csv">jm0c00151_si_002.csv (1.49 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00151&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00151%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00151" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a63549c622362","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
